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ABSTRACT 
Cerebral hypoperfusion can occur in normal ageing and is proposed to underlie white 
matter disturbances observed in the ageing brain. Moreover, cerebral hypoperfusion 
and white matter attenuation are early events in the progression of Alzheimer’s 
disease (AD). White matter mostly consists of myelinated axons which have distinct 
protein architecture, segregated into defined regions; the axon initial segment (AIS), 
the node of Ranvier, paranode, juxtaparanode, and internode. These sites are 
essential for action potential initiation and/or propagation and subsequently effective 
brain function. At the outset of the studies in the thesis there was evidence that the 
different regions within the myelinated axons are vulnerable to injury and disease. 
Thus it is hypothesised that in response to normal ageing and/or cerebral 
hypoperfusion these structures are altered and associated with cognitive impairment 
and that these effects are exacerbated in a transgenic mouse model (APPSw,Ind, J9 
line) which develops age-dependent amyloid-β (Αβ) pathology.  
The first study aims to investigate the effect of normal ageing and Aβ deposition on 
myelinated axons and on learning and memory. To address this, the effects of normal 
ageing on the integrity of the AIS, nodes of Ranvier, myelin, axons, synapses and 
spatial working memory are examined in young and aged wild-type and 
TgAPPSw,Ind mice. A significant reduction in the length of nodes of Ranvier is 
demonstrated in aged wild-type and TgAPPSw,Ind mice. In addition, the length of 
AIS, is significantly reduced in the aged wild-type animals while the young 
TgAPPSw,Ind have significantly shorter AIS than the young wild-type mice. These 
effects are not influenced by the presence of Aβ. Myelin integrity is affected by age 
but this is more prominent in the wild-type animals whilst axonal integrity is intact. 
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Moreover, there is an age-related decrease of presynaptic boutons only in the 
TgAPPSw,Ind mice. Contrary to the original hypothesis, working memory 
performance is not altered with age or influenced by increasing Aβ levels.  
The second study aims to examine the effects of cerebral hypoperfusion in 
combination with Αβ pathology and/or ageing on cognitive performance and the 
structure of myelinated axons. To address this, the effects of surgically induced 
cerebral hypoperfusion on the integrity of the nodes of Ranvier, paranodes, myelin, 
axons and spatial working memory performance are investigated in young and aged 
wild-type and TgAPPSw,Ind mice. A decrease in nodal length is observed in 
response to hypoperfusion in young and aged animals. This effect is shown to be 
exacerbated in the young TgAPPSw,Ind animals. Moreover, the disruption of the 
nodal domain is shown to occur without any gross alterations in myelin and axonal 
integrity. It is also demonstrated that in response to hypoperfusion, spatial working 
memory performance is defected in young and aged animals of both genotypes. This 
deficit is exacerbated in the young TgAPPSw,Ind. The observed changes in the nodal 
structure are associated with poor working memory performance indicating 
functional implication for the nodal changes.  
These data highlight that structures within myelinated axons are vulnerable to ageing 
and cerebral hypoperfusion. Therefore, the development of strategies that minimize 
injury or drive repair to these regions is necessary together with therapeutic 
approaches against the vascular insults that induce hypoperfusion and lead to white 
matter attenuation and cognitive decline. In the future, it would be interesting to 
investigate how alterations at the AIS/nodes of Ranvier affect neuronal excitability.  
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1.1 White matter  
Early post-mortem observations of the central nervous system (CNS) introduced the 
concept of white matter and separated it from the grey matter (Meckel, 1817) on the 
basis of their colour difference upon examination with the naked eye 
(macroarchitecture). White matter is present throughout the CNS tissue of vertebrate 
animals. In humans, more than 50% of the total brain volume accounts for white 
matter (Figure 1.1A). This fraction of white matter abundance is by far the greatest 
seen in any species (Fields, 2008). In mice, for example, white matter is only 25% of 
the total brain volume. 
The interest in white matter began in the 19
th
 century. In 1858, Rudolf Virchow 
introduced the concept of neuroglia (Greek γλία,"glue, something sticky") for white 
matter. However, it was only considered to be a type of connective tissue without 
cellular components (Virchow, 1860). Later in the 19
th
 century, Camillo Golgi was 
the first who showed that glia contains cellular components different from the 
nervous cells (Golgi, 1870). In the early 20
th
 century, Santiago Ramon y Cajal and 
his pupil Pío del Río-Hortega described the three major cellular components: the 
astrocytes, the oligodendrocytes and the microglia. Hortega demonstrated the 
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myelinating properties of the oligodendrocytes rendering them the CNS equivalent of 
the Schawnn cell found in the peripheral nervous system (PNS). 
It is now recognised that white matter integrity is essential for normal brain function. 
White matter maintains the communication between the different brain regions and 
disruption to its components could lead to breakdown of the communication between 
the neurons of different brain regions that may ultimately translate into cognitive 
impairment. Alterations to white matter have been implicated in ageing and 
neurodegenerative diseases and associated with cognitive dysfunction. Throughout 
the thesis the integrity of white matter components in response to normal ageing and 
challenges to the brain (low blood flow, amyloid-β) will be closely examined. 
 
1.1.1 Components of white matter 
White matter consists of glial cells, blood vessels and myelinated axons. Axons 
connect neurons residing in different grey matter areas of the CNS and facilitate their 
communication (Figure 1.1B). In the CNS, glial cells are approximately 10 times 
more abundant than the neurons (Coyle and Schwarcz, 2000). Glia include different 
cell types such as astrocytes, microglia and oligodendrocytes.  
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Figure 1.1 White matter and its components. [A] Schematic of a coronal section of 
the human brain showing areas of grey and white matter tissue (Bear et al., 2007). 
[B] White matter consists of blood vessels, astrocytes, microglia, oligodendrocytes 
and axons (image adapted from http://en.wikipedia.org/).  
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1.1.1.1 Astrocytes 
Astrocytes are the most numerous cell types in the CNS and second most abundant in 
white matter. Astrocytes serve multiple roles; their function has been implicated in 
the maintenance of synapses (Allen and Barres, 2005), the homeostasis of 
extracellular ions (Laming et al., 2000), the function of the vasculature (Mulligan and 
MacVicar, 2004), the regulation of signaling (McIver et al., 2013), the trophic 
support of the oligodendrocytes (Paspalas and Papadopoulos, 1998) and the initiation 
of the myelination (Franklin and Ffrench-Constant, 2008).  
 
1.1.1.3 Oligodendrocytes 
The oligodendrocytes are the most prevalent cell type in the white matter. They are 
the cells that produce myelin, a substance comprised of 70% lipids and 30% proteins 
(Raine, 1984). They extend processes that wrap around axons in a process known as 
myelination. The nature of myelination is segmented, with the myelin segments 
being interrupted by gaps of unmyelinated axon known as nodes of Ranvier (Figure 
1.2). One oligodendrocyte may ensheath multiple surrounding axons and different 
segments of myelin on the same axon may originate from different oligodendrocytes. 
Myelination acts as insulation proving higher conduction velocity of the electric 
impulses along the axons. It has been shown that conduction velocity increases up to 
100 times in the myelinated axons in comparison with the unmyelinated ones (Fields, 
2008). The presence of the myelin sheath is advantageous because it offers secure 
 5 
signal transduction between the different brain regions and high speed conduction of 
the electric impulses by saving energy and space (Quarles et al., 2006). 
The myelinating oligodendrocytes originate from oligodendrocyte precursor cells 
(OPCs) and they are the product of a precise developmental program (Bradl and 
Lassmann, 2010). This includes the differentiation of the OPCs to pre-/immature 
oligodendrocytes which then differentiate into mature myelinating oligodendrocytes 
expressing multiple myelin-specific proteins (detailed later in chapter 1.1.2.1). The 
oligodendrocytes insulate the axons with myelin and have multiple other roles. For 
example, they are responsible for the clustering of sodium channels at the nodes of 
Ranvier which is necessary for saltatory conduction (Kaplan et al., 1997; Kaplan et 
al., 2001). In addition, they are necessary for axonal survival (Uschkureit et al., 2000; 
Garbern et al., 2002) and fast axonal transport (Edgar et al., 2004) and they also 
provide trophic support to the neurons with the production of neurotrophic factors 
such as glial cell line-derived neurotrophic factor (GDNF), brain-derived 
neurotrophic factor (BDNF), or insulin-like growth factor-1 (IGF-1) (Du and 
Dreyfus, 2002).  
The formation of the myelin sheath is a long process that proceeds from the caudal to 
the most rostral regions of the brain (Baumann and Pham-Dinh, 2001) and in some 
regions can form even during the sixth decade of life (Benes et al., 1994). However, 
myelination and the support of the myelin sheaths by the oligodendrocytes is 
extremely energy demanding and requires high amounts of oxygen and ATP 
(McTigue and Tripathi, 2008). The high metabolic rate of the oligodendrocytes 
produces toxic hydrogen peroxide and reactive oxygen species that need to be 
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metabolised (McTigue and Tripathi, 2008). In addition, the oligodendrocytes have 
high content in iron and low concentration in the anti-oxidative enzyme glutathione 
(Thorburne and Juurlink, 1996) which combined with the toxic byproducts of the 
metabolism makes them susceptible to oxidative damage.  
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Figure 1.2 The myelinating oligodendrocytes. Oligodendrocytes produce myelin 
and extend processes that wrap around the axon. The nature of myelination is 
segmented, with the myelin segments being interrupted by gaps of unmyelinated 
axon known as nodes of Ranvier (image adapted from http://en.wikipedia.org/).  
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1.1.1.4 Blood vessels 
Blood supply to the white matter is mediated by a vascular network delivering 
oxygen, glucose and nutrients necessary for the cellular metabolism. From the pial 
network running on the surface of the brain, smaller arteries branch out and penetrate 
into the brain tissue (Cipolla, 2009). The penetrating arterioles further branch out at 
different directions going thought the cortex to the sub-cortical white matter. These 
arteries terminate in the capillary bed which is characterised by small branched 
vessels that supply distinct areas of white matter with blood (Lierse and Horstmann, 
1965). This places the white matter at the end of the blood supply route (Pantoni, 
2002) and it may be more vulnerable to cerebral blood flow (CBF) fluctuations 
(Pantoni and Garcia, 1997). This will be outlined in further detail in chapter 1.3.2. 
 
1.1.2 The myelinated axon 
Ramon Y Cajal was the first to introduce the concept of directionality for signal 
transmission and neuronal communication (Llinas, 2003). As mentioned earlier, the 
myelin sheaths insulate the axons and subsequently increase the velocity of the 
electric impulses along the axons by increasing the electrical resistance and 
decreasing the capacitance of the axonal membrane. The electric impulses are called 
action potentials (AP) and result from information processing of excitatory and 
inhibitory signals which converge at the neuron for the generation of an all-or-
nothing response. The segmented nature of myelination allows salutatory conduction 
of the action potentials. Action potential initiation and propagation is mediated by 
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molecular domains of the myelinated axon with unique morphological and functional 
characteristics. These domains are: (1) the axon initial segment (AIS) which is a 
region of unmyelinated axon located close to the soma just before the first myelin 
segment and is where the action potential is generated, (2) the node of Ranvier which 
is a region of unmyelinated axon found between neighbouring myelin segments and 
is rich in voltage-gated sodium (Na
+
) channels, (3) the paranode, the region where 
the myelin loops contact the axonal membrane, (4) the juxtaparanode, a region rich 
in potassium (K
+
) channels and (5) the internode, where the myelin is compactly 
wrapped (Figure 1.3).  
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Figure 1.3 Molecular domains of the myelinated axon. Schematic representation of 
a pyramidal neuron showing the localisation of the axon initial segment (AIS), the 
nodes of Ranvier, the paranodes, the juxtaparanodes and the internodes on the axon. 
Image adapted by Kole and Stuart (2012).  
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1.1.2.1 Myelin specific proteins  
Myelin has a unique composition which facilitates its insulating properties. It has a 
low content of water (40%) and its dry weight is comprised by high content in lipids 
(70-85%) and low content in protein (15-30%) (Quarles et al., 2006). The proteins 
and the lipids are produced by the oligodendrocytes. In the CNS the major protein 
components of myelin are oligodendrocytes-specific and almost 80% of myelin’s 
protein load is comprised by two proteins, the myelin basic protein (MBP) and the 
proteolipid protein (PLP). Other abundant proteins are the 2’,3’- Cyclic Nucleotide 
3’- Phosphodiesterase (CNPase), the myelin associated glycoprotein (MAG) the 
myelin oligodendrocyte glycoptotein (MOG) and the oligodendrocyte-myelin 
glycoprotein (OMgp). 
MBP is a family of membrane proteins located exclusively on the cytoplasmic 
surface. The family includes different isoforms differentially expressed in the various 
stages of oligodendrocyte maturation and their role is to facilitate compaction of the 
appositional cytoplasmic surfaces (Omlin et al., 1982; Roach et al., 1985). In humans 
there are four isoforms of different molecular weight (21.5, 20.2, 18.5 and 17.2kDa), 
with the 18.5 and 17.2kDa isoforms being the most abundant. In mice there are also 
four isoforms (21.5, 18.5, 17 and 14kDa), with the 18.5 and 14kDa being the most 
abundant (Campagnoni and Macklin, 1988; Staugaitis et al., 1990). PLP is a 30 kDa 
transmembrane protein with both the N- and C- terminals at the cytoplasmic side and 
second most abundant myelin protein. Its role is the compaction and stabilization of 
the myelin sheath (Nadon and West, 1998). CNPase is another myelin protein; it can 
be found in two isoforms (CNP1 and CNP2) and has a 2’,3’- Cyclic Nucleotide 3’- 
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Phosphodiesterase enzymatic activity (Lazzarini, 2004). MAG is a 100 kDa protein 
found on the oligodendroglial membranes of the myelin sheath that surround the 
axons and is involved in signalling mechanisms between the oligodendrocytes and 
the axons (Quarles, 2007). Other myelin proteins are MOG, which is a 26 KDa 
protein found on the outer surface of the myelin sheaths, and OMgp which is a 120 
kDa expressed by both oligodendrocytes and neurons (Quarles, 2002). 
 
1.1.2.2 Axonal cytoskeleton 
The axonal cytoskeleton is a three dimensional structure contributing to the structural 
architecture of the axon as well as to axonal transport. It comprises of three different 
filament components namely microtubules, neurofilaments and microfilaments. The 
core structural protein of microtubules is tubulin, which comprise of α- and β- 
tubulin heterodimers which polymerize and align in such way for the formation of a 
25 nm hollow tube. In addition, microtubules interact with multiple microtubule-
associated proteins. Multiple roles have been attributed to microtubules including 
organelle transport, neuritic extension during development and maintenance of 
intracellular compartmentalisation. The second type of filaments, are neurofilaments, 
a rope-like structure of 8-10 nm diameter with projecting side arms. Neurofilaments 
are formed by three subunits; the light (60-70 kDa, NF-L), medium (130-170 kDa, 
NF-M) and heavy (180-200 kDa, NF-H) chain. In addition α-internexin and 
peripherin may interact with neurofilaments. Neurofilaments are important for 
maintaining the morphology of the axons and axonal transport. Alterations in the 
levels and the phosphorylation of neurofilaments have been linked to neurological 
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diseases such as AD, motorneuron disease, Parkinson’s disease and others (Al-
Chalabi and Miller, 2003). Finally, the third type of filaments are microfilaments 
which comprise of polymerized actin (43-kDa). The actin cytoskeleton has multiple 
roles including cell migration and adhesion, distribution of the proteins at the plasma 
membrane and their restriction at respective compartments. 
 
1.1.2.3 Nodes of Ranvier  
Myelin sheaths throughout axons are segmented and interrupted by gaps of 
unmyelinated axon, the nodes of Ranvier, which serve the long distance rapid 
saltatory propagation of the action potentials. Action potentials are all-or-nothing 
responses initiated by the rapid influx of Na
+
 via voltage-gated sodium channels such 
as Nav, Na+/K+ ATPases and Na+/Ca+ antiporters which are accumulated at the 
nodes of Ranvier (Duflocq et al., 2008; Pan et al., 2006). There are different subtypes 
of Nav channels with Nav1.6 being the most abundant in the adult CNS and Nav1.2 
being expressed during development (Boiko et al., 2001; Kaplan et al., 2001). The 
Nav channels are comprised of an α subunit forming a pore through the axolemma 
and two β subunits interacting with cell adhesion molecules, extracellular matrix 
molecules and cytoskeletal scaffolds (Rasband, 2011). Targeting of Nav channels at 
the membrane of the nodes of Ranvier is controlled by the oligodendrocytes and 
includes the formation of a macro-molecular complex of multiple interacting proteins 
such as the cytoskeletal adaptor protein ankyrin G (AnkG), the actin binding protein 
βIV-spectrin, as well as the cell-adhesion molecules neurofascin 186 KDa isoform 
(NF186) and NrCAM (Rasband, 2011) (Figure 1.4A). Clustering of the Nav channels 
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at the nodes of Ranvier appears to be dependent on AnkG (Zhou et al., 1998; Pan et 
al., 2006; Dzhashiashvili et al., 2007). The neuron specific NF186 is responsible for 
AnkG recruitment at the node while AnkG is responsible for βIV-spectrin 
recruitment at the node (Dzhashiashvili et al., 2007; Susuki and Rasband, 2008b; 
Lacas-Gervais et al., 2004). 
 
1.1.2.4 Paranodes 
The paranodes are the principal site of axon-glial contact and serve as a diffusion 
barrier for the ion channels accumulated on either side of the paranode at the nodes 
of Ranvier and the juxtaparanodes (Figure 1.4A). This is achieved by the formation 
of septate-like junctions between the myelin loops of the oligodendrocytes and the 
axon membrane. The septate-like junctions have been thoroughly studied and it has 
been shown that a heterotrimeric molecular complex formed by contactin associated 
protein (Caspr) and contactin located on the axolemma and glial 155 KDa 
neurofascin isoform (NF155), is necessary for the axon-glial interaction. When any 
of the three members of the complex is absent, paranodal disruption and impaired 
signal propagation is observed (Bhat et al., 2001; Boyle et al., 2001; Pillai et al., 
2009; Sherman et al., 2005). Moreover, if the paranodal formation is disrupted, this 
subsequently influences the voltage gated sodium channels clustering at the nodes of 
Ranvier (Rios et al., 2003). It is proposed that Caspr is recruited at the paranodal 
region before myelination at the time of the first axon-glial interaction and Caspr and 
NF155 extracellular interaction is also necessary for Caspr recruitment at the 
paranodes (Eisenbach et al., 2009; Pedraza et al., 2009). Finally, the paranodal 
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complex interacts with the cytoskeletal adaptor protein 4.1B, which can be found in 
paranodes and juxtaparanodes, via the intracellular domain of Caspr. The 4.1B 
protein is in turn linked to the actin cytoskeleton (Denisenko-Nehrbass et al., 2003).   
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Figure 1.4. Protein architecture of molecular domains of the myelinated axon. [A] 
The nodes of Ranvier are populated with voltage gated sodium channels (Nav), they 
are stabilised at the axonal membrane via interaction with NF186, NrCAM and 
AnkG. AnkG is a scaffold protein which binds on βIV spectrin to stabilize the nodal 
complex on the actin cytoskeleton. The paranodes are the principal site of axon-glial 
contact. Contactin, NF155 and Caspr interact to form septate-like junctions between 
the axonal membrane and the paranodal loops. The juxtaparanodes are rich in 
potassium channels (Kv). [B] The AIS is a region of unmyelinated axon located close 
to the soma before the first myelin segment with the nodes of Ranvier. It is rich in 
Nav channels (Nav1.6, 1.2 and 1.1) and in potassium channels. The AIS is also a 
post-synaptic site for axo-axonic synapses and the γ-aminobutyric acid (GABA) 
receptor is expressed at the AIS plasma membrane. Image adapted from Mayer and 
Meinl (2012).   
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1.1.2.5 Juxtaparanodes  
The juxtaparanodes are found adjacent to the paranodes and are characterised by 
accumulation of Shaker-type potassium channels (Kv) on the axonal membrane 
(Figure 1.4A). Their formation is controlled by a diffusion barrier formed by the 
septate-like junctions of the paranodes and the assembly of the juxtapanodal complex 
from axonal and glial interacting proteins that anchors on the cytoskeleton (Susuki 
and Rasband, 2008a). The juxtaparanodal complex is a heterotrimeric complex 
formed by TAG-1 (contactin-2) which is a cell adhesion molecule expressed on glial 
and axonal membranes, Caspr2 which is a second member of the Caspr family and 
the Kv channels (Poliak et al., 1999; Traka et al., 2003). Similar to the paranodal 
complex, Caspr2 of the juxtaparanodal complex interacts with 4.1B that anchors the 
whole complex on the actin cytoskeleton. TAG-1 is essential for juxtaparanodal 
organisation and Kv clustering (Savvaki et al., 2008). 
  
1.1.2.6 Internodes 
The internodes are the part of the myelinated axon found between neighbouring 
nodes of Ranvier and are characterized by compact myelin (Figure 1.4A). Typical 
myelin proteins such as MAG and MOG are expressed on the glial membranes of the 
internodes. MAG is expressed on the glial membrane most proximal to the axon 
while MOG is located on the outmost glial membrane. MBP and PLP are also 
expressed at the internodes. Moreover, the length of internodes is important for the 
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velocity and the configuration of action potential during saltatory conduction (Brill et 
al., 1977). 
 
1.1.2.7 Axon Initial Segment 
The axon initial segment (AIS) is a region of unmyelinated axon located close to the 
neuronal soma before the first myelin segment (Figure 1.4B). It has a role in action 
potential generation, configuration and propagation (Buffington and Rasband, 2011). 
The AIS shares some remarkable similarities in protein architecture with the nodes of 
Ranvier. It is highly rich in voltage-gated sodium channels (Nav), Nav1.6 is the 
abudant type (Caldwell et al., 2000) but Nav1.2 and Nav1.1 can also be found on the 
axonal membrane of the AIS (Buffington and Rasband, 2011). Similar to the nodes 
of Ranvier, during development Nav1.2 is replaced by Nav1.6. However, in the AIS, 
Nav1.2 instead of being completed ablated it is restricted to proximal part of the AIS 
(Boiko et al., 2003; Hu et al., 2009). These channels provide the influx of Na+ 
necessary for action potential initiation (Peles and Salzer, 2000). Nav channels 
together with axon specific proteins NF186 and NrCAM interact with AnkG, the 
cytoskeletal scaffolding protein. AnkG interacts with spectin βIV to provide 
stabilisation to the actin cytoskeleton of the axon (Berghs et al., 2000; Buffington 
and Rasband, 2011). In the AIS, axon-glial interaction is not necessary for Nav 
channel recruitment at the axonal membrane (Bennett and Baines, 2001) which is in 
contrast to the glial-dependent mechanism at nodes. AnkG appears to be essential for 
Nav channel targeting at the AIS and when it is ablated the formation of the AIS 
protein complexes fails (Hedstrom et al., 2008). Moreover, NF186 has been shown to 
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be responsible for AIS maturation leading to the switch from Nav1.2 to Nav1.6 
expression (Buttermore et al., 2012).  
The plasma membrane of the AIS is enriched with potassium channels (Pan et al., 
2006). The Kv1 subtype interacts with Caspr2 at the AIS but the exact mechanism for 
AIS targeting is not known (Horresh et al., 2008; Ogawa et al., 2008; Ogawa et al., 
2010). In contrast, the Kv7 subtype, KCNQ2 and KCNQ3 interact with AnkG which 
targets and stabilises the channels at the AIS plasma membrane (Pan et al., 2006).  
The AIS also acts as a post-synaptic site for what is known as “axo-axonic” synapses 
(Huang et al., 2007). These synapses are implicated in synaptic integration and action 
potential generation. The GABA receptor is expressed on the AIS postsynaptic 
membrane and there is evidence that NF186 modulates the assembly of GABAergic 
synapses (Ango et al., 2004; Burkarth et al., 2007). Moreover, a few studies have 
shown that the AIS structure shows remarkable levels of activity-dependent plasticity 
and has the ability to change its size or location on the axon in response to altered 
electrical activity or synaptic input (Kuba et al., 2010; Grubb and Burrone, 2010a).  
 
1.1.1.2 Microglia  
Microglia are the main immune cells of CNS. Microglial cells are differentiated 
macrophages residing in the brain with an important role in brain injury and 
inflammation. Under normal conditions, in the healthy brain, they can be found in 
their “resting” ramified state, which is characterized by small soma and fine short 
processes and they are constantly surveying their environment. Any type of insult, 
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infection or disease which disrupts or alters brain homeostasis and potentially could 
be a danger to the brain results in what is known as “microglial activation” 
(Kettenmann, 2006). When activated, microglial cells lose their morphological 
complexity acquiring an amoeboid appearance. `Activated microglia are recruited at 
the site of the insult and are implicated with increased proliferation and migration of 
more activated microglial cells to the site of injury, phagocytosis of tissue debris, 
damaged cells or pathogens, release of chemotactic molecules which recruit immune 
cells to the CNS, antigen presentation and regulation of the extent of the immune 
response. In the aged brain as well as in many neurodegenerative diseases such as 
multiple sclerosis, Alzheimer’s disease (AD) and Parkinson’s disease, increased 
microglial activation is a common feature (von Bernhardi et al., 2010; Tambuyzer et 
al., 2009). In AD, in particular, microglial activation is well described and has been 
associated with the deposits of pathological proteins (amyloid-β, Aβ) to the brain 
parenchyma (Wisniewski et al., 1989). 
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1.2 The ageing brain  
Age has been highlighted as the most important risk factor for white matter 
attenuation and cognitive decline in healthy individuals. Studies in healthy 
individuals have suggested that, with ageing, there is a decline of cognitive processes 
such as the recall of verbal information, working memory, short-term recall and the 
speed of processing information (Craik et al., 1994; McDonald-Miszczak et al., 
1995; Petersen et al., 1992; Zelinski and Burnight, 1997). White matter mediates the 
communication of distinct brain regions and its properties that have been described 
earlier confer the speed of processing and conduction of information that is essential 
for higher cognitive functions (Bartzokis et al., 2004). Thus deterioration of myelin 
integrity disrupts signal conduction and communication between the different brain 
regions and subsequently may alter cognitive functions.  
Numerous studies using both histopathological and neuroimaging techniques have 
provided evidence about the nature of changes in white matter integrity that may 
contribute to the decline of the cognitive performance. For example, 
histopathological studies in humans have shown that the length of myelinated axons 
is decreased by approximately 45% between 20 and 80 years of age, reducing by 
10% every decade (Marner et al., 2003). Tang et al. (1997) also observed a 
significant reduction in myelinated fiber length and reported a loss in small caliber 
fiber with age. Other age-related changes in white matter include the decrease in the 
total number of the myelinated fibers (Meier-Ruge et al., 1992; Marner et al., 2003) 
and loss of myelin staining (Kemper, 1994; Lintl and Braak, 1983). There is also 
evidence that late-life myelinated fibers are more sensitive and the first lost in the 
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ageing brain (Bartzokis et al., 2003) In support of this data, detailed electron 
microscopy studies in aged non-human primates have shown the formation of splits 
and cavities (“balloons”) within the lamellae of the myelin sheath (Peters and 
Sethares, 2002; Peters et al., 2000; Feldman and Peters, 1998). In addition, evidence 
from non-human primates studies show a direct association between the percentage 
of fibers with age-related alterations and the level of cognitive impairment (Peters et 
al., 2001). 
There are a few studies in monkeys and rodents showing age-related changes in the 
excitable domains of the myelinated axons. For example, Hinman et al. (2006) 
showed an increased number of axons with the Kv1.2 channel abnormally localized 
within the paranodal region in aged monkeys and rats. Moreover, examination of the 
paranodal region with electron microscopy in aged mice showed paranodal 
disruption as indicated by the pilling of the paranodal loops and loss of transverse 
bands (Shepherd et al., 2012). 
Neuroimaging studies have also provided strong evidence connecting white matter 
alterations and normal ageing. A dominant feature of ageing is the reduction of total 
brain volume which accelerates after 50 years of age (Raz and Rodrigue, 2006). A 
number of studies have shown that white matter loss is more prominent than grey 
matter loss in aged individuals (Allen et al., 2005; Bartzokis et al., 2003; Jernigan et 
al., 2001). In addition, the presence of white matter lesions which appear as areas of 
increased signal (hyperintensities, Figure 1.5) on T2-weighted images of magnetic 
resonance imaging (MRI) scans is a well-established observation in the aged white 
matter. These hyperintensities are present in more than half of the individuals over 
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65 years of age (Enzinger et al., 2006) and their number correlates with the level of 
cognitive decline (Bunce et al., 2007; DeCarli et al., 1995; Hedden et al., 2012). 
Diffusion tensor imaging (DTI) has also been used to examine microstructural 
myelin integrity by measuring fraction anisotropy (FA) which is a measure of the 
anisotropy of diffusion of water in the brain based on its tendency to diffuse along 
the length of the myelinated fibers. FA studies have shown alterations in white 
matter integrity with increasing age in regions of the prefrontal cortex, the striatum 
and the corpus callosum (Gunning-Dixon et al., 2009; Janowsky et al., 1996; Salat et 
al., 2005; Sullivan et al., 2001). Moreover, there is evidence that deterioration of 
white matter integrity examined with DTI is associated with poor cognitive 
performance (Bucur et al., 2008; Deary et al., 2006; Kennedy and Raz, 2009; Jacobs 
et al., 2013; Kerchner et al., 2012; Papp et al., 2013).  
In addition to white matter alterations, the ageing brain is also characterised by a 
decrease in synaptic density which has also been suggested to be a contributing 
factor to age-related cognitive decline (Dickson et al., 1995; Scheff et al., 2006; 
VanGuilder et al., 2011). Synapses form between presynaptic boutons of the axons 
and the post-synaptic dendritic spines. A decrease in synaptic density has been 
observed in the brain of aged humans, primates and rodents (Geinisman et al., 1986; 
Bourgeois and Rakic, 1996; Liu et al., 1996). In addition there is evidence from 
studies in aged rats that the excitatory synaptic transmission changes with ageing 
(Burke and Barnes, 2010). Such alterations in synaptic transmission combined with 
alterations in myelin integrity that is essential for effective signal conduction could 
potentially result in perturbations synaptic plasticity and subsequently long term 
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potentiation (LTP) which is indicative of how the memory mechanisms function 
(Kumar and Foster, 2007).  
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Figure 1.5 White matter hyperintensities. Image of a MRI scan from an 80 year old 
individual, white matter lesions are showing as hypersintensities (asterisks). Image 
reproduced from Debette and Markus (2010).  
* * 
 26 
1.3 Chronic cerebral hypoperfusion  
1.3.1 Cerebral blood flow and metabolism 
Cerebral blood flow (CBF) supplies the brain with glucose and oxygen necessary for 
its function. In humans, almost 80% of cerebral perfusion is supplied by the carotid 
while the two vertebra arteries, which join together to create the basilar artery, 
contribute to the remaining 20%. The brain, which is only 2% of the total body 
weight, receives 15% of the cardiac blood flow output and uses for its normal 
function 20% and 25% of the total body oxygen and glucose respectively (Zauner 
and Muizelaar, 1997). The neurons use almost 75% of the oxygen supply and almost 
80% of the energy produced is used for the maintenance of the ionic gradients 
necessary for action potential generation and propagation (Zauner and Muizelaar, 
1997). Thus, reduction or ablation of CBF may have severe effects on normal brain 
function. 
 
1.3.2 Chronic cerebral hypoperfusion in normal ageing 
Chronic cerebral hypoperfusion, or reductions in CBF, occurs in the normal ageing 
brain CBF is reduced gradually and continuously over time and during the eighth 
decade CBF is 20-25% lower than that of the third decade (Buijs et al., 1998; 
Stoquart-ElSankari et al., 2007). Total blood volume that flows into the brain, as well 
as oxygen consumption reduce by approximately 0.5% every year from the third to 
the eighth decade (Leenders et al., 1990). Morphological alterations in vasculature 
and particularly in the microvasculature have been reported including thickening of 
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the vascular wall, arteriosclerosis, and increase in arteriolar tortuosity, capillary loss 
and lipohyalinosis, (Brown and Thore, 2011; Farkas and Luiten, 2001; Kalaria, 
1996). These types of cerebrovascular pathologies have been linked with CBF 
reduction, impairment of white matter integrity and cognitive decline both in humans 
and in animal models (Appelman et al., 2010; Breteler et al., 1994; Farkas et al., 
2007; Pantoni and Garcia, 1997; Sekhon et al., 1994; Shibata et al., 2004).  
The exact mechanism that links the chronic cerebral hypoperfusion and white matter 
alterations is unclear. In the elderly, as indicated earlier, CBF is approximately 20-
25% lower to that of young individuals (Buijs et al., 1998; Stoquart-ElSankari et al., 
2007). Moreover, the brain regions with lower CBF such as the white matter appear 
to be more vulnerable to CBF fluctuations (Pantoni and Garcia, 1997). A likely 
explanation could be that, as described in chapter 1.1.1.4, white matter is at the end 
of blood supply with each penetrating arteriole providing blood to distinct white 
matter regions. Thus any reduction in CBF cannot be compensated by surrounding 
vessels because it is at a vascular end-zone (Borch et al., 2010; Rowbotham and 
Little, 1965). 
In addition, cerebral hypoperfusion in the human ageing brain may be caused by a 
large variety of vascular risk factors such as hypotension, hypertension, diabetes 
mellitus, atherosclerosis and cardiovascular disease (de la Torre, 2010). This makes 
it difficult to determine the exact cause of cerebral hypoperfusion and white matter 
pathology. Therefore, the development of animal models simulating cerebral chronic 
hypoperfusion alone is highly important because it could possibly unravel the 
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mechanisms by which hypoperfusion affects white matter integrity and cognitive 
performance. 
 
1.3.3 Models of chronic cerebral hypoperfusion 
Investigation, in isolation, of the effects of hypoperfusion on white matter integrity 
and cognition is possible with the development of animal models. The model that is 
used most often is the permanent bilateral common carotid artery occlusion 
(BCCAO) or 2 vessel occlusion (2VO) in the rat. In this model, hypoperfusion is 
induced with a surgical procedure by ligating the two common carotid arteries. 
Shortly after surgery, a significant reduction in CBF is observed which appears to be 
more severe in the cortex and in white matter areas (~35-45% of the baseline) than in 
the hippocampus (~65% of the baseline) (Choy et al., 2006; Ohta et al., 1997; Otori 
et al., 2003; Tomimoto et al., 2003; Tsuchiya et al., 1992). After one week there are 
signs of recovery but the CBF remains significantly lower than the baseline up to 4 
weeks after surgery (Otori et al., 2003; Tomimoto et al., 2003; Tsuchiya et al., 1992). 
Only after 8 weeks or longer is there complete recovery of CBF in some areas and 
signs of vascular remodeling (Choy et al., 2006; Otori et al., 2003).  
Induction of hypoperfusion with 2VO results in neuropathological changes such as 
neuronal cell death, synaptic loss, microglial activation and white matter alterations. 
Increased neuronal cell loss is observed in the hippocampus, particularly in the CA1 
region after one week (Farkas et al., 2006; Schmidt-Kastner et al., 2001), and is 
further increased over time (Farkas et al., 2004; Liu et al., 2006). Synaptic loss has 
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also been reported and associated with cognitive decline (Liu et al., 2005). In 
addition white matter integrity is disrupted after the onset of hypoperfusion. The 
optic tract is particularly sensitive in this model due to its direct supply with blood 
from the internal carotid artery (Ohta et al., 1997; Takizawa et al., 2003; Wakita et 
al., 2002) but the corpus callosum is also affected. A variety of white matter 
pathologies are observed including white matter rarefaction and vacuolation (Ohta et 
al., 1997; Wakita et al., 2002), disruption of the myelin sheaths (Farkas et al., 2004) 
and oligodendroglial and astrocytic cell death (Lee et al., 2006; Tomimoto et al., 
2003). Cognitive testing of the rats showed deficits in spatial and non-spatial 
memory and in anxiety-related tasks after the onset of 2VO (Farkas et al., 2007). 
However, in this model it could not be established whether neuronal cell loss or 
white matter alterations are driving the observed poor cognitive performance in the 
behavioural tests. At the same time in this model the visual system is severely 
compromised that could affect performance in cognitive tests using visual cues 
(Farkas et al., 2007).  
A second model that has been used to investigate the effects of hypoperfusion is a 
model of bilateral common carotid artery stenosis to the Mongolian gerbil. In this 
model, stenosis of arteries is achieved with the surgical application of wire coils 
(microcoils) of known diameter around the common carotid arteries inducing modest 
reduction to the blood flow. Stenosis with a 0.2-0.3 mm diameter microil showed 
grey matter damage as early as one week after the induction of hypoperfusion whilst 
white matter lesions (Hattori et al., 1992) develop after 8 weeks. In addition, after 2 
months of hypoperfusion axonal changes are observed (Kurumatani et al., 1998) 
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whilst impairment in cognitive performance is reported 3 months after the induction 
of hypoperfusion (Kudo et al., 1993).  
In 2004, Shibata et al adapted the bilateral common carotid artery stenosis model to 
the mouse. Application of microcoils with different diameter induces different levels 
of blood flow reduction after surgery. The 0.16 mm diameter microcoil reduces CBF 
to ~50% of the baseline 2 hours after surgery which gradually recovers to ~80% of 
the baseline after 1month. Using the 0.18mm diameter microcoil decreases CBF to 
~70% of the baseline 2 hours after hypoperfusion induction which also recovers to 
nearly 85% after one month.  
The use of the 0.18 mm microcoil in the common carotid artery model results in the 
development of diffuse white matter pathology (Holland et al., 2011; Shibata et al., 
2004). The initial study on this model by Shibata et al. (2004), using the 0.18 mm 
microcoil, reports that some white matter lesions first appear after 14 days in the 
corpus callosum, the caudate and the internal capsule; however, after 30 days from 
the onset of hypoperfusion there is severe white matter pathology in the same 
regions. Moreover, some damage in the optic tract is also observed but there is no 
evidence of any ischemic damage (Shibata et al 2004). In a later study, Shibata et al. 
(2007) show that 8 weeks after the induction of hypoperfusion, the hypoperfused 
animals performed poorly compared to controls in the 8-arm radial arm maze 
paradigm, which tests spatial working memory. In our lab, the 0.18 mm microcoil 
has also been used to investigate the integrity of white matter components (Coltman 
et al., 2011; Reimer et al., 2011) and cognitive performance in response to cerebral 
hypoperfusion (Coltman et al., 2011). For example, Coltman et al. (2011) investigate 
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white matter integrity in parallel with cognitive performance and it is demonstrated 
that in the absence of any grey matter pathology spatial working memory deficits are 
linked with disruption in myelinated fibers detected with antibodies against MAG 
and degraded MBP. However, in other tests of spatial memory such as the spatial 
reference memory in Morris water maze, no defect in the hypoperfused animals is 
observed one month after hypoperfusion (Coltman et al., 2011). In addition, in some 
hypoperfused animals some ischemic neurons are observed (Coltman et al., 2011). 
Moreover, detailed investigation of the myelinated axons showed that the nodes of 
Ranvier and the paranodes are vulnerable to the effects of hypoperfusion (Reimer et 
al., 2011). For example, as early as three days from the induction of hypoperfusion 
the length of Nav1.6 positive nodes of Ranvier was increased, an effect that persisted 
at one month. Moreover, investigation of paranodal integrity showed a loss of the 
paranodal NF155 from the paranodal region as early as 3 days after hypoperfusion 
whilst examination of the paranodal region with electron microscopy showed loss of 
the paranodal septate-like junctions after one month from the induction of 
hypoperfusion (Reimer et al., 2011).  
The common carotid artery stenosis mouse model is a very good tool for 
investigating the effects of hypoperfusion on white matter. It is well described that 
bilateral carotid stenosis (using microcoils of 0.18 mm diameter) induces diffuse 
white matter alterations which in turn are associated with specific cognitive 
impairment. Moreover, it can be useful for studying mechanisms implicated in AD 
since cerebral hypoperfusion is known to be an early feature of AD occurring prior to 
the onset of clinical symptoms (described in detail in chapter 1.4.4). This model will 
 32 
be used in the thesis to study the effects of hypoperfusion on myelinated axon 
integrity and cognition in a mouse model of AD (Chapter 4).   
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1.4 Alzheimer’s disease 
Alzheimer’s disease (AD) is a highly heterogeneous and multifactorial 
neurodegenerative disorder characterized by progressive cognitive decline 
accounting for 50-75% of dementia cases worldwide. It is estimated that there are 36 
million patients worldwide. Over the next decades this figure is estimated to rise to 
66 million by year 2030 and 115 million by 2050 (World Alzheimer Reports 2010, 
http://www.alz.co.uk). In the United Kingdom the number of AD patients is 
estimated at 800,000 and expected to rise to 1 million by 2021 
(http://www.alzheimers.org.uk). AD comes third, after cardiovascular disease and 
depression, in the healthcare costs worldwide. In 2012, dementia related costs 
accumulated to £23 billion in the UK.  
 
1.4.1 Pathology of Alzheimer’s disease 
AD was named after the German psychiatrist and neuropathologist Alois Alzheimer 
who was the first to describe the clinical and pathological symptoms of the disease in 
1907 (Alzheimer, 1907). AD is characterized by the progressive deterioration of 
cognitive functions, the accumulation of β-amyloid (Aβ) in extracellular insoluble 
neuritic plaques and blood vessels, and the formation of intraneuronal neurofibrillary 
tangles (NFT) containing hyperphosphorylated tau protein. There is evidence that Αβ 
deposits (plaques) and NTF are present in the brain even at the early pre-clinical 
stages of the disease (Braak and Braak, 1997). The brain areas mostly affected are 
the cortex, hippocampus, entorhinal cortex and amygdala (Wenk, 2003) known to 
have an important role in higher cognitive functions such as learning and memory. 
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Severe brain atrophy and neuronal loss are also observed (Castellani et al., 2010). 
Definite diagnosis for AD can only be done post-mortem with the detection of Aβ 
plaques and NFT in the brain of the patients. However, the recently developed 
methods for in vivo imaging of Aβ are promising for the development of a tool to aid 
AD diagnosis (McKhann et al., 2011; Morris et al., 2009; Roe et al., 2013).  
The reason for the development of AD remains unknown. However, there is a very 
small proportion (~1%) of familial AD cases (Hardy, 2009), early-onset, that can be 
attributed to the presence of dominant hereditary genetic mutations. These mutations 
are located at genes responsible for amyloid precursor protein (APP) or presenilins 1 
(PS1) and presenilin 2 (PS2) which are components of the γ-secretase enzymatic 
complex (Seiffert et al., 2000). So far more than 20 mutations in the APP gene and 
approximately 200 mutations in the presenilin genes have been identified (Kitazawa 
et al., 2012). These genes encode for proteins responsible for Αβ generation and 
affect Αβ production by increasing the levels of total Αβ or of specific Αβ species 
(Aβ40 and Aβ42) altering the ratio of Αβ42 to Aβ40 (Chartier-Harlin et al., 1991; 
Chui et al., 1999; Mullan et al., 1992). For the rest of late-onset or sporadic AD 
cases, there are numerous epidemiological studies highlighting a variety of risk 
factors. Age has been one of the most prominent factors as the prevalence of AD is 
doubled every 5 years after the age of 60 (Jorm et al., 1987).  
Amyloid-β deposition is a pathophysiological hallmark of AD. Aβ is a 4 kDa peptide 
(Glenner et al., 1984), 39-43 amino acids in length, which derives from the abnormal 
processing of APP. APP is a transmembrane protein expressed in abundance in the 
human brain. Its normal function has not yet been fully defined, however it has been 
reported that APP is implicated in synaptic transmission, axonal transport, cell 
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adhesion, cholesterol metabolism (Turner et al., 2003; Zheng and Koo, 2006). APP is 
proteolyticaly processed by at least 3 different proteases namely α-, β- and γ-
secretases via two different pathways; the non-amyloidogenic and the amyloidogenic 
which leads to the generation of Aβ protein (Nunan and Small, 2000) (Figure 1.6A). 
In the non-amyloidogenic pathway, APP is initially cleaved by α-secretase inside β-
amyloid domain producing a large soluble N-terminal fragment (sAPP-α), believed 
to be neuroprotective (Furukawa et al., 1996), and C-terminal fragment (C83). The 
C83 fragment is subsequently cleaved by the γ-secretase enzymatic complex 
producing a 3 KDa fragment known as p3 (Cole and Vassar, 2007). During the 
amyloidogenic pathway APP is processed by β-secretase (β-amyloid cleaving 
enzyme, BACE) for the generation of a secreted sAPP-β fragment and a C-terminal 
(C99) fragment which remains anchored on the plasma membrane. The C99 
fragment is subsequently cleaved by the γ-secretase enzymatic complex producing 
the Aβ peptides (Nunan and Small, 2000). The main products from amyloidogenic 
processing of APP are the 40 amino acids long Aβ40 and the 42 amino acids long 
Aβ42. In the early-onset AD the genetic mutations in APP, PS1 or PS2 genes 
dramatically increase Aβ42 production which highlights the key role of Aβ in the 
pathogenesis of AD. Aβ peptides are prone to polymerarization and form fibrils 
(Figure 1.6B) that aggregate in the vessels (cerebral amyloid angiopathy, CAA) or 
extracellularly in the brain forming Aβ plaques. Αβ42 is more hydrophobic and 
likely to form insoluble fibrils and is found in the extracellular plaques whilst Aβ40 
is primarily found in vasculature and associated with CAA (Jarrett et al., 1993).  
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Figure 1.6 Processing of APP and Aβ polymerization. [A] APP is proteolytically 
processed by α-, β- and γ-secretases via two different pathways; the non-
amyloidogenic and the amyloidogenic with leads to the generation of Aβ protein. [B] 
Aβ is prone to polymerization; it forms oligomers, then protofibrils and then fibrils 
that aggregate to form Aβ deposits.  
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The discovery the Aβ peptide which is the primary component of the amyloid 
plaques, a pathological feature of AD, together with the identification of the 
mutations in the APP gene responsible for early-onset AD lead to the hypothesis that 
Aβ deposition, which is an early event in AD, is the cause of AD pathology and all 
the other pathologies (NFT, neuronal loss and dementia) observed are driven by Aβ 
production and imbalanced clearance (Hardy and Selkoe, 2002; Hardy and Higgins, 
1992). This is now known as the amyloid cascade hypothesis. 
In support of the amyloid cascade hypothesis there is evidence for the neurotoxic 
properties of Αβ. The soluble oligomeric forms of Aβ have been shown to be highly 
neurotoxic compared to the insoluble Αβ species (Lesne et al., 2006; Shankar et al., 
2008) and proposed to damage synapses (Lambert et al., 1998). Moreover, the 
oligomeric Aβ levels and not the total burden of amyloid plaques correlate with 
cognitive deficits (LaFerla et al., 2007; Giannakopoulos et al., 2003) while the Aβ42 
type is suspected to be more toxic than the Aβ40 (Findeis, 2007). However, in 
contrast to what was predicted by the amyloid hypothesis, in clinical trials of 
immunization against Aβ, despite removing the Aβ plaques no concomitant 
improvement in AD symptoms was observed (Holmes et al., 2008). Additionally, 
there is evidence of amyloid plaque deposition in the brains of healthy non-demented 
individuals (Becker et al., 2011). The amyloid cascade hypothesis however does not 
give a satisfactory explanation for the early-events in AD progression occurring prior 
to Aβ deposition which may trigger Aβ pathology. Therefore, in an effort to 
formulate a hypothesis that better accounts for the data in AD research, Hardy (2009) 
updated the amyloid hypothesis by introducing the concept of vascular damage as a 
 38 
contributing factor in AD neurodegeneration which may both induce Aβ damage or 
be the result of Aβ deposition.   
 
1.4.2 Risk factors for the development of Alzheimer’s disease 
Over the last decades several risk factors have been highlighted to play a role in the 
development of sporadic AD. Age is shown to be the single most important risk 
factor for the development of AD (Bartzokis, 2004). It appears that the incidence rate 
of AD is lower than 1% at the age of 65 years whereas it rises to over 25% at the age 
of 85 years (Breteler, 2000). Other factors associated with the development of AD 
include traumatic brain injury (Heyman et al., 1984), and vascular risk factors such 
as diabetes mellitus, cerebral ischemia, atherosclerosis, arteriosclerosis, 
hypertension, hypercholesterolemia, cardiovascular disease and cerebrovascular 
disease (de la Torre, 2010).  
In addition, the APOEε4 allele was the first genetic variation found to influence the 
risk for AD development; with abundance rate in the general population around 14% 
APOEε4 increases the risk for AD 3-4 times in the heterozygous carriers 
(APOEε2/ε4 or APOEε3/ε4) and more than 10 times in the homozygous (Farrer et 
al., 1997). Over the last years more genes associated with sporadic AD have been 
highlighted including genes encoding for sortilin-related receptor 1 (SORL1) 
(Rogaeva et al., 2007), clusterin (CLU) (Harold et al., 2009; Lambert et al., 2009), 
phosphatidylinositol-binding clathrin assembly protein gene (PICALM) (Harold et 
al., 2009; Lambert et al., 2009), triggering receptor expressed on myeloid cells 2 
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protein (TREM2) (Guerreiro et al., 2013), bridging Integrator 1 BIN1 (Seshadri et 
al., 2010), protein phosphatase 1, regulatory subunit 3B PPP1R3B (Kamboh et al., 
2012), complement receptor 1 (CR1) ATP-binding cassette sub-family A, member 7 
(ABCA7), membrane-spanning 4 subfamily A (MS4A4E/MS4A6E), ephrin receptor 
A1 (EPHA1), CD33 and CD2-associated protein (CD2AP) (Hollingworth et al., 
2012). Thus a number of genes have now been identified that can modify risk of 
development of AD. 
The numerous risk factors for AD indicate that it is a highly complicated disease 
affecting an increasing number of individuals. Therefore, the development over 
almost the last 20 years of multiple mouse models featuring aspects of AD-related 
pathologies has been helpful in the investigation of how these may affect brain 
function and has increased the understanding of the mechanisms underlying the 
disease.  
 
1.4.3 Models of Alzheimer’s disease  
The identification of specific genetic mutations responsible for early-onset familial 
AD was crucial for the generation of transgenic AD mouse models. Mice do not 
naturally develop age-related Αβ aggregation and deposition possibly because the 
mouse APP protein differs from human APP by three amino acids (De Strooper et 
al., 1995). Therefore, the most popular strategy for transgenic AD mouse models 
generation is the overexpression of one or more familial AD associated mutated 
genes.  
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So far more than 50 different transgenic models have been described, overexpressing 
human wild-type or mutant APP (www.alzforum.org/res/com/tra/app/default.asp). 
Introducing one or more human APP mutations into the mouse genome usually 
results in the recapitulation of some features of AD pathology such as age dependent 
Aβ deposition and cognitive decline. Other pathophysiological features of AD 
observed in the mouse models include astrocytic reactivity, microglial activation, 
dystrophic neurons, synaptic loss and disrupted electrophysiology, however just the 
expression of mutated APP alone does not appear to induce the NFT pathology or 
severe neuronal loss observed in AD (Borchelt et al., 1996; Games et al., 1995; 
Hsiao et al., 1996; Mucke et al., 2000; Sturchler-Pierrat et al., 1997; Kitazawa et al., 
2012). 
The extent and the age of onset of Aβ pathology is related to the type of mutations 
expressed and the type of promoters used to drive transgene expression. The first 
model that was developed was the PDAPP, which expresses the human Indiana 
nutation (APPInd, V717F) driven by the platelet derived growth factor (PDGF) 
promoter. Aβ pathology is first observed at 6-9 months of age and is further 
progressed with advancing age (Games et al., 1995). Astrocytic reactivity is also 
observed adjacent to the Αβ deposits together with synaptic loss (Games et al., 
1995). Some studies report a 12-30% decrease in the volume of the hippocampus and 
the dentate gyrus (Redwine et al., 2003; Wu et al., 2004a). Cognitive performance is 
affected in PDAPP mice as young as 3 months old; they have impaired recognition 
and episodic memory that further deteriorates with age (Chen et al., 2000; Dodart et 
al., 1999). Moreover, incorporation of the same APP mutant transgene in another 
model (H6) was accompanied with hippocampal synaptic loss and neurodegeneration 
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which was not associated with Αβ deposition in the brain suggesting that soluble Αβ 
may lead to neurodegeneration (Hsia et al., 1999).  
An APP mutation that has been broadly used in AD mouse models is the Swedish 
double mutation (K670N/M671L, APPSwe). A popular model is the Tg2576 mouse 
that expresses the APPSwe mutation under the control of hamster prion promoter 
that drives expression at the spinal cord and areas of the forebrain (Hsiao et al., 
1996). This transgenic mouse model develops dense Aβ plaques at 10-12 months of 
age. Cognitive deficits however, are reported as early as six months of age prior to 
any Aβ plaque pathology implicating oligomeric Aβ-mediated toxicity (Alpar et al., 
2006). Other AD-related pathological features observed in this model are synaptic 
loss at the entorhinal cortex as well as dendritic spine loss (Dong et al., 2007). 
However, no significant loss of neurons was reported in the Αβ affected areas in the 
Tg2576 model (Irizarry et al., 1997). A second model that expresses the APPSwe 
mutation but under the control of a different promoter (Thy-1.2) is the APP23. In this 
model, Aβ plaques are reported at the age 6 months and are exacerbated with age. 
Moreover, there is extensive activation of microglia adjacent to the Aβ plaques and 
evidence of phosphorylated tau (Sturchler-Pierrat et al., 1997). Hippocampal 
neuronal loss is also observed at 14-18 months old animals particularly at the CA1 
area (Calhoun et al., 1998).  
Studies of mouse models that express single APP mutations indicate that the 
temporal and regional profile of the development of Αβ pathology and the 
development of cognitive deficits or other AD-related pathologies is dependant on 
the mutation that is expressed. For that reason, a strategy that is used for the 
development of AD models is the introduction of more than one APP mutation in a 
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single APP transgene in an effort to accelerate Aβ pathology. For instance, there are 
two lines (J20 and J9 line) with the Swedish and the Indiana mutation incorporated 
on the same APP transgene (APPSw,Ind) under the PDGF promoter. However, the 
relative levels of the APPSw,Ind transgene expression in the J9 line is almost half of 
that of the J20 line animals (Mucke et al., 2000). The temporal profile and the 
severity of Aβ pathology are different as well. For example both lines develop Aβ 
deposition by 5-7 months of age, in the J20 line, however, there is rapid Aβ 
pathology up to 8-10 months of age while in the J9 line Aβ deposition is a slower 
process that continues up to 21-25 months of age (Mucke et al., 2000). In addition, 
comparison between J9 and J20 animals of the same age shows more severe Αβ 
pathology in the J20 animals (Mucke et al., 2000). Interestingly, the synaptic loss is 
observed in both lines by 2-4 months of age before any Aβ deposition, which 
correlates with Αβ levels but not with the Αβ plaque load (Mucke et al., 2000). 
Additionally, in both lines impaired synaptic transmission is observed by 2-4 months 
of age (Harris et al., 2010; Hsia et al., 1999) and long-term potentiation (LTP) 
deficits are observed in animals from 2-22 months of age (Dziewczapolski et al., 
2009; Harris et al., 2010). Behavioural deficits have also been described in these two 
lines. J9 mice perform poorly in tasks testing spatial learning and memory (Raber et 
al., 2000; Dziewczapolski et al., 2009) as early as 6 months on age (Raber et al., 
2000) whereas the J20 mice are reported to have impaired cognitive performance in 
spatial and non-spatial learning and memory and anxiety-related tasks by 2-3 months 
of age (Harris et al., 2010). 
Moreover, introduction to the mouse genome of multiple transgenes alters the 
temporal and regional profile of Aβ pathology. For example expression of both 
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mutant presenilin and mutant APP transgenes accelerates Aβ deposition and 
cognitive impairment in comparison with lines expressing a single APP mutant 
transgene (Borchelt et al., 1997). In addition, expression of mutant presenilin 
transgene alone results in high levels of Aβ42 (Duff et al., 1996). 
One pathological hallmark of AD that the APP and/or presenilin transgenic mouse 
models do not develop is the neurofibrillary tangles (NFT). Moreover, there are not 
any AD-related mutations in tau therefore in order to develop mouse models with tau 
pathology it was necessary to use transgenes that drive the expression of human 
mutant tau (P301L) responsible for frontotemporal dementia and Parkinsonism 
(Hutton et al., 1998). Overexpression of human mutant tau (P301L) in mice results in 
widespread tau pathology in the brain, neuronal loss, cognitive impairment and 
motor deficits (Lewis et al., 2000). In an effort to model both Aβ and NFT pathology 
observed in AD, the 3xTg-AD mouse model that expresses mutant APP (APPSwe), 
presenilin 1 (M146V) and tau (P301L) was developed (Oddo et al., 2003). In this, Aβ 
pathology in the form of intracellular deposits is observed at 3 months whilst Aβ 
plaques are reported at 6 months. NTFs are observed at 12 months of age. Moreover, 
synaptic transmission and LTP impairment is observed at 6 months (Oddo et al., 
2003). Cognition is also impaired in the 3xTg-AD mice and is reported as a 
deterioration of long-term retention at 4 months (Billings et al., 2005).  
The AD transgenic models have uncovered key mechanisms underlying AD 
neuropathology. There are, however, fundamental differences between human AD 
and how features of AD are recapitulated in mouse models that highlight the need for 
careful interpretation of the acquired data. For example, the mutations expressed in 
the AD models are associated with early onset familial AD that accounts for only a 
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small proportion of AD patients. Moreover, in contrast with humans, the appearance 
of Αβ deposition in the majority of AD models normally requires higher levels of 
APP expression. A possible explanation is that in humans the AD pathology 
develops over decades and in the mouse models this pathology is concentrated in the 
shorter life span of the mice. There are however some species such as the rhesus 
macaque, the cat and the dog that normally develop age related Αβ pathology and 
cognitive impairment (Gunn-Moore et al., 2007; Head, 2011; Ichinohe et al., 2009). 
Despite the fact that the pathology in these models has similarities with sporadic AD, 
the time needed for the appearance of the pathology, the ethical implications and the 
high cost are restrictive factors for their broader use. Thus mice are the most 
common model of choice for investigating AD due to ease of manipulation and 
maintenance, low cost and a short breeding cycle. 
 
1.4.4 Cerebral hypoperfusion and Alzheimer’s disease  
Regional reductions in cerebral blood flow are a feature of AD which can be 
observed from early preclinical stages of the disease and persist over disease 
progression (de la Torre, 2009). Early studies investigating cerebral blood flow in 
AD patients using inhalation or intravenous injection of a radioactive tracer e.g. 
133
Xenon and computed tomography (CT), single photon emission computed 
tomography (SPECT) or 2-deoxy-2-[F-18]fluoro-D-glucose (FDG-PET) imaging 
highlighted that CBF is significantly decreased in the temporoparietal cortex of AD 
patients compared to age-matched healthy individuals(Komatani et al., 1988). These 
findings have been further confirmed by more sophisticated and higher resolution 
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perfusion weighted magnetic resonance imaging (PW-MRI) techniques such as 
arterial spin labeling (ASL) MRI. It was shown using ASL-MRI that there is a ~40% 
overall reduction in CBF in the AD patients compared to age-matched healthy 
individuals (Asllani et al., 2008), there are, however, some specific regional patterns 
with regions such as the posterior cingulate and the lateral parietal cortex 
consistently affected (Austin et al., 2011). Moreover, the level of CBF reduction has 
been associated with the severity of cognitive impairment (Roher et al., 2012). 
Studies investigating blood perfusion in healthy ageing, AD, and mild cognitive 
impairment (MCI) which is considered to be a prodromal state of AD have shown 
that in both AD and MCI the CBF is significantly reduced compared to the healthy 
aged individuals but exacerbated in AD compared to MCI cases (Rombouts et al., 
2005). In addition, functional MRI (fMRI) studies have been a useful tool 
investigating functional connectivity namely the interregional synchronization of 
blood flow fluctuations (increases or decreases) in response to neuronal activity. 
These studies have shown that functional connectivity is disrupted in AD and 
progressively deteriorates in parallel with disease pathology (Zhang et al., 2010b). 
Moreover, during episodic memory and working memory tests, blood flow 
fluctuations in the MCI and AD patients is reduced in comparison with the healthy 
individuals. They are, however, more prominent in the AD cases (Rombouts et al., 
2005). These findings imply that CBF reduction is an early event in disease 
progression. 
Cerebrovascular pathology, observed in up to 90% of AD patients, has been 
proposed to underlie CBF reductions. This is suggested to result in energy, oxygen 
and nutrient deficiency in the brain while promoting disease progression and occurs 
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even prior to any overt neuronal of cognitive damage (Jellinger, 2002; de la Torre, 
2002). Cerebrovascular pathologies linked with AD include CAA, microvascular and 
blood-brain barrier (BBB) disruption, microinfarctions, cerebral hemorrhages and 
other vascular lesions (Jellinger, 2010). In addition, studies in animal models have 
linked cerebrovascular dysfunction with BBB dysfunction which is suggested to 
impair clearance of Aβ from the brain and promote accumulation in the brain and/or 
the blood vessels (Deane et al., 2008; Deane et al., 2004; Eisele et al., 2010; Zlokovic 
et al., 2010; Zlokovic, 2005). Increasing Aβ levels further may impede 
cerebrovascular integrity (Bell et al., 2009; Deane et al., 2004). CAA is observed in 
more than 80% of AD patients (Jellinger, 2010; Bell and Zlokovic, 2009) and is 
linked with microvascular damage (Kalaria, 2002). SPECT imaging has shown that 
CBF is significantly reduced in AD patients in regions where CAA pathology is 
observed (Chung et al., 2009). In addition, CAA pathology increases the risk of 
cerebral haemorrhages while the prevalence of vascular lesions is associated with the 
CAA (Olichney et al., 1997) and cognitive impairment (Cordonnier, 2011).  
The use of animal models has been helpful in further understanding the relationship 
between the cerebral hypoperfusion and vascular disturbances with AD-related 
pathology. For example, it was demonstrated that Aβ40 has vasoconstrictive 
properties and induced endothelial cell damage by excess production of free radicals 
(Thomas et al., 1996). Moreover, Niwa et al. (2002b) showed that in a transgenic 
model that develops aspects of AD (Tg2576) CBF and glucose utilization is reduced 
prior to the development of Αβ deposits. This is further confirmed by several studies 
in multiple APP mutant mice that have shown regional or full-brain decreases in 
blood flow (Hebert et al., 2013; Weidensteiner et al., 2009; Badea et al., 2010; 
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Delatour et al., 2006; Wu et al., 2004b) It has also been demonstrated that vascular 
dilatory responses (Iadecola et al., 1999; Park et al., 2004) and vascular 
autoregulation which is the ability to control CBF, is impaired in APP mutant mice 
(Iadecola et al., 1999; Niwa et al., 2002a; Niwa et al., 2000). Moreover, there is 
evidence that surgically induced hypoperfusion in APP mutant mice may increase Aβ 
levels (Kitaguchi et al., 2009; Yamada et al., 2011; Koike et al., 2010). 
 
1.4.5 White matter alterations and Alzheimer’s disease 
In addition to the alterations in CBF, a large number of studies has highlighted the 
involvement of white matter pathology in the development of AD (Brun and 
Englund, 1986b; Englund et al., 1988; Bartzokis et al., 2000; Braak et al., 2000; 
Bartzokis et al., 2003). Alterations in white matter integrity are observed early in 
disease development even before any clinical symptoms (Bartzokis et al., 2003; 
Douaud et al., 2013; Stokin et al., 2005) and studies in both humans and animal 
models have indicated that they could occur prior to any Αβ or NFT pathology 
(Desai et al., 2010; Desai et al., 2009; deToledo-Morrell et al., 2007; Redwine et al., 
2003; Stokin et al., 2005). Post-mortem examination of AD brains has shown that in 
~65% of the cases white matter pathology in combination with AD pathology is 
observed (Roher et al., 2002). 
White matter pathology that has been described in post-mortem brains of AD patients 
includes myelin damage, astrogliosis, microglial activation, axonal loss and 
reduction in the number of oligodendrocytes (Brun and Englund, 1986a; Brun and 
Englund, 1986b; Brun and Englund, 1981; Englund et al., 1988). In addition, 
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multiple MRI studies have provided evidence of changes in white matter volume 
(Balthazar et al., 2009; Li et al., 2008) and white matter hyperintensities (Gouw et 
al., 2008; Yoshita et al., 2006) in AD and during the progression of the disease. As 
described in chapter 1.2.1 alterations in white matter integrity can be observed in 
healthy aged individuals and there is evidence that white matter hyperintensities 
detected with MRI (T2 weighted) can be detected even 10 years before MCI (Silbert 
et al., 2012). MCI is considered to be prodromal to AD (Lonie et al., 2010) with 10% 
of MCI patients progressing to AD every year (Petersen, 2004). DTI studies have 
shown that in comparison with non-demented age-matched individuals, white matter 
integrity is compromised in MCI but this occurs to a greater extent in the brain of 
AD (O'Dwyer et al., 2011; Bosch et al., 2012). This finding suggests that there is a 
relationship between white matter integrity and cognitive performance (Douaud et 
al., 2013; Zhang et al., 2013). Regions that are affected in AD are located in both the 
posterior and anterior cerebral white matter (Chen et al., 2009; Mielke et al., 2009) 
whilst regions which are myelinated later in life appear to be more susceptible to 
myelin break-down (Bartzokis et al., 2004).  
Although there is compelling evidence supporting white matter alterations in AD, 
studies in APP mutant mouse models have provided information about the nature of 
these alterations and which components of white matter are particularly vulnerable. 
For example, Desai et al. (2009) showed, in the 3xTg-AD mice, myelin disruption 
and decrease in the expression of myelin marker such as MBP and CNPase in the 
hippocampus and entorhinal cortex before the onset of Αβ or NFT pathology. In 
addition, impairment in the expression of Nav1.6 channels, loss of oligodendrocytes 
and changes in axonal morphology is reported (Desai et al., 2010; Desai et al., 2009). 
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Similarly, in another AD mouse model (APP/PS1) axonopathy, that develops in an 
age-related manner (Wirths et al., 2007), and fibre tract atrophy (Chen et al., 2011; 
Delatour et al., 2006) have been reported. Neuroimaging studies using DTI in mice 
expressing APP transgene have shown axonal and myelin damage (Song et al, 2004; 
Sun et al, 2005). 
White matter alterations are considered to be linked with cerebrovascular pathology 
(Pantoni, 2002) which is driven by the deterioration in vascular integrity and 
disruption of BBB (Young et al., 2008). Therefore it is not surprising that white 
matter alterations have been linked with hypoperfusion (Fernando et al., 2006; 
Ruitenberg et al., 2005). For example, Fernando et al. (2006) showed in post-mortem 
tissue that at regions of white matter damage, identified as hyperintensities on MRI, 
the vascular morphology is altered and markers of ischemia are expressed which 
suggests that hypoperfusion may underlie the observed white matter alterations. In 
addition, Farkas and Luiten (2001) showed in patients with MCI that white matter 
damage and reductions in CBF coexist before the development of AD. Furthermore, 
evidence from animal models (described in chapter 1.3.3) suggest that cerebral 
hypoperfusion induces selective white matter damage that may be associated with 
cognitive impairment (Coltman et al., 2011; Holland et al., 2011; Shibata et al., 2004; 
Shibata et al., 2007).  
Although white matter damage occurs in both normal ageing and AD, the reason for 
which it is exacerbated in AD is not clear. There is some evidence that the Aβ 
oligomers are toxic to myelin and the oligodendrocytes (Torp et al., 2000; Xu et al., 
2001). In addition, Aβ may promote oligodendroglial cell death by inducing of 
oxidative stress and mitochondrial dysfunction (Castellani et al., 2002; Juurlink et al., 
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1998; Schapira, 1996; Dragicevic et al., 2010). However, Bartzokis (2011) suggested 
that white matter attenuation is a primary event in AD development and suggests that 
ageing disrupts the homeostasis of oligodendrocytes resulting in a failure of repair 
mechanisms, Aβ deposition and subsequent signal transduction failure and cognition 
impairment. Although the myelin model explains some features of AD, this needs 
further validation by studies in animal models.  
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1.5 Hypotheses and aims of the thesis  
The general aim of the thesis is to investigate the structure of myelinated axons and 
in particular their excitable regions (nodes of Ranvier, axon initial segment) and their 
susceptibility to the effects of normal ageing, cerebral hypoperfusion and increasing 
levels of Aβ.  
It was hypothesized that the AIS and nodes of Ranvier would be altered in ageing 
and that these effects would be exacerbated in the presence of increased levels of Aβ 
and that would be associated with impairment in learning and memory. Additionally 
it was hypothesised that altered synaptic input would play a role in AIS alterations 
given its activity-dependent plasticity. To address this, the effects of normal ageing 
on the integrity of the AIS, nodes of Ranvier, myelin, axons and synapses as well as 
on spatial working memory were examined in young and aged wild-type and 
TgAPPSw,Ind mice (Chapter 3). 
In addition, it was hypothesised that the integrity of the nodes of Ranvier and the 
paranodes would be altered in response to hypoperfusion and that these effects would 
be exacerbated in the presence of increased levels of Aβ and associated with working 
memory deficits in young and aged mice. To address this, the effects of cerebral 
hypoperfusion on the integrity of the nodes of Ranvier, paranodes, myelin and axons 
and on spatial working memory performance was investigated in young and aged 




2 Materials and Methods 
2.1 Animals 
All animals in the studies described in the present thesis were housed at 22°C with 
12h light/dark intervals. Food and water were freely available throughout the 
duration of the experiments except during testing at the radial arm maze where food 
intake and body weight of the animals was closely monitored. All experiments were 
carried out under the appropriate personal and project UK Home Office licenses and 
in accordance with the Animals (Scientific Procedures) Act (1986). 
The effects of ageing and hypoperfusion on white matter in relation to Alzheimer’s 
disease were investigated in a transgenic mouse model harbouring the familial 
Alzheimer’s disease linked mutations K670N/M671L and V717F (APPSw,Ind; J9a 
line) where expression of the transgene is regulated by the platelet-derived growth 
factor (PDGF) promoter. As described by Hsia et al. (1999) the line was originally 
derived by microinjection of the PDGF-APPSw,Ind transgene into (C57BL/6 × 
DBA/2) F2 single-cell embryos. The line was obtained via Professor L. Mucke at 
Gladstone Institute and bred in house at the University of Edinburgh. Maintenance of 
the line was achieved by crossing heterozygous TgAPPSw,Ind transgenic animals 
with non-transgenic (C57Bl/6J, Charles River, UK) resulting in the generation of 
TgAPPSw,Ind mice heterozygous for the APP transgene and wild-type littermates.  
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2.2 Chronic cerebral hypoperfusion surgery 
The induction of chronic cerebral hypoperfusion was performed as previously 
described (Shibata et al., 2004); surgeries were undertaken by Dr. Catherine Gliddon 
or Dr. Philip Holland. Animals were initially anaesthetized in a perspex box with 5% 
isoflurane. They were then transferred to a face mask and maintained under 
anaesthesia with 1.5% isoflurane. After a midline cervical incision, the common 
carotid arteries (CCA) were exposed and 0.18 mm diameter microcoils (Sawane 
Spring Co., Hamamatsu, Japan) were applied to each CCA. Between the application 
of the first and the second microcoil there was a 30 min interval. In the sham animals 
the same surgical procedure as in the hypoperfused was followed with the exception 
of microcoil application. Core body temperature was maintained at 37˚C. Finally, the 
cervical incision was closed with sutures. Following surgery the animals were given 
mashed food and were closely monitored for indications of poor recovery such as 
overt body weight loss. Animals that lost more than 20% of their pre-surgical weight 
or had poor recovery were culled.   
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2.3 Behavioural testing 
Prior to any behavioural testing the animals selected for the studies were handled for 
5 minutes over a period of 5 days in order to decrease stress due to handling during 
the experiments. 
 
2.3.1 Spatial working memory assessment in the eight-arm radial maze 
The eight-arm radial maze apparatus and its dimensions are shown in Figure 2.1. The 
radial arm maze (Stoelting Co. Europe, Dublin, Ireland) consisted of an octagonal 
central platform (20 cm diameter) with 8 equally spaced arms (47 cm length) 
radiating from it, each containing a small well at the distal end with a food pellet, 
confined by a 20 cm high transparent plastic wall and with a computer operated door 
at the entrance. The maze was placed in a well-lit room 1 m above the floor on a 
stable base with several extramaze two and three dimensional brightly coloured cues. 
The computer operated doors were controlled remotely by Any-Maze software 
(Stoelting Co. Europe, Dublin, Ireland), and the researcher could control their 
opening/closing. A camera attached to the ceiling, directly above the maze, tracked 
the animals’ movements and video recordings of the trials detailing the behaviour 
and position of the animals during each task were produced by AnyMaze software 
(Stoelting Co. Europe, Dublin, Ireland). 
One week prior to testing, mice were individually housed and subjected to food 
deprivation resulting in a reduction of body weight by 10–15%, which was 
maintained throughout the behavioural testing. Two pretraining days preceded the 
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actual task. On the first pretraining day all doors were open and food pellets (Bio-
Serv, USA) were scattered all over the maze and animals were free to explore for 5 
minutes. During the second pretraining day, each animal was placed at the entrance 
of an arm and monitored until having successfully retrieved a food pellet from the 
well at the distal end of the arm; this was repeated for all eight arms. Following 
pretraining, animals were trained over 16 days; for each daily testing session each 
arm was baited with a single food pellet or reward. Each session was initiated by 
placing the animal in the central area of the maze with all the doors closed. Once the 
animal was recognised by the software all doors opened and the animal was allowed 
to explore the maze and make an arm choice. The moment the body of the animal 
fully entered an arm the doors for the other seven arms closed and that was recorded 
as the first arm entry. The animal was monitored until found in the central area again; 
at that point the researcher confined the animal to the central platform for 5 seconds 
by remotely closing all doors. After the 5 second delay all doors opened and the 
animal was free to make another choice. This was repeated until all arms were 
entered or the maximum testing time (25 minutes) had elapsed. The number of novel 
(correct) entries in the first eight arm entries, the number of total arm entries, the 
number of revisiting errors and the duration of the task for all trials were recorded.  
 
2.3.2. Exclusion criteria 
Animals that were unable to perform in the eight-arm radial arm maze due to seizing 
behaviour during testing were excluded from further analysis   
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Figure 2.1 Eight-arm radial arm maze apparatus. [A] Schematic representation and 
dimensions of the eight-arm maze apparatus used for testing working memory 
performance. The central platform is 20 cm in diameter, each arm is 47 cm long and 
7cm wide and at the end of each arm a 3.5 cm diameter food well is found [B] 
Photograph of the eight-arm radial arm maze apparatus used for all experiments. The 
maze is placed 1 m above ground and extramaze cues surround the maze for spatial 
navigation  
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2.4 Perfusion and tissue preparation  
2.4.1 Perfusion for immunohistochemistry and biochemistry 
Animals selected for biochemical and immunohistochemical analysis were 
transcardially perfused. Animals were anaesthetized in 5% isoflurane in a Perspex 
box. The depth of the anaesthesia was evaluated by the presence of a hind-paw pinch 
reflex. Once it was confirmed that this reflex was absent the animal was transferred 
to a face mask on its back and kept under anesthesia for the whole procedure. The 
skin was cut to expose the thoracic cavity and the diaphragm was carefully cut. Then 
the ribs were cut through bilaterally with care not to damage the lungs and bent 
backwards and fixed to place for the heart to be exposed which was very carefully 
cleared from the surrounding connective tissue. A needle was placed into the left 
ventricle and fixed with a haemostat and then the left atrium was snipped. Through 
the clamped needle, 20 mL of 0.9% heparinised saline in phosphate buffer was 
administered at a rate of 2mL/min. After perfusion the animals were immediately 
decapitated and the brains were dissected from the skull and bisected across midline. 
The left hemibrains was post-fixed for 24 hours at 4˚C in 20 mL of 4% 
paraformaldehyde in phosphate buffer. From the right hemibrain a 2 mm 
hippocampal slice was coronally dissected using a mouse brain matrix as a guide 
[0.72mm to 2.74 mm interaural according to Franklin and Paxinos (1997)]. The 
hippocampal slice as well as the rest of the brain were placed in 1.5 mL Eppendorf 




2.4.2 Tissue preparation and sectioning for immunohistochemistry 
After 24 post-fixation in 4% paraformaldehyde the brains were attached to a tissue 
mount with super glue (Loctite, Henkel, Germany). After a few seconds while 
making sure that the glue was set, the tissue was submerged in a phosphate buffer 
(PB) bath at room temperature to avoid dehydration. The hemibrains were cut 
sagittaly into 50 μm sections in a PB bath at room temperature (RT) by a vibrating 
(frequency set at 60 Hz and amplitude at 0.9 mm) razor blade (Wilkinson Sword Ltd, 
UK) starting at lateral 2.40 ± 0.1 mm, according to Franklin and Paxinos (1997) 
using a vibratome (Hyrax V50, Zeiss, Germany). The vibratome was set at an 
optimal speed of 8 mm/s. All sections were stored free-floating in 1.5 mL of 
cryoprotective medium (30% glycerol/30% ethylene glycol in phosphate buffer) at -
20˚C in 24-well plates for immunohistochemical staining.  
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2.5 Immunohistochemistry 
Sections selected for immunohistochemical experiments were taken out of the -20˚C 
and allowed to adjust to room temperature and placed in 24-well plates with 1 mL of 
cryoprotective medium in each well. Cryoprotective medium was washed off with 
three 15 minutes washes with phosphate buffered saline (PBS, pH7.4), added in each 
well with a Pasteur pipette. 
 
2.5.1 Fluorescent immunohistochemistry 
At the onset, any trace of cryoprotective medium was removed by three 15 minute 
washes with PBS (pH7.4) containing 0.1% Triton-X100 (PBSTx). Antigen retrieval 
was performed as detailed in Table 2.1. Non-specific binding sites were blocked 
using 0.25 mL 3% normal serum of the appropriate species (depending on the 
species where the secondary antibodies used were produced) in PBSTx for 1 hour. 
Sections were then incubated overnight at 4
o
C with 0.25 mL primary antibody or 
antibody cocktail at the optimal dilution (Table 2.1) in blocking solution. On the next 
day, sections were taken out of the cold room and allowed to reach room 
temperature. They were then washed three times for 15 minutes with PBSTx before 
adding 0.25 mL of secondary antibody or antibody cocktail in PBSTx and incubated 
overnight at 4ºC. The secondary antibodies used are detailed in Table 2.1 and were 
always against the species in which the primary antibodies were raised. Finally, after 
a series of washes with PBSTx (30 minutes), PBS (two washes for 15 minutes) and 
phosphate buffer (PB, pH7.4; 2 mL for 20 minutes) the sections were mounted onto 
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SuperFrost slides (WVR International, Lutterworth, UK) with Vectashield hard set 
mounting medium containing, if necessary, the nuclear stain 4',6-diamidino-2-
phenylindole (DAPI) (H-1500, Vector Laboratories, U.S.A). All washes and 
antibody incubations were performed on a shaker at room temperature, unless it is 
otherwise stated. 
 
2.5.2 Nissl neuronal cell body stain 
Nissl neuronal cell body staining was performed after completion of fluorescent 
immunohistochemistry protocol if necessary. After the last two PBS washes (15 
minutes) described above sections were incubated in 0.25 mL of fluorescent Nissl 
stain (1:20, NeuroTrace® 640⁄660 Deep-Red, Invitrogen, UK) solution for 20 
minutes. Sections were then washed with PBSTx for 15 minutes followed by a 2 
hour wash in PBS and a 20 minute wash in PB. Sections were then mounted onto 
SuperFrost slides (WVR International, Lutterworth, UK) with Vectashield hard set 
mounting medium. All washes and incubations were performed on a shaker at room 
temperature. 
 
2.5.3 Chromogenic Immunohistochemistry 
To ensure that every trace of cryoprotective medium was removed free-floating 
sections were washed 3 times with PB. The sections were mounted onto SuperFrost 
slides (WVR International, Lutterworth, UK) and air-dried for a minimum of 30 
 61 
minutes. Sections were then rehydrated in phosphate buffer (PB, pH7.4). After 
rehydration of the sections, endogenous peroxidase was blocked by incubation for 30 
min with 3% H2O2 in methanol at room temperature. Antigen retrieval was 
performed in 10mM citrate buffer (pH 6) in a pressure cooker (MenaPath 
AccessRetrieval Unit, Model MP-2002-CE, A. Menarini Diagnostics Ltd. UK) filled 
with 0.5 L of distilled water. The retrieval programme was run for 10 minutes with 
pressure at 100˚C with an additional 10 minutes of cooling time. Sections were then 
taken out of the pressure cooker and allowed to cool down to room temperature for 
an extra 10 minutes followed by a 2 minute wash with PBS. Then non-specific 
epitopes were blocked with 0.25 mL of 10% normal serum from the appropriate 
species and 0.5% bovine serum albumin for 60 minutes. Blocking solution was then 
drained from the slides and 0.25 mL of primary antibody (detailed in Table 2.1) in 
blocking solution was applied to the sections which were incubated overnight at 4°C 
in a cold room. The next day, the sections were taken out of the cold room and 
allowed to come to room temperature. They were then washed two times for 10 
minutes by immersion in PBS followed by a 60 minute incubation with 0.25 mL of 
secondary antibody (against the species in which the primary antibody was raised) in 
PBS (1:100 dilution, Vector Laboratories, Burlingame, CA, USA). Another two 10 
minutes washes in PBS followed. The ssignal was enhanced by applying 0.25 mL of 
Avidin-Biotinylated enzyme Complex (Elite ABC Kit, Vector Laboratories, 
Burlingame, CA, USA) for 60 minutes followed by two 10 minutes washes in PBS. 
Immunostaining was visualized (brown staining) by incubating the sections for three 
minutes in 3, 3΄-diaminobenzidine (DAB kit, Vector Laboratories, Burlingame, CA, 
USA). The 3, 3΄-diaminobenzidine was washed off in running water for 10 minutes. 
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The sections were then dehydrated with serial washes in graduated alcohol solutions 
and xylene as described in Table 2.2. The final step was mounting the sections in 
DPX mounting medium (Thermo Fisher, Loughborough, UK) and coverslipping. 
 
2.5.4 Optimisation of antibodies 
Before performing any immunohistochemical experiment the optimal dilution of 
each primary antibody and the optimal antigen retrieval method was determined. 
Optimal dilutions were determined with concentration-curve experiments where 
different dilutions of the primary antibodies were used on serial sections from the 
same animal. The dilution and the antigen retrieval method that gave the most 
specific cellular staining with the lowest background were chosen as optimal. 
Negative controls were used in all immunohistochemical experiments; they 
underwent identical treatment without primary antibody application and minimal 
staining was detected. 
 
2.5.5 Exclusion criteria 
After performing the immunohistochemical experiments the quality of 
immunostaining was examined. In some isolated cases the tissue at the region of 
interest was disrupted or the quality of immunostaining was poor (minimal staining) 
compared to all the other sections indicating technical issues. In these sections 


































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 2.2 Dehydration sequence in graduated alcohol solutions and xylene 
Solution Time in solution 
70% Ethanol in dH2O 2 minutes 
90% Ethanol in dH2O 2 minutes 
100% Ethanol 2 times for 5 minutes 
Xylene 10 minutes 
 
2.5.6. Regions of interest 
The regions of interest examined in this thesis included the corpus callosum and 
regions within the hippocampus such as CA3 and the stratum lacunosum moleculare 
(Figure 2.2).  
 
Figure 2.2 Regions of interest selected for examination. Sagittal diagram of the 
mouse brain with highlighted regions of interest; corpus callosum in blue (■), CA3 in 
yellow (■) and stratum lacunosum moleculare in green (■). Image adapted from 
Franklin and Paxinos (1997).  
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2.6 Image acquisition and quantitative image analysis 
Image acquisition and quantitative image analysis were performed by the author who 
was blind to the experimental conditions. To ensure reproducibility of the image 
analysis, images or image stacks acquired from three randomly selected animals 
were analysed accordingly for a minimum of three times. Reproducibility was 
achieved once there was less than a 10% difference of the three measurements from 
the median value. 
 
2.6.1 Image acquisition 
Before imaging sections that underwent fluorescent immunohistochemistry were 
screened at a fluorescent Leica DMR microscope (Leica Microsystems U.K.) to 
identify, by eye, the brightest stained section. This allowed determining the optimal 
imaging settings at the confocal and avoiding imaging at saturated levels of intensity. 
Then the sections were imaged with a Zeiss upright Axioskope LSM510 or with a 
Zeiss inverted AxioObserver LSM710 confocal laser scanning microscope using 
LSM software or ZEN software (ZEISS, Germany) respectively as the user interface 
at 1024x1024 pixels resolution. A pinhole of 1 Airy unit and identical confocal 
imaging settings for detector gain, digital offset, digital gain and laser power were 
used.  
Chromogenic immunohistochemistry was imaged with an Olympus BX51 
microscope (Olympus UK, Southendon-Sea, UK) using a QImaging MicroPublisher 
 66 
3.3 camera (QImaging, Surrey, BC, CA) and QCapture Pro 7 software (QImaging, 
Surrey, BC, Canada) at 2048×1536 resolution. 
 
2.6.2 Quantification of MBP and total neurofilament immunostaining 
Fluorescently labelled sections with anti-MBP and anti-pan neurofilament 
(SMI312R) antibodies were imaged at the stratum lacunosum moleculare of the 
hippocampus and/or the corpus callosum with a confocal laser scanning microscope. 
Single optical images were acquired at a depth of 4 μm from the surface of the 
section and used to evaluate MBP and total neurofilament immunostaining. Images 
were opened using ImageJ as 8-bit colour images. Fluorescent intensity of all images 
was filtered with the application of a threshold that subtracts low intensity pixels due 
to non-specific/background staining. In order to determine the threshold value 5 grid 
boxes (20 x 20 pixels) per section were analysed in areas as good representation of 
the background intensity. From all the boxes, the average mean grey value (MGV) 
and standard deviation (SD) of the background was determined. The threshold was 
determined as the average mean grey value of the background plus three times its 
standard deviation (threshold = average MGV+3×SD). Background was subtracted 
consistently from all images. The percentage of the area (area fraction) occupied by 
MBP or SMI312R staining for each group and the fluorescent intensity (mean grey 




2.6.3 Quantification of myelin bulbs 
Observation of MBP immunostaining staining from the stratum lacunosum-
moleculare of the hippocampus revealed regional abnormalities of the myelin 
staining resembling bulbs on some myelinated fibres. These structures resemble in 
the myelin “balloons” observed with electron microscopy (Feldman and Peters, 
1998). The number of these myelin sheath bulbs which were defined as any MBP-
immunopositive formation that interrupts the continuity of the myelinated fibre, with 
a diameter 20% larger than the diameter of the fibre. The analysed image stacks were 
acquired with a Zeiss Axioskope LSM 510 confocal laser scanning microscope using 
a 40× oil-immersion objective (numeric aperture 1.3), from fluorescence labelled 
sections for MBP and total neurofilament. The corresponding Nyquist settings of 
4.6× zoom and 0.16 μm z-steps were used to allow image deconvolution (Huygens 
Professional Deconvolution Software; SVI). After deconvolution, which produces 
16-bit images, the images were transformed into 8-bit format. Before transformation 
the pixel intensities of 16-bit images were equalized across the full range of the 
histogram using ImageJ so that intensities at the 8-bit images are better distributed. 
Two adjacent confocal 40-slices stacks were acquired per animal where the average 
number of myelin sheath bulbs from two 76.8x76.8x10 μm
3
 confocal stacks was 





2.6.4 Quantification of synaptophysin immunostaining 
Presynaptic terminal density was assessed using an anti-synaptophysin antibody in 
the CA3 area of the hippocampus. Images were acquired with a Zeiss inverted 
AxioObserver LSM710 confocal laser scanning microscope using a 40× oil-
immersion objective (numeric aperture 1.3). Two adjacent single optical images were 
acquired from the CA3 region of each animal at a depth of 4 μm from the surface of 
the section. Images were opened using ImageJ as 8-bit colour images As described in 
chapter 2.6.2 the background was subtracted consistently from all images and the 
percentage of the area (area fraction) occupied by presynaptic terminals was 
determined and values from the two images were averaged for each animal to be 
used for further analysis. 
 
2.6.5 Nodes of Ranvier measurements 
Images were acquired with a 63× oil-immersion objective (numerical aperture 1.4) 
from sections labelled with anti-Nav1.6 channels and anti-Caspr antibodies. Nav1.6 
staining and Caspr immunostaining were imaged on the red channel and the green 
channel respectively. The corresponding Nyquist settings, 3.1× zoom and 0.13 μm z-
steps were used to allow image deconvolution (Huygens Professional Deconvolution 
Software; SVI). The 16-bit images produced after deconvolution, were transformed 
into 8-bit format. Before transformation the pixel intensities of 16-bit images were 
equalized across the full range of the histogram using ImageJ so that intensities at the 
8-bit images were better distributed. The length and width of the Nav1.6 positive 
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clusters as well the nodal gap length which is the space between two Caspr positive 
domains were measured in image stacks spanning 10 μm using the straight line tool 
on ImageJ. Having confirmed first that the gap is occupied by a Nav1.6 cluster, the 
distance between the two closest points of the Caspr domains was measured (Figure 
2.3 A). Only Nav1.6 clusters found between two Caspr positive domains on either 
side were analysed and due to their irregular shape the maximum length and width 
were measured (Figure 2.3 B). Furthermore, by moving between the slices of the 
stack it was possible secure that the full length of the Nav1.6 clusters or nodal gaps 
was measured in nodes imaged at an. Analysis was performed in the first 30 
appearing nodes in the acquired 47 × 47 × 10 μm
3
confocal stack for each animal. 
 
 
Figure 2.3 Measurements at the nodes of Ranvier. Measuring the nodal gap length 
between two Caspr positive paranodes [A] and the Nav1.6 cluster length and width 
[B]. Image of a complete node of Ranvier from the stratum lacunosum moleculare of 
the hippocampus [C]. Scale bar 2 μm.  
 
2.6.6 Quantification of nodal density 
The number of the nodes of Ranvier was determined on the same image stacks 
acquired for the nodal length measurements (described at chapter 2.6.5). The 
numerical density of the nodes was assessed in 47 × 47 × 10 μm
3
 confocal stacks 
from the hippocampus or in 47 × 47 × 5 μm3 confocal stacks for the corpus 
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callosum. Only complete nodes namely Nav1.6 clusters that were paired with Caspr 
immunolabelled paranodes on either side were counted in maximum intensity z-
collapsed stacks. The original stacks were used at the side as a reference guide to 
secure that the overlapping nodes, which are difficult to separate within the collapsed 
stack, are counted. Nodes located on the first optical section and crossing the upper 
and the left edge of the stack were not counted.  
 
2.6.7 Axon initial segment length measurements 
Sections labelled with AnkG, Caspr and Nissl stain for neuronal cell bodies were 
imaged. Image stacks were acquired with a Zeiss inverted AxioObserver LSM710 
confocal laser scanning microscope using a 40× oil-immersion objective (numeric 
aperture 1.3). Two adjacent image stacks 30 μm thick were acquired from the CA3 
region of the hippocampus of each animal in order to ensure imaging of complete 
AIS. An AIS was considered complete when the neuronal cell body and the first 
paranode, labelled for Caspr, could be identified. Measurement of each AIS was 
achieved by isolating the mini-stacks that contained a complete AIS, collapsing the 
stack by using the z-collapse maximum intensity tool on ImageJ software and 
following the shape of the AIS from the cell body to the first paranode using the 
segmented line tool on ImageJ software. In total the length of 20 complete AIS 




2.6.8 Quantification of number of AIS 
The number of the AIS was determined on the same image stacks acquired for the 
AIS length measurements (described at 2.6.7). The numbers of AIS were assessed in 
212 × 212 × 10 μm
3
 confocal stacks. AnkG positive structures with typical AIS 
morphology indicated by a length >5μm, a wide base and a tapered end were counted 
in maximum intensity z-collapsed stacks. The original stacks were used at the side as 
reference guide to secure that all AIS are counted in regions where multiple AIS 
were overlapping. AIS located on the first optical section and crossing the upper and 
the left edge of the stack were not counted. 
 
2.6.9 Quantification of Kv1.2 immunostaining  
Sections stained for Kv1.2 and Caspr were imaged at an inverted Zeiss Axioskope 
LSM 710 with a 63× oil-immersion objective (numerical aperture 1.4). The 
corresponding Nyquist settings, 3.1× zoom and 0.13 μm z-steps were used to allow 
image deconvolution (Huygens Professional Deconvolution Software; SVI). A 4 μm 
(30 slices) thick confocal stack was acquired from the corpus callosum. After 
deconvolution, which produces 16-bit images, the images were transformed into 8-
bit format (as described in chapter 2.6.3). The background was subtracted 
consistently from all images by setting a common threshold for the red (Kv1.2) and 
the green (Caspr) channels (as described in chapter 2.6.2). For each slice of each 
stack the area occupied by Caspr staining and then the volume was calculated by 
multiplying with the z-step. Next the area occupied by both Kv1.2 and Caspr was 
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determined. This was achieved by subtracting from the area occupied by Kv1.2 
positive staining the binary mask of the area that was not occupied by Caspr positive 
staining for each slice of each stack with the Math tool on ImageJ. Then the volume 
that was occupied by both Kv1.2 and Caspr staining was determined by multiplying 
with the z-step and expressed as a percentage of the total Caspr volume. 
 
2.6.10 Quantification of amyloid-β immunostaining 
Sections immunolabelled for Aβ with the 6E10 antibody were imaged at the stratum 
lacunosum moleculare of the hippocampus using a ×20 objective at an Olympus 
BX51 microscope. Images were opened with ImageJ and converted into greyscale. 
The background was subtracted consistently from all images by setting a common 
threshold (as described in chapter 2.6.2). The percentage of the area (area fraction) 
covered with amyloid deposits was determined and used for further analysis.  
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2.7 Biochemistry 
2.7.1 Tissue homogenization 
Tissue stored at -80˚C for biochemical analysis was homogenized in ice cold tissue 
homogenisation buffer containing sucrose (250mM), Tris Base (20mM), 
ethylenediaminetetraacetic acid (EDTA; 1mM) and ethyleneglycoltetraacetic acid 
(EGTA; 1mM). Protease (1:100 dilution; Merck Biosciences AG, Germany) and 
phosphatase inhibitors (1:50 dilution Merck Biosciences AG, Germany) were added 
to the buffer before use. Homogenisation was performed with a Dounce homogeniser 
on ice. Homogenised samples were centrifuged at rotor speed of 3000 rpm for 5 
minutes at 4˚C with a Sigma 1-13 benchtop centrifuge (Sci Quip Ltd., Shrewsbury, 
UK). This short centrifugation allows the separation of the total homogenate from 
small pieces of non-homogenized tissue and facilitates the handling of the lysate in 
biochemistry experiments. Supernatant was carefully removed and was ready be used 
for assessing protein concentration. 
 
2.7.2 Protein concentration assessment 
Total protein concentration of each sample was determined with a BCA 
(bicinchoninic acid) protein assay (Thermo Fisher Scientific (Cramlington, UK). 
Working dilutions (1:10) in tissue homogenisation buffer (THB) of the homogenates 
and the standards were prepared and loaded in triplicate on to 96-well plates. 
Working reagent (solution of 4% cupric sulphate mixed 1:50 with a solution of 
sodium bicarbonate, bicinchoninic acid, sodium carbonate and sodium tartrate in 
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0.1M sodium hydroxide) was added to each well and incubated for 30 minutes at 
37˚C. The plates were left to cool down to room temperature for a few minutes and 
then the absorbance at 562 nm was read with a Dynex MRX plate reader (Dynex 
Technologies Ltd., Worthing, UK). For each sample (homogenate or standard) three 
values were obtained and the average was calculated. The readings for the standard 
were used to produce a standard curve and subsequently calculate the protein 
concentration in each sample. Before use samples were stored at -20˚C in 5μL 
aliquots. 
 
2.7.3 Enzyme-linked immunosorbent assay (ELISA) 
Tissue homogenates (prepared as described in chapter 2.7.1) with known protein 
concentration (determined as described in chapter 2.7.2) were used to determine total 
human Aβ42 (hΑβ42) concentration in TgAPPSw,Ind animals using a commercially 
available ELISA kit (Invitrogen, Camarillo, CA). On a 192-well ELISA kit 50μL of 
standards of hAβ42 peptide at different concentration (1000, 500, 250, 125, 62.5, 
31.25, 15.63 and 0 pg/mL) or samples (in duplicate) diluted 2.5 times with Standard 
Diluent Buffer were loaded. One well was kept empty to serve as the chromogen 
blank. Then 50 μL of human Aβ42 detection antibody were loaded to each well 
except from the chromogen blank. After incubating for 3 hours at room temperature 
with shaking, liquid in the wells was aspirated and the wells were thoroughly washed 
4 times with Wash Buffer. Next 100 μL of anti-rabbit IgG HRP. Working Solution 
was added to each well except from the blank followed by a 30 minute incubation at 
room temperature. After four thorough washes (Wash Buffer) 100μL of Stabilized 
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Chromogen was added to each well and the plate was incubated in the dark at room 
temperature for 30 minutes. Then 100μL of Stop Solution were gently mixed with 
the solution changing from blue to yellow. Absorbance was read for all wells at 450 
nm with a plate reader blanked against the chromogen blank. Next the standard curve 
was produced and the concentration in human hAβ42 corrected for the sample 
dilution was determined by using the average reading of the duplicates of each 
sample. The experiment was run twice and the average hAβ42 concentration between 
the two experiments for each sample was calculated. The final hAβ42 concentration 
was expressed as pg of hAβ42 in mg of total protein. 
 
2.7.4 Western blotting 
Samples with 1 μg/μL or 4 μg/μL final protein concentrations were prepared using a 
4x Laemelli buffer (1:4 dilution) and THB. Control sample from brain homogenate 
(prepared as described at chapter 2.7.1) from two 20 months old APPSw,Ind animals 
(perfused as described at chapter 2.4.1) was prepared in the same way.  
The proteins were denaturated at 70˚C for 10 minutes in a water bath. The 
appropriate amount of sample protein (Table 2.3) was loaded on precast NuPAGE 4-
12% Bis-Tris gels (Life Technologies, Carlsbad, CA) together with 5 μL of a 
molecular marker (LiCor Biosciences, Lincoln, Nebraska, USA). Control sample was 
also loaded on each gel. Samples were run with a 2-[N-morpholino] ethanesulfonic 
acid-sodiumdodecyl sulphate (MES-SDS) running buffer (Life Technologies, 
Carlsbad, CA) at 80V for approximately 90 minutes.  
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The proteins were then transferred to Amersham hybond-P polyvinylidene fluoride 
(PVDF) membrane at 30V for 2.5 hours in an XCell II™ Blot Module (Life 
Technologies, Carlsbad, CA). Successful transferring of the proteins onto the PVDF 
membrane was evaluated by staining gels in Coomasie Blue (Bio-Rad, Hemel 
Hempstead, UK) for one hour. Coomasie Blue detects proteins left on the gels and 
when these were strongly or unevenly stained, which is evidence of poor transfer or 
uneven loading, they were rerun. After transfer, PVDF membranes were rinsed in 
PBS and incubated for 1 hour on a shaker in Odyssey blocking buffer (1:1 in PBS, 
LiCor Biosciences, Lincoln, Nebraska, USA) in order to block non-reactive sites. 
Blocking buffer was then drained and the membranes were incubated overnight on a 
shaker at 4
o
C with a cocktail of primary antibodies against the protein of interest 
(detailed in Table 2.3) and against Glyceraldehyde 3-phosphate dehydrogenase 
(1:100000 dilution, rabbit or mouse anti-GAPDH, Sigma-Aldrich Ltd., Poole, UK) 
made in Odyssey blocking buffer containing 0.1% Tween-20. The following day 
after six washes (for 5 minutes) with PBS-0.1% Tween-20, the membranes where 
incubated for 45 minutes at room temperature with the appropriate secondary 
antibodies (Table 2.3) (1:3000 dilution; LiCor Biosciences, Lincoln, Nebraska, USA) 
in Odyssey blocking buffer-0.1% Tween-20-0.01% SDS in light proof boxes and 
then washed again (6 times for 5 minutes) with PBS-0.01% Tween-20 before a final 
wash in PBS. The membranes were then left to dry protected from light before being 
imaged using the Odyssey infrared imaging system (LiCor Biosciences, Lincoln, 













































































































































































































































































































































































































































































































































































2.7.5 Quantification of protein levels 
Scanned images of western and dot blot membranes were analysed using Odyssey 
application software (version 3.0; Li-Cor, Cambridge, UK) in order to quantify the 
fluorescent intensity of the bands or dots of interest. 
For each protein of interest, western blots were run in duplicate. Fluorescent intensity 
(in arbitrary units) for the band corresponding to the protein of interest was expressed 
as a ratio of the intensity of the GAPDH band from the same sample to normalise for 
loading variation. The average ratio value from the duplicates of each sample was 
used for analysis. Bands were excluded from analysis when there were bubbles or 
other noise that made intensity calculations impossible. Fluorescent intensity of the 
GAPDH bands from each sample was averaged between the duplicates and 
compared with an independent samples t-test between groups to confirm that 
GAPDH is an accurate loading control and was not changed between groups. The 
test was performed for every set of western blots. No difference between groups in 
GAPDH intensity was ever observed (p > 0.05). An example of this comparison is 
shown in Figure 2.4. Similarity of the images and of the values obtained between 
duplicates was used to confirm reproducibility of the blots.  
In the dot blots, fluorescent intensity of each dot was quantified. Each sample was 
loaded in duplicate and the average intensity from each sample was expressed as a 
ratio of the average intensity value from the control sample. Any dot with evidence 
of noise was excluded from analysis.  
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Figure 2.4 Western blot reproducibility. [A] Similarity values obtained between 
duplicates (run A and B) was used to confirm reproducibility of the blots; shown 
here an example of data from total neurofilament (SMI312) blots [B & C] Integrated 
GAPDH intensity was used to normalise for loading variation. No differences were 
detected (p > 0.05) between the different groups. Here a representative example of 
young hypoperfused and sham WT and TgAPPSw,Ind animals where no effect of 
genotype or hypoperfusion is observed. WT sham: n=12, WT hypoperfused: n=14, 
TgAPPSw,Ind sham: n=13, TgAPPSw,Ind hypoperfused n=13. Graphs show mean ± 
SEM.  
 80 
2.8 Statistical analysis 
All experiments were performed blind with regard to conditions (genotype, age or 
surgery).  
Behavioural performance in the 8-arm radial arm maze was analysed using SPSS 
v14.0 software (IBM, New York, USA). The number of novel (correct) entries in the 
first eight arm entries and the number of revisiting errors in the 8-arm radial arm 
maze task, expressed in two-trial blocks (average value of the measure for two 
consecutive days) were analysed. Difference of the means was assessed with two-
way repeated measures ANOVA for the appropriate factors followed by Tukey’s 
post hoc test if necessary. Additionally, the Greenhouse-Geiser correction was used 
when data violated sphericity (p < 0.05 at Mauchly’s test). Difference of the means 
for number novel entries in the first eight arm entries from chance reported to be 5.3 
entries (Olton and Samuelson, 1976) was analysed using student’s unpaired t-test. 
Cumulative frequency distribution of nodal length and AIS length measurements 
expressed as percentages were analysed with the two-sample Kolmogrov-Smirnov 
test. This analysis was performed with an open source statistics application 
developed by Kirkman (1996).   
MBP, total neurofilament, Aβ and synaptophysin immunostaining, number of myelin 
bulbs, nodes of Ranvier and AIS, protein levels (except Aβ and hAPP) detected with 
western blot, and Kv1.2/Caspr colocalization were analysed using GraphPad Prism 
v5.0 (Graphpad Software Inc. El Camino Real, USA). Difference of the means was 
assessed with a two-way ANOVA for the appropriate factors followed by 
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Bonferroni’s post hoc test if necessary. Difference of the means in Aβ42 
concentration and Aβ and hAPP protein levels was analysed using the student’s 
unpaired t-test. Association between means was analysed with the Spearman’s 
correlation analysis. 
All graphs were generated using GraphPad Prism v5.0 (Graphpad Software Inc. El 
Camino Real, USA). Statistical significance was established at p < 0.05. However, 
Bonferroni correction (Bland and Altman, 1995) was applied when multiple-
comparisons were performed simultaneously using identical datasets. Significance (p 
< 0.05) was Bonferroni corrected by dividing with the number (n) of comparisons 
using the identical datasets (p < 0.05/n).  
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2.9 Sample size calculations 
In order to secure that the studies are well-powered which means that if there is a 
difference between the investigated groups there is an increased chance of it to be 
detected, the adequate sample size for difference of the means was calculated were 
necessary. Firstly, the standardized difference (d) was calculated which equals to the 
target difference divided by the standard deviation. These values are not known in 
advance and are estimated based on the published literature of similar studies using 




         where n is the size of the group, d is the standardized difference and 
         is a constant determined by the values of the chosen statistical significance 
(p) and power. The studies included in the thesis comprise of a maximum of four 
groups therefore the use of identical data for multiple comparisons and the need for 
Bonferroni correction (described above) is a possibility resulting in stricter criteria 
for the calculation of sample size. Here for the calculation of sample size a p = 0.01 





3 Age-related changes in myelinated axons and cognition in wild-type and TgAPPSw,Ind mice 
 
3.1 Introduction 
Myelin alterations are a key feature of the ageing brain and are exacerbated in AD, 
and have been linked with poor cognitive function (Bartzokis et al., 2003; Salat et al., 
2005; Salat et al., 2009). Moreover, neuronal excitability is altered particularly 
within hippocampal networks (Disterhoft and Matthew Oh, 2003; Gleichmann and 
Mattson, 2010) in both normal ageing and AD. In view of the importance of the AIS 
and nodes of Ranvier in initiating and propagating action potentials, disruption of 
these regions could have a major impact on neuronal function in normal ageing and 
in AD. To date, there have been very few studies investigating the vulnerability of 
these regions and their structural integrity in normal ageing or AD.  
From the limited studies in ageing, there is evidence that components of the nodes 
are disrupted in ageing rodents and in aged primates (Rios et al., 2003; Hinman et al., 
2006; Shepherd et al., 2012). Moreover, in a transgenic mouse model featuring AD-
related pathology there is evidence of changes in Nav1.6 channel immunoreactivity 
(Desai et al., 2009). From studies using animal models of multiple sclerosis there is 
evidence that demyelination is the underlying mechanism for nodal disruption 
(Coman et al., 2006; Lasiene et al., 2008).  
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At the outset of the studies described in the thesis there were no studies which had 
investigated changes in AIS structure in normal ageing or AD. There was however 
some evidence that its integrity is challenged in response to other types of injury 
such as stroke (Schafer et al., 2009; Hinman et al., 2013) or brain trauma (Baalman et 
al., 2013) and a few studies have shown that AIS structure shows remarkable levels 
of activity-dependent plasticity in response to altered electrical activity or synaptic 
input (Kuba et al., 2010; Grubb and Burrone, 2010a). Synaptic loss has been 
described in aged non-demented individuals and is exacerbated in AD patients 
(Bertoni-Freddari et al., 1990) and correlates to cognitive impairment (Coleman and 
Yao, 2003). This is also supported by studies in aged rodents and AD mouse models 
where synaptic loss has been observed (Rutten et al., 2005; Geinisman et al., 1986; 
Landfield and Lynch, 1977).  
 
3.1.1 Hypothesis and aims 
Given the similar molecular architecture, it was hypothesised that the AIS and nodes 
of Ranvier would be altered in ageing and that these effects would be exacerbated in 
the presence of increased levels of Aβ. Additionally, it was hypothesised that altered 
synaptic input would play a role in AIS alterations given its activity-dependent 
plasticity. Moreover, alterations in these structures are hypothesised to be associated 
with impairment in learning and memory. To address this, the integrity of myelinated 
axons with a focus on the AIS and nodes of Ranvier, the synapses as well as 
cognitive performance were examined in young and aged wild-type and 
TgAPPSw,Ind mice which show increased amyloid levels with increasing age.  
 85 
3.2 Materials & Methods 
3.2.1 Animals 
The transgenic mouse model used in this study is described in chapter 2.1. 
Experiments were performed in young (6 months old, n=14) and old (18-19 months 
old, n=15) TgAPPSw,Ind mice and compared to aged-matched wild-type C57Bl/6J 
control littermates (young n=14, old n=13).  
 
3.2.2. Behavioural testing  
Spatial working memory assessment for the animals was performed as described in 
chapter 2.3.1. The number of novel (correct) entries in the first eight arm entries, the 
number of total arm entries, the number of revisiting errors and the duration of the 
task for all trials were recorded 
 
3.2.3 Neuropathological assessment 
3.2.3.1 Perfusions and tissue preparation  
Five days after completion of the behavioural experiments the animals were 
sacrificed for further immunohistochemical and biochemical analysis as described in 
chapter 2.4.1. Tissue was prepared for immunohistochemical and biochemical 




Immunohistochemical experiments were performed on serial 50 μm sagittal sections 
starting at lateral 2.40 ± 0.1 mm, according to Franklin and Paxinos (1997). If 
necessary, exclusion criteria were applied after immunostaining as described in 
chapter 2.5.5. Immunohistochemisty for Aβ was performed as described in chapter 
2.5.3 to detected Aβ deposition in the hippocampus. The integrity of the myelinated 
axons was examined using antibodies against myelin basic protein (MBP) and total 
neurofilament. Alterations in the length and the number of nodes of Ranvier were 
examined using antibodies against Caspr and Nav1.6. In addition, the length of AIS 
was examined using antibodies against AnkG and Caspr combined with Neurotrace 
staining for the neuronal bodies. Moreover, synaptic integrity was investigated using 
an antibody against synaptophysin. The fluorescent immunochemistry and 
Neurotrace staining techniques used are described in chapters 2.5.1 and 2.5.3 
respectively. The Aβ load was assessed in the hippocampus as described chapter 
2.6.10 Myelin and axonal integrity was assessed in stratum lacunosum moleculare of 
the hippocampus in sections stained for MBP and total neurofilament as described in 
chapter 2.6.2. Myelin bulbs were also quantified at the same region as described in 
chapter 2.6.3. The length and the width of the Nav1.6 clusters, the nodal gap length 
and the number of the nodes were examined in the stratum lacunosum moleculare of 
the hippocampus in sections stained for Nav1.6 and Caspr as described in chapters 
2.6.5 and 2.6.6. The length and the number of the AIS as well as synaptic integrity 
were examined in the CA3 region of the hippocampus as described in chapters 2.6.7, 
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2.6.8 and 2.6.4 respectively. In some animals imaging was impossible because of 
poor quality of staining and tissue (exclusion criteria described in chapter 2.5.5). The 
final analysis was conducted in group sizes detailed in table 3.1. 
Table 3.1 Group sizes of the animals included in final analysis 
Analysis 









AIS length and 
number 
14 12 14 15 
Nodal length, width 
and number 
11 12 14 15 
MBP analysis 14 12 14 15 
Total neurofilament 
analysis 
13 12 14 15 
Aβ deposition 13 12 13 15 
Synaptophysin 14 13 14 15 
 
3.2.4 Western blotting 
Before proceeding to tissue homogenisation as described in chapter 2.7.1, the 
hippocampi from the 2mm hippocampal coronal slices of the right hemibrain (cohort 
1) were dissected. The procedure was performed on a glass plate directly placed on 
ice. The hippocampi were then homogenized as described in chapter 2.7.1. Protein 
concentration was determined as described in chapter 2.7.2. MBP and pan 
neurofilament levels were determined using anti-MBP and anti-pan neurofilament 
antibodies whilst Aβ levels and human APP (hAPP) levels we determined with an 
anti Aβ antibody (clone 6Ε10). The details of the western blot technique and the 
antibodies used are described in chapter 2.7.4. Quantification of the protein levels for 
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MBP, total neurofilament, hAPP, monomeric Aβ and trimeric Aβ was performed as 
detailed in 2.7.5. 
 
3.2.5 Statistical analysis   
The AIS and nodal length measurements were analysed using the two-sample 
Kolmogrov-Smirnov test. Τhe number of nodes and AIS, results for Aβ, MBP, total 
neurofilament and synaptophysin immunostaing and MBP and total neurofilament 
western blot analysis were analysed with 2-way-ANOVA with genotype and age as 
the factors followed by Bonferroni’s post hoc test if necessary. Results for hAPP and 
amyloid-β western blot analysis were analysed using the student’s unpaired t-test. 
Data acquired at the 8-arm radial arm maze was analysed with two-way (effect of 
age and genotype over training days) repeated measures ANOVA followed by 
Tukey’s post hoc test. Spearman’s correlation analysis was used to associate changes 
between the Nav1.6 cluster and AIS length, Aβ levels and number of errors in the 8-
arm radial arm maze. The software used for statistical analysis and graph generation 
is detailed in chapter 2.8. For all statistical tests significance was established at p < 
0.05, except from the Kolmogrov-Smirnov test where the Bonferroni correction was 
applied adjusting significance at p < 0.025 as described in chapter 2.8 because 
identical datasets where used simultaneously twice.  
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3.3 Results 
3.3.1 Decreased AIS length in response to ageing in wild-type animals 
and in young TgAPPSw,Ind compared to wild-type mice 
The length of the AIS is proposed as a key mechanism to regulate neuronal 
excitability. The first aim of the study was to assess whether the length of the AIS 
may be altered in ageing and in response to increasing Aβ levels in CA3 pyramidal 
neurons of the hippocampus. The hippocampus is the primary region affected by Aβ 
deposition whilst the CA3 serves an important role in hippocampal circuitry. The 
AIS was immunolabeled for ankyrin-G and the length measured from the neuronal 
cells bodies identified by Neurotrace stain to the first paranode identified by Caspr 
immunolabelling (Figure 3.1 A). In general AIS were readily identifiable in all 
sections and there were no obvious morphological alterations in any of the individual 
mice. Quantification of the length of a number of AIS was undertaken in all cases. In 
the wild-type animals, the average length of AIS was found to be 49.2 ± 0.4 μm at a 
young age and 45.5 ± 0.4 μm in the older animals whilst in the young TgAPPSw,Ind 
average AIS length was 47.7 ± 0.4 μm and 46.8 ± 0.4 μm in the aged TgAPPSw,Ind. 
In the first instance the effect of age was studied in wild-type and TgAPPSw,Ind 
mice on AIS length. Notably, a significant decrease by 7.4 ± 1.2% in the length of 
the AIS was detected in aged wild-type when compared to young mice (p < 0.001, D 
= 0.2343; Figure 3.1 B and F). However, no significant change in the length of AIS 
was observed in the aged TgAPPSw,Ind when compared to younger animals (p = 
0.034, D = 0.1171; Figure 3.1 C and G). Following on from this, it was determined 
whether the alterations in AIS length may be differentially affected in TgAPPSw,Ind 
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mice compared to wild-type littermates. At a young age, a significant decrease by 3 ± 
1.2% in the length of AIS in young TgAPPSw,Ind mice when compared to wild-type 
animals of the same age (p < 0.01, D = 0.1610; Figure 3.1 D and H). However in the 
aged mice there was no difference in the AIS length between wild-type and 
TgAPPSw,Ind mice (p = 0.311, D = 0.0825; Figure 3.1 E and I).  
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Figure 3.1 AIS shortens in response to normal ageing in the wild-type animals and 
in young TgAPPSw,Ind compared to wild-type mice at CA3 pyramidal neurons. 
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The AIS [A] was immunolabeled for AnkG (red), the length was measured from the 
neuronal soma stained with Neurotrace stain (blue) to the first paranode labelled with 
Caspr (green). There was a significant age-dependent decrease (p < 0.001) of AIS 
length in the WT [B, C & F] but not in the TgAPPSw,Ind animals [D, E & G]. 
Young TgAPPSw,Ind animals had significantly (p < 0.01) shorter AIS than WT [B, 
D & H]. No significant change between aged animals of different genotypes was 
observed [C, E & I]. Twenty complete AIS arising from 20 pyramidal neurons of the 
CA3 were measured per animal. Length values were plotted as percentage of 
cumulative frequency distribution. WT young: n=14, WT old: n=12, TgAPPSw,Ind 
young: n=14, TgAPPSw,Ind old n=15. [A] Scale bar 5 μm. [B-E] Scale bar 20 μm.   
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3.3.2 Number of AIS unchanged with ageing in both wild-type and 
TgAPPSw,Ind animals 
Next it was determined whether the overall number of AIS changed with age or 
between genotypes by stereologically counting the number of AIS structures in the 
same confocal stacks used for AIS length measurements (Figure 3.2 A-D). The 
number of AIS was found to be unchanged by either age (F (1-51) = 0.1382, p = 
0.7116) or genotype (F (1-51) = 0.9817, p = 0.3265) and there was no interaction 
between age and genotype (F (1-51) = 3.391, p = 0.0714) (Figure 3.2 E). These 
findings combined with those described in chapter 3.1 suggest that although ageing 
and genotype may have an impact on the size of AIS, this does not result in a change 
in the number.  
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Figure 3.2 Number of AIS remains unchanged with ageing in both wild-type and 
TgAPPSw,Ind mice. The number of nodes was counted in 212x212x10 μm
3
 confocal 
stacks at the CA3 region of the hippocampus immunolabeled with AnkG [A-D]. 
Two-way ANOVA for age and genotype did not show any significant effect of 
genotype or age in the number of AIS (p > 0.05) [E]. WT young: n=14, WT old: 
n=12, TgAPPSw,Ind young: n=14, TgAPPSw,Ind old n=15. Scale bar 20 μm. 
Graphs show mean ± SEM.  
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3.3.3 Changes in nodal size in response to ageing in both wild-type and 
TgAPPSw,Ind animals 
Since the nodes of Ranvier share a similar molecular architecture to the AIS, it was 
predicted that alterations similar to those found at the AIS occur at the nodes of 
Ranvier with ageing and with Aβ. Nodal changes were examined in the stratum 
lacunosum moleculare of the hippocampus that contains fibres arising from the CA3 
where the alterations in AIS length were observed. In general, the nodes were readily 
identifiable (Nav1.6 immunopositive clusters bounded by pairs of Caspr 
immunopositive domains) in all sections and there were no obvious morphological 
alterations between the individual mice. The size of the nodes of Ranvier was 
investigated by measuring the length and the width of Nav1.6 clusters (Figure 3.3). In 
the wild-type animals, the average length of Nav1.6 cluster was found to be 1.40 ± 
0.03 μm at a young age and 1.23 ± 0.03 μm in the older animals whilst in the young 
TgAPPSw,Ind average Nav1.6 cluster length was 1.39 ± 0.03 μm and 1.21 ± 0.03 μm 
in the aged TgAPPSw,Ind. There was a significant reduction in the length of Nav1.6 
cluster in aged wild-type (p < 0.001, D = 0.1806, Figure 3.3 B) and TgAPPSw,Ind 
animals (p < 0.001, D = 0.1931, Figure 3.3 C) by 12.4 ± 2.8% and 13.1 ± 3.2% 
respectively when compared to young animals of the same genotypes. However, 
there was no significant effect of genotype on Nav1.6 cluster length; TgAPPSw,Ind 
mice had similar nodal lengths when compared to wild-type mice at both a young (p 




Figure 3.3 Nav1.6 cluster length is decreased with normal ageing in wild-type and 
TgAPPSw,Ind mice in the stratum lacunosum moleculare of the hippocampus. 
Nav1.6 sodium channels (red) clusters bounded by the paranodal protein Caspr 
(green) outline the node of Ranvier [A]. There is a significant age-dependent 
decrease (p < 0.001) in the length [B & C] of the Nav1.6 clusters in both WT and 
TgAPPSw,Ind animals. No effect (p > 0.05) of genotype was observed in either 
young or aged TgAPPSw,Ind animals [D & E]. The lengths of thirty Nav1.6 clusters 
per animal were analysed and plotted as percentage of cumulative frequency 
distribution. WT young: n=11, WT old: n=12, TgAPPSw,Ind young: n=14, 
TgAPPSw,Ind old n=15. Scale bar 2 μm.  
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A similar pattern of changes was observed in the width of Nav1.6 clusters. In the 
wild-type animals, the average width of Nav1.6 cluster was found to be 0.91 ± 0.01 
μm at a young age and 0.87 ± 0.01 μm in the older animals whilst in the young 
TgAPPSw,Ind average Nav1.6 cluster width was 0.94 ± 0.01 μm and 0.89 ± 0.01 μm 
in the aged TgAPPSw,Ind. The width of the Nav1.6 domain was significantly 
reduced in the aged wild-type (p < 0.01; D = 0.1280 Figure 3.4 A) by 4.3 ± 2.1% but 
not in the aged TgAPPSw,Ind animals (p = 0.043, D = 0.1038, Figure 3.4 B) when 
compared to the young animals of the same genotypes. Moreover, there was no 
significant effect of genotype on Nav1.6 clusters width; TgAPPSw,Ind mice had 
similar Nav1.6 clusters width when compared to wild-type mice at both a young (p = 
0.181, D = 0.0799, Figure 3.4 C) and old age (p = 0.257, D = 0.0783, Figure 3.6 D).   
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Figure 3.4 Nav1.6 cluster width is decreased with normal ageing in wild-type mice 
in the stratum lacunosum moleculare of the hippocampus. There is a significant 
age-dependent decrease (p < 0.01) in the width of the Nav1.6 clusters in WT [A] but 
not in TgAPPSw,Ind animals [B]. No difference (p > 0.05) was observed between 
WT and TgAPPSw,Ind either at a young [C] or old age [D]. The widths of thirty 
Nav1.6 clusters per animal were analysed and plotted as percentage of cumulative 
frequency distribution. WT young: n=11, WT old: n=12, TgAPPSw,Ind young: 
n=14, TgAPPSw,Ind old n=15.  
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Since a decrease in the Nav1.6 cluster length was observed in the aged animals, it 
was then investigated whether the paranodes were similarly altered. In the wild-type 
animals, the average nodal gap length was found to be 1.07 ± 0.03 μm at a young age 
and 0.95 ± 0.02 μm in the older animals whilst in the young TgAPPSw,Ind average 
nodal gap length was 1.08 ± 0.03 μm and 0.98 ± 0.02 μm in the aged TgAPPSw,Ind. 
It was shown that the nodal changes in Nav1.6 length were mirrored in those seen 
with Caspr immunolabelling. Nodal gap was shown to be reduced in both the aged 
wild-types (p < 0.01, D = 0.1528, Figure 3.5 A) and the aged TgAPPSw,Ind (p < 
0.01, D = 0.1385, Figure 3.5 B) by 11.1 ± 3.2% and 9.5 ± 3.4% respectively when 
compared to the young animals of the same genotypes. However, there was no 
significant effect of genotype on nodal gap length; TgAPPSw,Ind mice had similar 
nodal gap lengths when compared to wild-type mice at both a young (p = 0.890; D = 
0.0441, Figure 3.5 C) and old age (p = 0.560, D = 0.0583, Figure 3. D).  
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Figure 3.5 Nodal gap decreased with normal ageing in wild-type and 
TgAPPSw,Ind mice in the stratum lacunosum moleculare of the hippocampus. 
There is a significant age-dependent decrease (p < 0.01) in the nodal gap [A-B] in 
both WT and TgAPPSw,Ind animals. No difference (p > 0.05) was observed between 
WT and TgAPPSw,Ind animals either at a young [C] or old age [D]. The nodal gap 
of thirty nodes per animal were analysed and plotted as percentage of cumulative 
frequency distribution. WT young: n=11, WT old: n=12, TgAPPSw,Ind young: 
n=14, TgAPPSw,Ind old n=15  
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3.3.4 Reduction in nodal length was not associated with reduction in 
AIS length  
To investigate whether the nodal length was associated with AIS length, for each 
animal the average Nav1.6 cluster length was plotted against the average AIS length. 
There was no significant correlation between AIS and Nav1.6 cluster length (Figure 
3.6, p = 0.1056, r = 0.227). These findings suggest that the changes in the length of 
AIS are not associated with the changes in nodal length. 
 
 
Figure 3.6 No association between the nodal and AIS length. Plotting the means of 
Nav1.6 cluster length together with the means of AIS length showed no significant 
association between with Nav1.6 cluster length and AIS length (p > 0.05, Spearman’s 
correlation analysis).  
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3.3.5 Number of nodes unchanged with ageing in both wild-type and 
TgAPPSw,Ind animals 
We next determined whether the overall number of nodes of Ranvier may be 
changed with age or between genotypes by stereologically counting the number of 
nodes in confocal stacks used for nodal measurements (Figure 3.7). The number of 
nodes was found to be unaffected by either age (F (1-48) = 0.4556, p = 0.5033) or 
genotype (F (1-48) = 2.368, p = 0.1311) and there was no interaction between age and 
genotype (F (1-48) = 1.036, p = 0.3145). These findings suggest that ageing or 




Figure 3.7 Number of nodes of Ranvier remains unchanged with ageing in the 
stratum lacunosum moleculare of the hippocampus. The number of nodes was 
stereologically counted in 47x47x10 μm
3
 confocal stacks of stratum lacunosum 
molecular of the hippocampus Two-way ANOVA for age and genotype did not show 
any significant effect of genotype or age in the number of nodes (p > 0.05). WT 
young: n=11, WT old: n=12, TgAPPSw,Ind young: n=14, TgAPPSw,Ind old n=15. 
Graphs show mean ± SEM.  
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3.3.6 Myelin alterations with normal ageing in the hippocampus  
Since myelin loss has been a feature of ageing and AD and myelin sheath alterations 
have been proposed to play a role in nodal disruption the integrity of myelin was next 
investigated in the stratum lacunosum moleculare; the same region where age-related 
decrease of nodal length was observed. This was achieved with immunolabelling for 
myelin basic protein (MBP) (Figure 3.8 A-D). Both the percentage area occupied by 
MBP as a measure for the myelinated fibers population and the intensity of MBP 
staining as a measure for the MBP content in the myelinated fibers were assessed in 
young (n=14) and old (n=12) wild-type mice and in young (n=14) and old (n=15) 
TgAPPSw,Ind mice. Notably, the area occupied by MBP staining was found to be 
reduced by age (p = 0.0234, F (1-51) = 5.463, Figure 3.8 E) but it was not affected by 
genotype (p = 0.1300, F (1-51) = 2.369) and there was not a significant overall 
interaction between age and genotype (p = 0.1741, F (1-51) = 1.900). Post-hoc 
analysis showed that there is a significant decrease in the percentage area occupied 
by MBP in the aged wild-type (p < 0.05, │t│= 2.559) but not in the aged 
TgAPPSw,Ind (p > 0.05, │t│= 0.6969) when compared to younger animals. 
Moreover, there was no significant difference between wild-types and TgAPPSw,Ind 
either at a young (p > 0.05, │t│= 2.046) or old age (p > 0.05, │t│= 0.1145).  
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Figure 3.8 Alterations of myelin integrity in response to ageing in the stratum 
lacunosum moleculare of the hippocampus. Myelin integrity was assessed in the 
stratum lacunosum moleculare of the hippocampus using myelin basic protein 
(MBP) immunostaining [A-D]. There was a significant overall effect of age in 
percentage area occupied by MBP (p < 0.05). Post-hoc testing showed that myelin 
density was significantly reduced (p < 0.05) in aged WT when compared to young 
WT mice. There was no significant difference (p > 0.05) in myelin density with 
increased Aβ in old TgAPPSw,Ind as compared to young TgAPPSw,Ind [I]. WT 
young: n=14, WT old: n=12, TgAPPSw,Ind young: n=14, TgAPPSw,Ind old n=15. 
*: p < 0.05. Graphs show mean ± SEM. Scale bar 20μm.  
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Similarly, the intensity of MBP staining was significantly reduced by age (p = 
0.0124, F (1-51) = 6.717) but not by genotype (p = 0.5329, F (1-51) = 0.3942) and no 
significant interaction between age and genotype (p = 0.2760, F (1-51) = 1.213) was 
observed (Appendix A1 A). Post-hoc analysis showed that a significant age-related 
decrease in the intensity of MBP staining in the wild-type animals (p < 0.05, │t│= 
2.54) but not in the TgAPPSw,Ind (p > 0.05, │t│= 1.084). Moreover, there was no 
significant difference between wild-types and TgAPPSw,Ind either at a young (p > 
0.05, │t│= 1.213) or old age (p > 0.05, │t│= 0.0337). 
Detailed observation of MBP staining revealed morphological alterations in the form 
of myelin bulbs that share similarities with the myelin sheath balloons observed in 
normal ageing. The number of myelin bulbs was stereologically counted in the same 
confocal stacks used for MBP measurements (Figure 3.9 A-D). Data showed a 
significant increase in the number of myelin bulbs in the aged animals (p = 0.0071, F 
(1-51) = 7.870) an effect which was independent of genotype (F (1-51) = 0.6524, p = 
0.4229) whilst no significant interaction between age and genotype (F (1-51) = 0.1033, 
p = 0.7492) was observed (Figure 3.9 E). These findings suggest that ageing has an 




Figure 3.9 Number of myelin bulbs increased with age in the stratum lacunosum 
moleculare of the hippocampus. The number of myelin bulbs was stereologically 
determined in 76.8x76.8x10 μm
3
 confocal stacks double stained for total 
neurofilament [A] and MBP [B] imaged at the stratum lacunosum moleculare of the 
hippocampus. There was a significant increase in the number of myelin bulbs [C & 
D] with age (p < 0.05) [E] but no significant difference between the genotypes was 
observed at any age. WT young: n=14, WT old: n=12, TgAPPSw,Ind young: n=14, 
TgAPPSw,Ind old n=15. [A-C] Scale bar 10 μm, [D] Scale bar 5 μm. Graphs show 
mean ± SEM.  
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3.3.7 No evidence of axonal damage with normal ageing in the 
hippocampus of both wild-type and TgAPPSw,Ind animals 
Given that loss of axons may be responsible for the observed age-related myelin 
alteration, therefore the integrity of axons was examined in the same region. This 
was achieved with immunolabelling for total neurofilament (SMI312) (Figure 3.10 
A-D). The percentage area occupied by total neurofilament and the intensity of 
SMI312 staining was assessed in young (n=13) and old (n=12) wild-type mice and in 
young (n=14) and old (n=15) TgAPPSw,Ind mice. It was shown that there was no 
significant effect of age (p = 0.4568, F (1-50) = 0.5624,) or of genotype (p = 0.3159, F 
(1-50) = 1.026) and no significant overall interaction between age and genotype (p = 
0.9843, F (1-50) = 0.0004) was observed in the percentage area occupied by total 
neurofilament (Figure 3.10 E). Similarly, no significant effect of age (p = 0.276, F (1-
50) = 1.212,) or of genotype (p = 0.8669, F (1-50) = 0.0284) and no significant overall 
interaction between age and genotype (p = 0.8158, F (1-50) = 0.0548) was observed in 
the intensity of SMI312 staining (Appendix A.1 B). This data suggests that although 
there is evidence of MBP staining loss in response to ageing this is not a result of 
axonal loss.   
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Figure 3.10 No alterations in axonal integrity in response to ageing in the stratum 
lacunosum moleculare of the hippocampus in both wild-type and TgAPPSw,Ind 
animals. Axonal integrity was assessed in the stratum lacunosum moleculare of the 
hippocampus using total neurofilament (SMI312) immunostaining [A-D]. Two-way 
ANOVA for age and genotype did not show any significant effect of genotype or age 
on percentage area occupied by total neurofilament (p > 0.05) [I]. WT young: n=13, 
WT old: n=12, TgAPPSw,Ind young: n=14, TgAPPSw,Ind old n=15. Graphs show 
mean ± SEM. Scale bar 20μm.  
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3.3.8 No change in levels of myelin basic protein and total 
neurofilament with ageing in both wild-type and TgAPPSw,Ind animals 
Levels of myelin basic protein (MBP) and total neurofilament were also examined in 
tissue homogenates from the hippocampus to determine if there are changes in 
protein levels overall. Western blotting for MBP showed four bands at 21.5, 18.5, 17 
and 14 KDa (Figure 3.11 A), all four bands were quantified. Western blotting for 
total neurofilament detected with the SMI312 antibody showed a band at 200 KDa 
(Figure 3.11 A), which was quantified. There was no significant effect of age (p = 
0.995, F (1-50) = 0.00003) or genotype (p = 0.7337, F (1-50) = 0.1171) and no 
significant interaction between age and genotype (p = 0.2872, F (1-50) = 1.157) in the 
levels of MBP (Figure 3.11 B). Similarly, there was no significant effect of age (p = 
0.5530, F (1-50) = 0.3567) or genotype (p = 0.2337, F (1-50) = 1.453) and no significant 
interaction between age and genotype (F (1-50) = 0.0015, p = 0.9694) in the levels of 
total neurofilament (Figure 3.11 C).  
 110 
 
Figure 3.11 No change in levels of myelin basic protein and total neurofilament 
with ageing. Total levels of MBP and total neurofilament levels were assessed in 
tissue homogenates of the hippocampus using western blotting [A]. It was shown that 
there was no significant overall effect of age or genotype (p > 0.05) in the levels of 
MBP [B] or total neurofilament [C]. WT young: n=14, WT old: n=12, TgAPPSw,Ind 
young: n=13, TgAPPSw,Ind old n=15.Graphs show mean ± SEM.  
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3.3.9 Increased presynaptic terminal density in young TgAPPSw,Ind 
compared to wild-type mice and age-dependent decrease in 
TgAPPSw,Ind mice. 
Synaptic loss is observed in both normal ageing and in AD. Synaptic input is 
proposed to play a role in the plasticity of AIS length, therefore presynaptic terminal 
density was assessed in the CA3 region of the hippocampus where the alterations in 
AIS length were found using immunolabelling for synaptophysin (Figure 3.12 A-D). 
The percentage area occupied by presynaptic terminals was assessed, as a measure of 
presynaptic terminal density, in young and old TgAPPSw,Ind and wild-type mice. 
There was a significant effect of age (p = 0.0227, F (1-52) = 5.514) and of genotype (p 
= 0.0135, F (1-52) = 6.541) in the density of presynaptic terminals. There was however 
no interaction between age and genotype (p = 0.0227, F (1-52) = 5.514). Notably, post-
hoc analysis showed that there is a significant decrease postsynaptic terminal density 
in the aged TgAPPSw,Ind mice (p < 0.05, │t│= 2.701) but not in wild-types (p > 
0.05, │t│= 0.9484) when compared to young animals of the same genotype (Figure 
3.12 E). Moreover, there was a significant increase in presynaptic terminal density in 
the young (p < 0.05, │t│= 2.507) but not in the aged (p > 0.05, │t│= 0.8161) 
TgAPPSw,Ind mice when compared to wild-type animals of the same age (Figure 
3.12 E). These findings suggest that synaptic density is different between the wild-
types and the TgAPPSw,Ind and that is reduced in response to ageing.  
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Figure 3.12 Increased presynaptic terminal density in young TgAPPSw,Ind 
compared to wild-type mice and age-dependent decrease in TgAPPSw,Ind mice. 
Presynaptic terminal density was assessed in the CA3 region of the hippocampus 
using immunolabelling for synaptophysin [A-D]. There was a significant effect (p < 
0.05) of age and genotype in the area occupied by presynaptic terminals [E]. The 
young TgAPPSw,Ind mice have more presynaptic terminals when compared to WT 
of the same age (p < 0.05) while the density of presynaptic terminals in the aged 
TgAPPSw,Ind mice is significantly reduced in comparison with young animal of the 
same genotype (p < 0.05). WT young: n=14, WT old: n=13, TgAPPSw,Ind young: 
n=14, TgAPPSw,Ind old n=15. *: p < 0.05. Graphs show mean ± SEM. Scale bar 
20μm.  
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3.3.10 Increased Aβ deposition in the stratum lacunosum moleculare of 
the hippocampus of aged TgAPPSw,Ind mice. 
Aβ deposition at the hippocampus was also examined in the animals included in the 
study in order to confirm the Aβ load since the collected data so far did not show and 
difference between the aged wild-type and TgAPPSw,Ind animals. Deposition of β-
amyloid was localised to the hippocampus and particularly in the stratum lacunosum 
moleculare of TgAPPSw,Ind mice where it was analysed (Appendix A2 A-D). There 
was no Aβ deposition in the wild-type animals. The extent of Aβ immunostaining 
was significantly increased in the TgAPPSw,Ind animals (Appendix A2 E) compared 
to the wild-types (p = 0.0007, F (1-50) = 13.17). Moreover, the extent of Αβ load in the 
stratum lacunosum was significantly increased with age (p = 0.0258, F (1-50) = 5.28). 
There was also a significant interaction between age and genotype (p = 0.0239, F (1-
50) = 5.42). Post-hoc analysis showed that the aged APPSw,Ind have a greater extent 
of Aβ in the stratum lacunosum moleculare occupied by β-amyloid when compared 
to young TgAPPSw,Ind (p < 0.01, │t│= 3.401) and aged wild-types (p < 0.001, 
│t│= 4.201). There was no significant difference between young and aged wild-type 
mice (p > 0.05, │t│= 0.02902) or young wild-type and young TgAPPSw,Ind mice (p 
> 0.05, │t│= 0.922). These findings confirm the aged dependent nature of Aβ 




3.3.11 Increased human amyloid precursor protein (hAPP) and 
monomeric Aβ levels in the hippocampus of aged TgAPPSw,Ind mice. 
Total levels of human amyloid precursor protein (hAPP) and levels Aβ species were 
also assessed in tissue homogenates to determine whether they are increased with 
age. Human APP, β-amyloid trimer and Aβ monomer were detected only in the 
TgAPPSw,Ind mice and not in wild-type mice. Western blotting for hAPP, β-
amyloid trimer and Aβ monomer showed bands at 100, 12 and 4 KDa respectively 
(Figure 3.13 A). Human APP levels were significantly increased in the ages 
TgAPPSw,Ind mice compared to the young (Figure 3.13 B, p = 0.0016, │t│= 3.567). 
Aβ trimer levels were unchanged in the aged TgAPPSw,Ind mice compared to the 
young (Figure 3.13 B, p = 0.2519, │t│= 1.174). Monomeric β-amyloid levels were 
significantly increased in the aged TgAPPSw,Ind mice when compared to young 
animals (Figure 3.13 B, p = 0.0343, │t│= 2.245). These findings show that both the 
expression of the hAPP and monomeric Aβ are elevated in the aged TgAPPSw,Ind 
mice. Thus the work indicates that despite the elevated levels of hAPP and Aβ in the 
aged TgAPPSw,Ind mice and their absence from the wild-type animals there is 
minimal effect of TgAPPSw,Ind genotype on nodal and AIS length, and gross 
myelin and axonal integrity.  
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Figure 3.13 Increased hAPP and monomeric β-amyloid levels in aged 
TgAPPSw,Ind mice. Human amyloid precursor protein (hAPP) and monomeric 
amyloid levels where assessed in tissue homogenates of the hippocampus using 
western blots [A]. In the TgAPPSw,Ind there was a significant increase of hAPP (p < 
0.01) and monomeric Aβ (p < 0.05) with ageing. Aβ trimer levels were unchanged. 
TgAPPSw,Ind young: n=12, TgAPPSw,Ind old: n=14. **: p < 0.01, *: p < 0.05. 
Graphs show mean ± SEM.  
 116 
3.3.12 Working memory is not affected in aged wild-type or 
TgAPPSw,Ind mutant animals 
Since the AIS and the nodes of Ranvier have an important role in neuronal function it 
was predicted that the alterations observed in these structures would have a 
functional impact on spatial working memory performance. Spatial working memory 
performance of young and old TgAPPSw,Ind mutant and wild-type mice was 
examined in the eight-arm radial arm maze task. Data for number of novel arm 
entries in the first eight entries, number of errors were analysed.  
All groups significantly increased the number of novel arm entries in the first eight 
entries across the training period (p < 0.0001, F (7-364) = 33.987, Figure 3.14 A-D) and 
by block 5 (a trial block is two days) performed significantly better (WT young, p = 
0.0012; WT old, p = 0.0025; TgAPPSw,Ind young, p = 0.0004; TgAPPSw,Ind, p = 
0.0292) than chance (5.3 entries) suggesting that all groups learn the task. However, 
there was no significant effect of age (p = 0.609, F (1-52) = 0.265, Figure 3.14 A and 
B) or genotype (p = 0.080, F (1-52) = 3.180, Figure 3.14 C and D) and no significant 
interaction between age and genotype (p = 0.129, F (1-52) = 2.376) observed in the 
number of novel arm entries in the first eight entries. Similarly, the number of errors 
was significantly decreased across the training trials in all groups period (p < 0.0001, 
F (7-364) = 24.137, Figure 3.15 A-D). Similar to the novel arm entries results, it was 
shown that there was no significant difference between the different age groups (p = 
0.716, F (1-52) = 0.133, Figure 3.15 A and B) or between the different genotypes (p = 
0.781, F (1-52) =0.078, Figure 3.15 C and D) and no significant interaction between 
age and genotype (p = 0.781, F (1-52) = 0.078) was observed in the number of errors. 
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These findings suggest that despite the observed alterations in the AIS and the nodes 
of Ranvier described earlier in this chapter in response to ageing or genotype, spatial 
working memory performance is not affected.  
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Figure 3.14 Number of novel arm entries is not changed in aged TgAPPSw,Ind 
and wild-type mice. All groups significantly increased (p < 0.05) the number of 
novel arm entries in the first eight entries across the training period of 16 days (a trial 
block is two days). By trial-block 4 the mice have learned the task and perform 
above chance (5.3 entries, dash line). Overall the aged WT [A] and TgAPPSw,Ind 
animals [B] make the same number of novel entries when compared to young 
animals of the same genotype (p > 0.05). Moreover, there was no significant 
difference (p > 0.05) in the number of novel arm entries between WT and 
TgAPPSw,Ind mice at either age [C & D]. WT young: n=14, WT old: n=13, 
TgAPPSw,Ind young: n=14, TgAPPSw,Ind old: n=15.Graphs show mean ± SEM.  
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Figure 3.15 Number of revisiting errors is not changed in aged TgAPPSw,Ind and 
wild-type mice. All groups significantly decreased (p < 0.05) the number of revisiting 
errors across the training period of 16 days (a trial block is two days). Overall the 
aged WT [A] and TgAPPSw,Ind animals [B] make the same number of errors when 
compared to young animals of the same genotype (p > 0.05). Moreover, there was no 
significant difference (p > 0.05) in the number of errors between WT and 
TgAPPSw,Ind mice at either age [C & D]. WT young: n=14, WT old: n=13, 
TgAPPSw,Ind young: n=13, TgAPPSw,Ind old: n=15.Graphs show mean ± SEM.  
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3.3.13 Working memory performance of young and aged wild-type and 
TgAPPSw,Ind animals in the 8-arm radial arm maze is not associated 
with the nodal or AIS length 
In order to investigate whether the measures of nodal length and AIS length can be 
related to working memory performance in the 8-arm radial arm maze, for each 
animal the average Nav1.6 cluster and AIS length was plotted against the number of 
revisiting errors at trial block 8 (Figure 3.16 A and B). There was no significant 
correlation between the number of revisiting errors and the Nav1.6 cluster length 
(Figure 3.16 A, p = 0.9467, r = 0.009909) or the AIS length (Figure 3.16 A, p = 
0.3862, r = 0.1192). These findings suggest that the observed changes in the length 




Figure 3.16 Working memory performance in the 8-arm radial arm maze is not 
associated with the nodal or AIS length. Plotting the number of revisiting errors 
(trial block 8) together with the means of Nav1.6 cluster length [A] and AIS length 
[B} showed no significant association (p > 0.05, Spearman’s correlation analysis).  
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3.3.14 Working memory performance of young and aged TgAPPSw,Ind 
animals in the 8-arm radial arm maze is not associated the hippocampal 
load of monomeric Aβ 
In order to investigate working memory performance in the 8-arm radial arm maze is 
related to the levels of Aβ in the hippocampus of the TgAPPSw,Ind mice for each 
animal the protein level of monomeric Aβ was plotted against the number of 
revisiting errors at trial block 8 (Figure 3.17). There was no significant correlation 
between the number of revisiting errors and the monomeric Αβ protein levels (p = 
0.5337, r = 0.1278). This data suggests there might not be a relation between Αβ load 




Figure 3.17 Working memory performance in the 8-arm radial arm maze is not 
associated with Αβ levels in the TgAPPSw,Ind mice. Plotting the number of 
revisiting errors (trial block 8) together with the levels of monomeric showed no 
significant association (p > 0.05, Spearman’s correlation analysis).  
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3.3.15 Summary of results 
The following table (Table 3.3) summarises the findings described in the present 
chapter. 
Table 3.2 Summary of results  
Feature examined Findings 
AIS length 
↓ in aged WT compared to young 
↓ in young APPSw,Ind compared to WT 
AIS number ↔ 
Nav1.6 cluster length  
↓ in aged WT and APPSw,Ind compared to young of the 
same genotype 
Nav1.6 cluster width  ↓ in aged WT compared to young 
Nodal gap length  
↓ in aged WT and APPSw,Ind compared to young of the 
same genotype 
Nodal number ↔ 
MBP (% area) ↓ in aged WT compared to young 
Number of myelin bulbs ↑ in aged animals compared to young 
SMI312 (% area) ↔ 
MBP and SMI312 
protein levels 
↔ 
Synaptophysin (% area) 
↑ increased in young APPSw,Ind compared to WT 
↓ decrease in aged APPSw,Ind compared to young 
Aβ deposition  ↑ increased in aged APPSw,Ind compared to young 
hAPP levels ↑ increased in aged APPSw,Ind compared to young 
Aβ monomer levels ↑ increased in aged APPSw,Ind compared to young 
Novel arm entries in the 
first 8 entries & number 









It is known that with both normal ageing and AD neuronal networks are 
compromised particularly within the hippocampus and this has been linked with 
cognitive decline (Rosenzweig and Barnes, 2003; Geula, 1998; Celone et al., 2006; 
Kanak et al., 2013). The AIS and the nodes of Ranvier are specialized regions within 
the myelinated axons responsible for action potential initiation and propagation. 
Disruption to the AIS and nodes of Ranvier integrity could have critical effects on 
nervous system function. This study demonstrates that the structure of the AIS and 
nodes of Ranvier are markedly affected with age. A significant reduction in the 
length of nodes of Ranvier was demonstrated in aged wild-type and TgAPPSw,Ind 
mice. In addition, the length of AIS was significantly reduced in the aged wild-type 
animals while the young TgAPPSw,Ind had significantly shorter AIS than the wild-
type mice of the same age. In contrast to the original hypothesis these effects on the 
nodes and AIS were not influenced by the presence of amyloid-β.  
It has previously been shown that both the AIS and nodes of Ranvier are sensitive to 
different types of brain injury (Schafer et al., 2009; Hinman et al., 2006; Hinman et 
al., 2013; Reimer et al., 2011). Thus it was hypothesised that ageing would also have 
an effect on these structures. In support of this hypothesis marked alterations in AIS 
length and nodes of Ranvier were demonstrated, although there were no changes in 
their number. Ageing appears to reduce the AIS length by 7.4% in the wild-type 
mice. Here, the changes in AIS length are observed in the CA3 of the hippocampus, 
a region that which plays an important role in hippocampal circuitry as it is 
suggested that information enters the hippocampus via projections of the entorhinal 
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cortex to the dentate gyrus that in turn projects on the CA3 (Gilbert and Brushfield, 
2009). Similar findings come from a rat model of mild traumatic brain injury (mTBI) 
induced by a blast wave where there was a 1-4% decrease in AIS length in the 
hippocampus of the injured animals associated with long-lasting memory impairment 
(Baalman et al., 2013). In animal models of stroke however the proximity to the 
infarct area has a differential effect on AIS alterations. For example, middle cerebral 
artery occlusion induced stroke leads to proteolytic ablation of proteins such as 
AnkG and βΙV spectrin and no AIS structures could be identified within the infarct 
area (Schafer et al., 2009). Furthermore, in a mouse model of photothrombotic stroke 
of the motor cortex where focal ischaemic lesions are induced with retrograde 
neuronal tracing, it was demonstrated that in the peri-infarct region AIS morphology 
and length changes; with the AIS in the injured animals decreased by 14%, almost 
double the level of change observed in our aged wild-type animals (Hinman et al., 
2013). The number of AIS was also examined and found to be unchanged in 
response to ageing. Given that alterations in AIS number have been observed after 
ischemic insults where cell death is occurring (Hinman et al., 2013; Schafer et al., 
2009), it could be suggested that here the number of neurons in the CA3 is preserved 
in response to ageing which is consistent with multiple studies both in aged humans 
and rodents (Rapp and Gallagher, 1996; Rasmussen et al., 1996; West, 1993). 
Although, the observations in the present study are limited to alterations of the AIS 
length, over the last few years a number of studies have suggested that a mechanism 
for regulating neuronal excitability is alteration of AIS length. For example, in the 
chick it was shown that auditory synaptic deprivation results in elongation of AIS 
and decrease of excitation threshold thus increasing neuronal excitability (Kuba et 
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al., 2010). Moreover, in mouse model of Angleman syndrome, elongation of the AIS 
was observed in hippocampal pyramidal neurons and paired with increased action 
potential amplitude and rate of rise as well as decreased action potential threshold 
and this was associated with increased expression of AnkG (Kaphzan et al., 2011). In 
contrast, when reduction of AIS length was simulated in a computational model of 
pyramidal neurons, an increase in the threshold and the interspike interval of neurons 
fired repeatedly was observed (Baalman et al., 2013).  
Similar to the AIS, the length of the nodes of Ranvier was markedly reduced in 
response to ageing in the wild-type animals. The reduction of nodal length was 
observed in the stratum lacunosum moleculare which contains fibres that arise from 
pyramidal neurons in the CA3 and project onto the CA1 (Gilbert and Brushfield, 
2009). The observed reduction in nodal length is consistent with a number of studies 
that have reported age-related changes at the nodes of Ranvier and the surrounding 
regions such as the paranodes and the juxtaparanodes both in rodents and non-human 
primates. For example, a decrease, of the same magnitude, in the length of Nav 
cluster at the nodes of has been previously observed in the optic nerve of 2 years old 
wild-type mice (Rios et al., 2003). In the same study, it was suggested that the 
paranodal interactions play a key role in Nav channel distribution at the node of 
Ranvier as they act as a diffusion barrier for Nav clustering. Furthermore, the 
paranodes have been shown to be disrupted in normal ageing. In aged rats it was 
shown that piling of the myelin sheath paranodal loops are a feature of ageing. 
Furthermore not all the paranodal loops were in contact with the axon and there was 
loss of transverse bands (Shepherd et al., 2012). At a molecular level, Hinman et al. 
(2006) have shown alterations in the molecular architecture of the paranodes and the 
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juxtaparanodes with ageing. For example, they observed reduced expression of Kv1.2 
channels which were also mislocalized in the Caspr positive paranodal region. 
Moreover, in a mouse model, where oligodendrocyte-myelin glycoprotein (OMGp) 
was ablated, disorganized paranodal loops and a reduction of the nodal length as seen 
here were observed and there was also significant reduction of conduction velocity 
(Nie et al., 2006). These findings combined with our data indicate that ageing is 
responsible for alterations in nodes of Ranvier architecture. Our study is limited to 
the structural observation of the nodes of Ranvier but there is evidence that both the 
paranodes and the juxtaparanodes are affected by ageing. To assess paranodal 
disruption examination of the septate-like junctions with electron microscopy or 
Kv1.2 distribution at the paranodes would be necessary. 
The nodes of Ranvier and the AIS have similar molecular composition and it was 
hypothesised that the observed decrease in their length may be associated. In contrast 
with what was hypothesised no association was found between the length of the AIS 
and the nodes. A possible explanation is that two different markers were used to 
evaluate the length of these structures which may not be directly comparable. 
However, in both regions, the Nav1.6 channels are anchored in high concentrations, 
by direct interaction with the scaffolding protein AnkG. In the AIS, AnkG has the 
main role for organization of the AIS components as it was shown that in neurons 
lacking AnkG no Nav1.6 clustering was observed at the AIS (Hedstrom et al., 2008; 
Rasband, 2010). Hence the close relation between AnkG and Nav1.6 targeting at AIS 
may suggest that the decrease of AIS length detected with AnkG observed in the 
present study could suggest loss of Nav1.6 channels from that region. Hinman et al. 
(2013) have shown, that in a stroke mouse model, in the peri-infarct area where 
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decrease of AIS length was shown by AnkG there was no change in AnkG to Nav1.6 
length ratio suggesting that there is loss of Nav1.6 channels from the AIS. 
Additionally, the observed decrease in nodal length could suggest that there is loss of 
Nav1.6 channels from the nodes of Ranvier as well. Notably, Nie et al. (2006) in an 
OMGp-null mouse model, observed reduced nodal length together with decreased 
Nav subunit α levels. Moreover, studies in Nav1.6-null mouse models have shown 
that neurons lacking Nav1.6 channels have reduced spike frequency (Van Wart and 
Matthews, 2006) and increased threshold for spike initiation (Royeck et al., 2008) 
highlighting the importance of these channels for neuronal excitability. Assessment 
of Nav1.6 channel levels would determine whether these channels are altered in 
response to ageing both in the nodes and the AIS Moreover, in order to further 
investigate the effect of reduced AIS and nodal length on the neuronal excitability in 
aged animals, electrophysiological approaches or computational modeling of the 
changes would be necessary. 
The next aim of the study was to examine myelin and axonal integrity. Here it was 
demonstrated that there is age-dependent loss of MBP immunostaining in the wild-
type animals and an overall increased number of myelin bulbs in the stratum 
lacunosum moleculare. The decrease in MBP staining is in accordance with 
published data from studies in human and non-human primates that have reported a 
loss of white matter volume as well as ultrastructural alterations of splits and cavities 
(“balloons”) within the lamellae of the myelin sheath (Bartzokis et al., 2003; 
Feldman and Peters, 1998; Peters, 2002). Studies in other species has shown reduced 
myelin staining in response to ageing has been observed in canines (Chambers et al., 
2012) whereas in aged primates both loss of myelin staining (Sloane et al., 2003) and 
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thinner myelin sheaths (Bowley et al., 2010) have been observed. The structural 
alterations in the myelin sheath (myelin bulbs) observed here in the aged animals 
have similarities to the ultrastructural changes to the myelin sheath (myelin balloons) 
reported both in aged rodents and non-human primates (Bowley et al., 2010; Luebke 
et al., 2010; Peters, 2009; Sugiyama et al., 2002; Shepherd et al., 2012). These 
structures are suggested to be indicative of neurodegeneration (Peters, 2009) and 
have also been observed during demyelination (Summers and Appel, 1987; Ludwin, 
1978). Further ultrastructural analysis of these structures in ageing and 
TgAPPSw,Ind mice would be required. 
 In the present study there were no alterations in axons as assessed by total 
neurofilament in the stratum lacunosum moleculare. This finding is similar to other 
studies which show myelin alterations precede axonal degeneration (Sandell and 
Peters, 2003; Desai et al., 2009). Western blot analysis of MBP and total 
neurofilament levels in tissue homogenates of the hippocampus indicated that the 
levels were not changed in response to ageing. The discrepancy between MBP 
immunostaining and western blotting data may be due to the sensitivity of the two 
methods to detect differences. Immunostaining allows the identification of specific 
regional alterations whereas western blotting can only detect gross changes in protein 
levels. For example, Desai et al. (2009) show regional changes in MBP 
immunostaining within the hippocampus of aged 3xTg animals but when MBP levels 
are examined in hippocampal homogenates no change was found. 
Myelin integrity has been hypothesised to play an important role in nodal structure 
and has been closely investigated in demyelinated diseases or injury both in the CNS 
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and the PNS. For example, in PNS remyelination after nerve injury thinner myelin 
and shorter nodes are observed (Gaudet et al., 2011). In addition, a key feature of 
remyelinated axons is the decreased length of internodes (Powers et al., 2012; 
Lasiene et al., 2008) which subsequently increases the number of nodes (Black et al., 
2006). Ageing, however, did not appear to have an effect on the number of nodes. 
This is in accordance with another study where the number of nodes was examined 
by assessing the number of Caspr positive paranodal pairs in aged (17-22 months) 
wild-type mice (Shepherd et al., 2012). However, the decrease in nodal length 
without any changes in the number of nodes may be reflecting reduction in 
hippocampal fibre length which has been reported by studies in aged humans, non-
human primates and rodents (Marner et al., 2003; Calhoun et al., 2004; Ypsilanti et 
al., 2008). In addition, in multiple sclerosis diffusion of Nav channels along axons 
has been observed which has been attributed to profound demyelination, a hallmark 
of the disease (Coman et al., 2006; Smith, 2007). Although the changes in the nodes 
of Ranvier that have been observed here with normal ageing cannot be compared to 
the severity of those observed in demyelinating diseases such as multiple sclerosis, it 
becomes evident that the integrity of axon-glial crosstalk plays an important role. 
The assembly of the macromolecular complex required for Nav targeting at the AIS 
and the nodes of Ranvier requires cytoskeletal integrity (Susuki and Rasband, 
2008b). However, there is some evidence that some components of cytoskeleton such 
as αΙΙ spectrin are compromised with normal ageing, for example in aged rats it has 
been shown that there are elevated products of cytoskeletal breakdown mediated by 
calpain (Bernath et al., 2006). Moreover, in aged rhesus monkeys it was shown that 
there is an increase in calpain-mediated proteolysis of oligodendrocyte proteins 
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(Sloane et al., 2003). Calpain has also been pointed out as a key mechanism for AIS 
remodelling after stroke, Schafer et al. (2009) have shown elevation of the βΙV 
spectrin and AnkG calpain-mediated proteolytic products. Although, cytoskeletal 
integrity examined with an anti-total neurofilament antibody was found to be intact 
in the aged animals, it cannot be rejected that other cytoskeletal components, such as 
βIV spectrin, may be affected. Further investigation for calpain-mediated proteolytic 
products in hippocampal tissue homogenates of aged animals would be necessary to 
confirm age-dependent calpain activation.  
In addition, normal ageing is characterized by increased mitochondrial dysfunction, 
oxidative stress and neuroinflammation which are processes that have been linked 
with the integrity of the nodes of Ranvier (Bagh et al., 2011; Boumezbeur et al., 
2010; Stichel and Luebbert, 2007). The mitochondria are subcellular structures 
essential for energy production in the cell. In the normal ageing brain, there is 
evidence that the mitochondria accumulate mutations resulting in reduced 
cytochrome oxidase activity (Lin et al., 2002) and have reduced respiratory rates 
making the brain more susceptible to oxidative stress (Boveris and Navarro, 2008; 
Chakrabarti et al., 2011). Moreover, they play an important role in nodal function as 
they provide the required energy for the maintenance of plasma membrane potential 
equilibrium (Chiu, 2011). There is some evidence that there is dysregulation of  
mitochondrial distribution when then the axon-glial junction is disrupted (Einheber et 
al., 2006) suggesting that local energy metabolism at the node of Ranvier is regulated 
by axon glial-integrity which may be disrupted in normal ageing. As mentioned 
earlier, mitochondrial dysfunction leads to oxidative stress in the ageing brain. 
Moreover, neuroinflammation has been described in the healthy aged brain of many 
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species (Luo et al., 2010). Both these processes (oxidative stress and 
neuroinflammation) have been shown to reduce the oligodendroglial population 
(Balabanov et al., 2007; Cammer and Zhang, 1999; Deng et al., 2004; French et al., 
2009). Therefore, given that nodal assembly and maintenance is under glial control, 
alterations in the oligodendroglial cell number due to normal ageing could have an 
impact on nodal integrity. 
The hippocampus is a region vulnerable to AD-related damage thus it was 
hypothesised that in a mouse model which develops age-related deposition of 
amyloid within the hippocampus, as seen here, alterations to AIS and nodes may be 
exacerbated. In the present study, there is a baseline difference in AIS length with the 
young APPSw,Ind animals having shorter AIS than the young wild-types. However, 
there was no difference in AIS length in the aged animals between TgAPPSw,Ind 
and wild-type animals. There are very few studies investigating the integrity of AIS 
in AD. Interestingly, there is some evidence that genetic polymorphisms of ANK3 
gene which encodes for AnkG have been linked with late-onset AD (Morgan et al., 
2007). In addition, a recent study by Santuccione et al. (2013) showed in AD patients 
increased immunoreactivity against AnkG in their serum which reversely correlates 
with slower cognitive decline and altered distribution of AnkG and accumulation at 
the Αβ plaques. The integrity of AIS before the onset of Aβ pathology has never 
before been investigated and the reduction of AIS length measured by AnkG may 
also reflect loss of Nav1.6 from the region. Indeed there is evidence that in 4-7 
months old TgAPPSw,Ind (J20 line) mice that the expression of Nav1.6 channels is 
reduced in the cortex (Verret et al., 2012). However, similar to the current study, 
when the integrity of AIS was examined proximal to Aβ deposits in another model 
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(AβPP/PS1) at 12 months of age, no change in AIS length between APP 
overexpressing animals and wild types was observed (Leon-Espinosa et al., 2012). 
These findings suggest Aβ may drive an initial decrease in AIS length at a young age 
which this in not further exacerbated by age but is comparable with the decrease 
induced by ageing in the wild-type animals.  
Furthermore, in the aged APPSw,Ind mice nodal length was reduced but there was 
no evidence that this was different from the wild-type mice suggesting that this is not 
influenced by the presence of amyloid. The reduction in nodal length is similar to 
that observed in the wild-types here and in other studies (Rios et al., 2003). In 
contrast, a study in another AD model (3xTg) which develops overt amyloid 
pathology showed Nav1.6 immunoreactivity was reduced in the mutant animals at 6 
months of age (Desai et al., 2009). However, in that study the effect of ageing is not 
taken into account as young wild-type animals are used as controls. In the same study 
myelin disturbances where proposed to underlie the reduced in Nav1.6 
immunostaining. Here, in contrast to what was hypothesized, MBP and total 
neurofilament levels were unchanged in the aged TgAPPSw,Ind mice compared to 
young animals, there was however a significant overall increase in the number of 
myelin bulbs the aged animals. Myelin disruption has been described both in AD 
patients and other mutant APP models (Stokin et al., 2005; Desai et al., 2009) 
(deToledo-Morrell et al., 2007) and, similar to ageing, can occur prior to axonal 
damage (Bartzokis et al., 2003). However, there is evidence that alterations of myelin 
staining in the hippocampus of APP mutant animals are region-specific, with some 
regions such as the CA1 being affected while others such as the CA3 are not (Desai 
et al., 2009) which could explain the absence of myelin changes in the TgAPPSw,Ind 
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mice. Moreover, the current study is limited to the use of MBP and total 
neurofilament for the evaluation of myelin and axonal integrity. Examination of the 
myelinated axons at the stratum lacunosum moleculare with electron microscopy 
would provide evidence of myelin sheath and axonal disruption at an ultrastructural 
level. Axonal integrity could also be examined by investigating the level of 
neurofilament phosphorylation as there is evidence that it is increased in another AD 
model (Yang et al., 2009) whilst myelin integrity could be further investigated with 
the use of markers such as MAG which has been sensitive to axon glial disruption 
(Reimer et al., 2011).  
A number of studies have shown that AIS structure is not stable and there are 
homeostatic changes in response to altered synaptic input leading to changes of AIS 
length or axonal position (Kuba, 2010; Kuba et al., 2010; Grubb and Burrone, 2010a; 
Grubb and Burrone, 2010b). In this study synaptic integrity was investigated with the 
presynaptic vesicle protein synaptophysin. Interestingly, it was observed that the 
young TgAPPSw,Ind mice have increased baseline synaptophysin staining. This 
could be attributed to the neurotrophic properties of the sAPPα (Furukawa et al., 
1996) which is produced via the non-amyloidogenic processing of APP and may play 
a role in synaptic preservation (Bailey et al., 2011). In addition there are some 
evidence from animal models that in the early stages of Αβ pathology there is an 
increase in cholinergic, glutamatergic and GABAergic synaptic boutons (Bell et al., 
2003; Hu et al., 2003). Nevertheless, in accordance with previous studies in the 
TgAPPSw,Ind mice that have shown a deficit in synaptic electrophysiology (Hsia et 
al., 1999) and with studies in multiple AD animal models (Hsia et al., 1999; 
Chapman et al., 1999; Auffret et al., 2010), data from this study showed an age-
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dependent loss of synaptophysin positive presynaptic vesicles in the hippocampus. 
However, it remains unclear if these synaptic changes can be related with activity 
dependent changes in AIS structure. Loss directly associated with the AIS in 
GABAergic synapses has been demonstrated in an AD model (Leon-Espinosa et al., 
2012). Moreover, loss of axoaxonic GABAergic synapses, which are thought to be 
inhibitory, has been concomitantly observed with a decrease in AIS length in an 
animal model of stroke (Hinman et al., 2013). It becomes evident that this study is 
limited to a gross evaluation of presynaptic boutons and further investigation of the 
types of synapses that might be affected by ageing and/or increased Αβ levels would 
provide further insight on whether synaptic input alters AIS structure.  
The last aim of this study was to evaluate spatial working memory at the eight arm 
radial arm maze in aged wild-type and TgAPPSw,Ind mice. It was hypothesised that 
the observed alterations at the AIS and the nodes of Ranvier would have an effect on 
spatial working memory. However it was shown that spatial working memory was 
not impaired with ageing in either the wild-type or the TgAPPSw,Ind animals. 
Moreover the length of the nodes and the AIS was not associated with the 
performance (number of revisiting errors) in the 8-arm radial arm maze. This data 
suggests that the observed changes in the AIS and the nodes of Ranvier are not of 
enough magnitude to cause working memory impairment. This 8-arm arm radial arm 
maze test was chosen due to previous evidence that white matter disruption may 
result in poor working memory performance in the 8-arm radial arm maze (Coltman 
et al., 2011). Moreover, it is well established that spatial working memory 
impairment may be detected by the eight-arm radial maze test in aged rodents 
(Barnes et al., 1980; de Toledo-Morrell et al., 1984; Beatty et al., 1987; Caprioli et 
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al., 1991; Mizumori et al., 1996). However, the aged mice have inherent cognitive 
variability; for example, in a study where spatial working memory performance was 
examined in young (4 months old) and aged (18 months), the old animals were 
divided into good performers and bad performers based on the number of errors and 
only the bad performers showed slower improvement in learning the task (Ikegami, 
1994). Moreover, in the same study, by baiting with food pellets only four arms 
which made the task more difficult as it decreased chance for “correct” choices both 
subgroups of aged animals made more errors than the young animals. Furthermore, 
in a study where spatial working memory was examined at a later age (24 months 
old) with a delayed matching to place protocol at the eight-radial arm maze severe 
cognitive performance was impaired (Lebrun et al., 1990). From these studies it 
could be suggested that detection of spatial working memory deficits in the radial 
arm maze is dependent on the difficulty of the behavioural protocol used which 
might not have been sensitive enough to decipher differences between groups in the 
present study. Although, the data presented here does not suggest spatial working 
memory performance being related to Aβ load, there is evidence that memory is 
challenged in response to ageing both in the wild-type and TgAPPSw,Ind mice in 
hippocampus-specific tasks. For example, the 6-month old TgAPPSw,Ind mice show 
learning and memory deficits in Morris water maze (Valero et al., 2011) whilst aged 
wild-types show impaired spatial memory at 12 months old in Barnes maze (Bach et 
al., 1999). In addition, the eight-arm radial arm maze has two limitations, the 
presence of odours and the need for food deprivation. Odours from the food pellet 
placed at the end of each arm or from previously tested animals that might have 
remained, despite the thorough cleaning of the maze after each test, and facilitate 
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navigation. Further electrophysiological investigation would be necessary to 
establish the functional impact of the observed changes at the nodes of Ranvier and 
the AIS. For example, electrophysiological measurements (whole cell patch-clamp) 
form the CA3 region on hippocampal slices may give information for the way action 
potential amplitude or threshold changes when the AIS are shorter within that region. 
Overall, it has been demonstrated that ageing has direct effects on AIS and nodes of 
Ranvier structure. Both the AIS and the nodes of Ranvier appear to be sensitive in 
cerebral blood flow reduction. For example, after a stroke there is a pronounced 
disruption of the ablation of the AIS structure (Schafer et al., 2009) in the infarct area 
whilst in the perinfarct area reduction of the AIS length is observed (Hinman et al., 
2013). More modest reductions in cerebral blood flow can also cause rapid changes 
in axon-glial integrity and disruption of Nav1.6 within the nodes of Ranvier (Reimer 
et al., 2011). Given that hypoperfusion and cerebrovascular pathologies have been 
observed in normal ageing and AD both in humans and animal models (Stoquart-
ElSankari et al., 2007; de la Torre, 2009), it could be suggested that it is driving the 
observed changes. Additionally, hypoperfusion has been associated with white 
matter disruption (Shibata et al., 2004; Appelman et al., 2010), whilst myelinated 
axon and axon-glial integrity are important for AIS and nodal structure (Coman et 
al., 2006; Reimer et al., 2011; Zonta et al., 2011). The potential implication of 
hypoperfusion in nodes of Ranvier disruption will be investigated in the following 
chapter. 
To summarise, this is the first study demonstrating structural alterations in the AIS 
and/or the nodes in response to ageing and amyloid in the hippocampus. In the 
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future, it would be important to investigate the impact of these alterations on the 
electrophysiological properties of the neurons in the ageing brain. These alterations 
in the context of complex neuronal networks may play a role the breakdown of 
effective neuronal communication leading to age-related cognitive decline. Therefore 
it is essential to identify the mechanisms underlying the observed structural 




4 Effects of hypoperfusion on myelinated axon integrity and cognition in young and aged wild-
type and TgAPPSw,Ind mice 
 
4.1 Introduction 
Alterations to myelinated axons is a key feature of the ageing brain (Peters, 2002; 
Peters, 2009) and these changes are exacerbated in AD (Salat et al., 2009). These 
changes are associated with impairments in cognitive ability. The previous chapter 
demonstrated alterations to the protein architecture of myelinated axons, specifically 
in the node of Ranvier and the AIS, with ageing and modulation by amyloid, a key 
feature of AD.  
The mechanism responsible for alteration to myelinated axons in ageing and in AD is 
not clear. Cerebral hypoperfusion is a feature of normal ageing and is closely related 
with white matter changes. Modelling of cerebral hypoperfusion in rodents now 
permits the investigation of the effects of hypoperfusion in isolation which could 
provide a greater understanding of mechanisms underlying white matter alteration in 
response to hypoperfusion. Studies in this chapter build on previous work in a model 
of hypoperfusion where it was demonstrated that as early as three days after the 
induction of hypoperfusion the protein architecture of the nodes of Ranvier is 
changed and this change persists after one month in parallel with alterations at the 
paranodes (Reimer et al., 2011). In addition, other hypoperfusion studies in mice 
have provided evidence of widespread myelin damage and poor working memory 
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performance (Holland et al., 2011; Shibata et al., 2004). However, no previous 
studies have investigated the integrity of the nodes of Ranvier in response to 
hypoperfusion in relation with amyloid pathology and age.   
 
4.1.1 Hypothesis and aims 
It was hypothesised that the integrity of the myelinated axons and particularly the 
nodes of Ranvier and the paranodes would be altered in response to hypoperfusion 
and that these effects would be exacerbated in the presence of increased levels of Aβ 
and associated with working memory deficits in young and aged mice. In order to 
address this hypothesis the effects of surgically induced hypoperfusion on the 
integrity of the nodes of Ranvier, paranodes, myelin and axons and in working 
memory performance was investigated in young and aged wild-type and 
TgAPPSw,Ind mice which show increased amyloid levels with increasing age.   
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4.2 Materials & Methods 
4.2.1 Animals 
The transgenic mouse model used in this study is described in chapter 2.1. Animals 
were examined at 4 months and 16-17 months of age at the start of procedures in 
separated studies. Surgical procedures were performed Dr Cath Gliddon and Dr 
Philip Holland. 
Young study: Behavioural performance was examined in hypoperfused (n=14) and 
sham operated (n=13) TgAPPSw,Ind and compared to aged-matched wild-type 
C57Bl/6J control littermates (sham n=14, hypoperfused n=13). During behavioural 
testing, some animals had seizures which lead to their exclusion from the study under 
the exclusion criteria described in chapter 2.3.2. The final group numbers were n=12 
for the wild-type sham, n=12 for the WT hypoperfused, n=13 for the TgAPPSw,Ind 
sham and n=10 TgAPPSw,Ind hypoperfused. Tissue harvested from animals of this 
cohort was used for all biochemical experiments and for examining gross myelin and 
axonal integrity. Nodal and paranodal integrity was examined in a separate age-
matched cohort. The size of the groups was n=9 for the TgAPPSw,Ind hypoperfused; 
n=9 for the wild-type hypoperfused; n=9 for the TgAPPSw,Ind sham and n=9 for 
wild-type sham. The use of a different cohort was necessary because tissue at the 
appropriate level from the behavioural cohort was in shortage.  
Aged study: Behavioural performance was examined in hypoperfused (n=15) and 
sham operated (n=11) TgAPPSw,Ind and compared to aged-matched wild-type 
C57Bl/6J control littermates (sham n=14, hypoperfused n=12). All experiments were 
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performed on tissue harvested from animals of this cohort. However, nodal and 
paranodal integrity, in order to facilitate imaging and analysis, was examined in a 
subset of animals from each group with simple random sampling. For random 
sampling, the experimental numbers for each group were written on identical pieces 
of paper, folded and placed in a dark container, and then another researcher without 
direct visual contact with the container chose n number of papers. This was repeated 
for each group and the adjusted group sizes were n=9 for the TgAPPSw,Ind 
hypoperfused; n=9 for the wild-type hypoperfused; n=9 for the TgAPPSw,Ind sham 
and n=9 for wild-type sham.  
For the nodal measurements sample size calculations at both ages were performed to 
determine that the study is adequately powered as described in chapter 2.9. From a 
previously published study on the same model and under similar conditions by 
Reimer et al. (2011), the target difference in the length of the nodes was 0.24 μm 
(approximately 10% difference) and the standard deviation 0.705 μm which makes 
the standardized difference (d) = 0.340. With the use of the formula described in 
chapter 2.9, the 202 nodes need to be measured for the study to be well-powered. If 
30 nodes per animal are measured, each group should include a minimum of 7 
animals. This criterion is met by both studies.   
 
4.2.2. Behavioural testing  
4.2.2.1 Spatial working memory assessment 
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Behavioural testing in the radial arm maze began 4 weeks after the induction of 
hypoperfusion. Spatial working memory assessment for the animals of the young and 
the aged cohort was performed as described in chapter 2.3.1. The number of novel 
(correct) entries in the first eight arm entries, the number of total arm entries, the 
number of revisiting errors and the duration of the task for all trials were recorded. 
The experiments were performed by the author and Dr Gillian Scullion.  
 
4.2.3 Neuropathological assessment 
4.2.3.1 Perfusions and tissue preparation  
Mice were sacrificed 8 weeks after surgery as described in chapter 2.4.1. Tissue was 




The integrity of myelinated axons was examined using antibodies against myelin 
basic protein (MBP) and total neurofilament. Alterations to the length and the 
number of nodes of Ranvier were examined using antibodies against Caspr and 
Nav1.6 and paranodal integrity was examined with Kv1.2 and Caspr double labeling. 
The fluorescent immunochemistry techniques used are described in chapter 2.5.1. 
Myelin and axonal integrity was assessed on single confocal images acquired with a 
Zeiss Axioskope LSM 710 confocal laser scanning microscope using a 20× objective 
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(numeric aperture 0.8), a pinhole of 1 Airy unit and x1 zoom in the corpus callosum 
in sections stained for MBP and total neurofilament as described in chapter 2.6.2. 
The length, the nodal gap length and the number of the nodes were examined in the 
corpus callosum and stratum lacunosum moleculare of the hippocampus in sections 
stained for Nav1.6 and Caspr as described in chapters 2.6.5 and 2.6.6. Colocalization 
of Kv1.2 and Caspr was examined at the corpus callosum as described in chapter 
2.6.7. In some animals imaging was impossible because of poor quality of staining 
and tissue (exclusion criteria described in chapter 2.5.5). The final analysis was 
conducted in groups whose size is detailed in table 4.1 for the young study and in 
table 4.2 for the aged.  
Table 4.1 Group sizes of the animals included in final analysis for the young study  
Analysis 
(young study) 









Nodal length, width 
and number 
9 8 8 8 
Kv1.2 9 9 8 9 
MBP and total 
neurofilament analysis 
10 12 13 10 
 
Table 4.2 Group sizes of the animals included in final analysis for the aged study  
Analysis 
(aged study) 









Nodal length and 
number 
8 8 9 8 
Kv1.2  9 8 9 9 
MBP and total 
neurofilament analysis 
11 13 11 12 
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4.2.4 Biochemistry 
The 2mm hippocampal coronal slices of the right hemibrain from the animals of the 
young and the aged were then homogenized as described in chapter 2.7.1. Protein 
concentration was determined as described in chapter 2.7.2. MBP, pan 
neurofilament, 200KDa neurofilament, APP and APP C-terminal fragments levels 
were determined using anti-MBP, anti-pan neurofilament, anti-neurofilament 
200KDa, anti-APP and anti-APP C-terminal fragments antibodies respectively. 
Western blotting was performed as described in 2.7.4 by the author and Dr Gillian 
Scullion. Human Aβ42 levels were detected ELISA as described in chapter 2.7.3, the 
experiment was run by Mrs Natalia Salvadores. Quantification of MBP, pan 
neurofilament, 200KDa neurofilament, APP, C83 and C99 fragments and oligomeric 
amyloid levels performed as detailed in 2.7.5. 
 
4.2.5 Statistical analysis  
All nodal length measurements were analysed using the two-sample Kolmogrov-
Smirnov test. Spearman’s correlation test was used to associate changes between the 
Nav1.6 cluster to nodal gap length ratio with working memory performance. The 
number of nodes, MBP and total-neurofilament intensity and area fraction, 
Kv1.2/Caspr colocalization and MBP, total neurofilament, NF200, APP and APP C-
terminal fragments levels and the gradient of the line generated between the numbers 
of errors in block 1 to block 8 (8-arm radial arm mase) were analysed by 2-way-
ANOVA with genotype and hypoperfusion as the factors, followed by Bonferroni’s 
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post hoc test if necessary. Differences in the levels of oligomeric Aβ or hΑβ42 
concentration in sham and hypoperfused TgAPPSw,Ind mice were analysed using 
the student’s unpaired t-test. Data acquired at the 8-arm radial arm maze was 
analysed with two-way (effect of hypoperfusion and genotype over training days) 
repeated measures ANOVA followed by Tukey’s post hoc test. Additionally, the 
Greenhouse-Geiser correction was used when data violated sphericity (p < 0.05 at 
Mauchly’s test). Software used for statistical analysis and the graph generation is 
detailed in 2.8. For all statistical tests ,significance was established at p < 0.05, 
except from the Kolmogrov-Smirnov test where the Bonferroni correction was 
applied adjusting significance at p < 0.025 as described in chapter 2.8 because 
identical datasets where used simultaneously twice.  
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4.3 Results 
4.3.1 Hypoperfusion decreases Nav1.6 cluster and nodal gap length in 
the nodes of Ranvier of the corpus callosum but not of the 
hippocampus in young animals 
The nodes of Ranvier are important for action potential propagation and there is 
evidence that they are altered in length in response to cerebral hypoperfusion. The 
first aim of the study was to assess whether the integrity of the nodal domain may be 
altered in response to hypoperfusion and increased levels of Aβ in young animals. 
The myelinated axons were investigated in both the corpus callosum, known to be 
susceptible to the effects of hypoperfusion, and the hippocampus (stratum lacunosum 
moleculare) which is the primary site of age-dependent amyloid deposition in the 
TgAPPSw,Ind animals. In general the nodes were readily identifiable (Nav1.6 
immunopositive clusters bounded by pairs of Caspr immunopositive domains) in all 
sections and there were no obvious morphological alterations between the individual 
mice. 
Examination of at the corpus callosum of young wild-type and TgAPPSw,Ind mice 
revealed alterations to the Nav1.6 channel clusters size and the nodal gap in response 
to hypoperfusion (Figure 4.1 A). In the wild-type animals the average length of the 
Nav1.6 cluster was found to be 2.32 ± 0.05 μm in the shams and 2.01 ± 0.05 μm in 
the hypoperfused animals whilst in the sham TgAPPSw,Ind the average Nav1.6 
cluster length was 2.22 ± 0.05 μm and 1.74 ± 0.04 μm in the hypoperfused 
TgAPPSw,Ind mice. There was a significant reduction in the length of Nav1.6 cluster 
length in the hypoperfused wild-types (p < 0.0001, D = 0.2444, Figure 4.1 B) and 
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TgAPPSw,Ind animals (p < 0.0001, D = 0.2879, Figure 4.1 C) by 13.6 ± 2.9% and 
21.9 ± 3% respectively when compared to sham animals of the same genotype. 
Moreover, there was a significant difference (by 13 ± 3.1%) in the Nav1.6 cluster 
length between hypoperfused wild-type and TgAPPSw,Ind animals (p < 0.0001, D = 
0.1851, Figure 4.1 E), suggesting that hypoperfusion has an even greater effect in 
reducing the Nav1.6 cluster length in the TgAPPSw,Ind mice. No difference was 
observed between sham wild-types and sham TgAPPSw,Ind (p = 0.095, D = 0.1084, 
Figure 4.3 D).  
Since a decrease in the Nav1.6 cluster length was observed in response to 
hypoperfusion, it was then investigated whether the paranodes were similarly altered. 
A decrease in the nodal gap length defined by pairs of Caspr immunopositive 
domains (Figure 4.1 A) was observed in the hypoperfused animals. In the sham wild-
type animals the average nodal gap length was 1.27 ± 0.04 μm and 1.02 ± 0.04 μm in 
the hypoperfused wild-type animals whilst in the sham TgAPPSw,Ind the average 
nodal gap length was 1.27 ± 0.05 μm and 0.81 ± 0.03 μm in the hypoperfused 
TgAPPSw,Ind mice. When comparing sham and hypoperfused animals a significant 
reduction in nodal gap length both in the wild-type (p < 0.0001, D = 0.2494, Figure 
4.2 A) and the TgAPPSw,Ind (p < 0.0001, D = 0.3512, Figure 4.2 B) mice by 20.1 ± 
4.1% and 35.9 ± 4.3% respectively was found. Additionally, the nodal gap was 
significantly smaller by 20.1 ± 4.4% in the hypoperfused TgAPPSw,Ind mice 
compared to the wild-type animals (p < 0.0001, D = 0.2232, Figure 4.2 D). No 
difference was observed between sham wild-type and TgAPPSw,Ind animals (p = 
0.733, D = 0.0603, Figure 4.2 C).  
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Figure 4.1 Nav1.6 cluster length is decreased in the corpus callosum of young 
animals in response to hypoperfusion and this effect is exacerbated in 
TgAPPSw,Ind mice. Nav1.6 sodium channels clusters bounded by the paranodal 
protein Caspr outline the node of Ranvier [A]. There is a significant decrease (p < 
0.0001) in the length [B & C] of the Nav1.6 clusters in both WT and TgAPPSw,Ind 
hypoperfused animals, an effect that is exacerbated (p < 0.0001) in the 
TgAPPSw,Ind mice [E]. No difference (p > 0.05) was observed between sham 
animals of both genotypes [D]. The lengths of thirty Nav1.6 clusters per animal were 
analysed and plotted as percentage of cumulative frequency distribution. WT sham: 
n=9, WT hypoperfused: n=8, TgAPPSw,Ind sham: n=8, TgAPPSw,Ind hypoperfused 
n=8. Scale bar 2 μm.  
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Figure 4.2 Nodal gap length is decreased in the corpus callosum of young animals 
in response to hypoperfusion and this effect is exacerbated in TgAPPSw,Ind mice. 
There is a significant decrease (p < 0.0001) in nodal gap length [B-C] in both WT 
and TgAPPSw,Ind hypoperfused animals, an effect that is exacerbated (p < 0.0001) 
in the TgAPPSw,Ind mice [E]. No difference (p > 0.05) was observed between sham 
animals of both genotypes [D]. The nodal gap lengths of thirty nodes per animal 
were analysed and plotted as percentage of cumulative frequency distribution. WT 
sham: n=9, WT hypoperfused: n=8, TgAPPSw,Ind sham: n=8, TgAPPSw,Ind 
hypoperfused n=8.  
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The stratum lacunosum moleculare of the hippocampus was the second region that 
was examined and no change in the Nav1.6 cluster or nodal gap length was observed 
in response to hypoperfusion (Figure 4.3 A). The length of the Nav1.6 cluster was not 
different between hypoperfused wild-type (p = 0.501, D = 0.0704; Figure 4.3 B) or 
TgAPPSw,Ind mice (p = 0.354, D = 0.0815, Figure 4.3 C) when compared to sham 
animals of the same genotype. Moreover, no significant difference in the Nav1.6 
cluster length was observed between the two genotypes in the sham (p = 0.327, D = 
0.0833, Figure 4.3 D) or the hypoperfused (p = 0.083, D = 0.1074, Figure 4.3 E) 
animals. Similarly, the nodal gap length was not different between hypoperfused 
wild-type (p = 0.225, D = 0.0889, Figure 4.4 A) or TgAPPSw,Ind (p = 0.882, D = 
0.0514, Figure 4.4 B) animals when compared to sham animals of the same 
genotype. Moreover, no significant difference in nodal gap length was observed 
between wild-type and TgAPPSw,Ind in the sham (p = 0.907, D = 0.0495, Figure 4.4 
C) or hypoperfused (p = 0.435, D = 0.0741, Figure 4.4 D) animals. 
These findings suggest that in the corpus callosum of the young animals, 
hypoperfusion is causing a decrease to the size of the nodes of Ranvier and this effect 
is exacerbated in the TgAPPSw,Ind mice. However, this effect is region-specific as 
the nodes of Ranvier in the stratum lacunosum moleculare of the hippocampus are 




Figure 4.3 Nav1.6 cluster is not altered in the hippocampus of young animals in 
response to hypoperfusion. Nav1.6 clusters bounded by the paranodal protein Caspr 
outline the node of Ranvier [A]. No significant change (p > 0.05) in the length of the 
Nav1.6 clusters in response to hypoperfusion was observed [B & C]. The Nav1.6 
clusters were not different (p > 0.05) between WT and TgAPPSw,Ind in the sham or 
the hypoperfused animals [D & E]. The Nav1.6 cluster lengths of thirty nodes per 
animal were analysed and plotted as a percentage of cumulative frequency 
distribution. WT sham: n=9, WT hypoperfused: n=8, TgAPPSw,Ind sham: n=8, 
TgAPPSw,Ind hypoperfused n=8. Scale bar 2 μm.  
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Figure 4.4 Nodal gap is not altered in the hippocampus of young animals in 
response to hypoperfusion. No significant change (p > 0.05) in nodal gap length in 
response to hypoperfusion was observed [A & B]. Nodal gap length was not different 
(p > 0.05) between WT and TgAPPSw,Ind in the sham or the hypoperfused animals 
[C & D]. The nodal gap lengths of thirty nodes per animal was analysed and plotted 
as percentage of cumulative frequency distribution. WT sham: n=9, WT 
hypoperfused: n=8, TgAPPSw,Ind sham: n=8, TgAPPSw,Ind hypoperfused n=8.  
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4.3.2 Hypoperfusion decreases Nav1.6 cluster and nodal gap length in 
the nodes of Ranvier of the corpus callosum and the hippocampus of 
aged animals 
The next aim of the study was to investigate whether the alterations to the nodal 
structure observed in response to hypoperfusion and increased Aβ levels in young 
mice would be exacerbated with ageing. Thus the same approaches to those used 
previously were employed to study nodes/paranodes in cohorts of aged wild-type and 
TgAPPSw,Ind mice.  
In the aged cohort the Nav1.6 cluster and nodal gap length were also analysed in the 
corpus callosum (Figure 4.5 A) and the stratum lacunosum moleculare of the 
hippocampus (Figure 4.7 A). In corpus callosum of wild-type animals the average 
length of the Nav1.6 cluster was found to be 1.82 ± 0.05 μm in the shams and 1.65 ± 
0.05 μm in the hypoperfused animals whilst in the sham TgAPPSw,Ind the average 
Nav1.6 cluster length was 1.8 ± 0.05 μm and 1.52 ± 0.04 μm in the hypoperfused 
TgAPPSw,Ind mice. Similar to the young cohort in the corpus callosum there was a 
significant reduction in the length of Nav1.6 positive domains in response to 
hypoperfusion both in wild-type (p < 0.01, D = 0.1661, Figure 4.5 B) and the 
TgAPPSw,Ind animals (p < 0.0001, D = 0.1917, Figure 4.5 C) by 9.7 ± 3.8% and 
15.7 ± 3.4% respectively when compared to sham animals of the same genotype. 
However, no significant difference in the Nav1.6 cluster length was observed 
between the two genotypes in the sham (p = 0.948, D = 0.0458, Figure 4.5 D,) or the 
hypoperfused (p = 0.190, D = 0.1012, Figure 4.6 E) animals.  
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Since a decrease in the Nav1.6 cluster length was observed in response to 
hypoperfusion, whether the paranodes were similarly altered was then investigated. 
Indeed similar changes were observed in the nodal gap length at the corpus callosum. 
In the sham wild-type animals the average nodal gap length was 0.97 ± 0.04 μm and 
0.72 ± 0.03 μm in the hypoperfused wild-type animals whilst in the sham 
TgAPPSw,Ind average nodal gap length was 0.92 ± 0.03 μm and 0.71 ± 0.03 μm in 
the hypoperfused TgAPPSw,Ind mice. Hypoperfusion significantly decreased the 
nodal gap length in both wild-type (p < 0.0001, D = 0.2077, Figure 4.6 A) and the 
TgAPPSw,Ind (p < 0.0001, D = 0.1949, Figure 4.6 B) animals by 25.3 ± 5.2% and 
22.9 ± 4.7% respectively. No changes were observed between the two genotypes in 
the sham (p = 0.498, D = 0.0727, Figure 4.6 C) or the hypoperfused (p = 0.839, D = 
0.577, Figure 4.6 D) animals.  
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Figure 4.5 Nav1.6 cluster length is decreased in the corpus callosum of aged 
animals in response to hypoperfusion. Nav1.6 clusters bounded by the paranodal 
protein Caspr outline the node of Ranvier [A]. There is a significant decrease in the 
length [B & C] of the Nav1.6 clusters in both WT (p < 0.01) and TgAPPSw,Ind 
hypoperfused animals (p < 0.0001). No difference (p > 0.05) was observed between 
genotypes in the sham or the hypoperfused animals [D & E]. The lengths of thirty 
Nav1.6 clusters per animal were analysed and plotted as percentage of cumulative 
frequency distribution. WT sham: n=8, WT hypoperfused: n=9, TgAPPSw,Ind sham: 
n=8, TgAPPSw,Ind hypoperfused n=8. Scale bar 2 μm.  
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Figure 4.6 Nodal gap length is decreased in the corpus callosum of aged animals 
in response to hypoperfusion. There is a significant (p < 0.0001) decrease in the 
nodal gap length [A & B] in response to hypoperfusion in both WT and 
TgAPPSw,Ind animals. No difference (p > 0.05) was observed between genotypes in 
the sham or the hypoperfused animals [C & D]. The nodal gap lengths of thirty nodes 
per animal were analysed and plotted as percentage of cumulative frequency 
distribution. WT sham: n=8, WT hypoperfused: n=9, TgAPPSw,Ind sham: n=8, 
TgAPPSw,Ind hypoperfused n=8.  
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In the aged cohort at the stratum lacunosum moleculare of the hippocampus, 
alterations to the Nav1.6 cluster and nodal gap length were observed in response to 
hypoperfusion (Figure 4.7 A). The average length of the Nav1.6 cluster was found to 
be 1.52 ± 0.04 μm in the shams and 1.40 ± 0.04 μm in the hypoperfused animals 
whilst in the sham TgAPPSw,Ind the average Nav1.6 cluster length was 1.56 ± 0.04 
μm and 1.38 ± 0.03 μm in the hypoperfused TgAPPSw,Ind mice. In hypoperfused 
wild-type the length of Nav1.6 clusters (p > 0.01, D = 0.1632, Figure 4.7 B) and the 
nodal gap length (p < 0.01, D = 0.1611, Figure 4.8 A) were significantly reduced 
compared to sham by 7.9 ± 3.2% and 13.4 ± 4.4% respectively. In the hypoperfused 
TgAPPSw,Ind animals, only the Nav1.6 cluster length was significantly decreased by 
11.9 ± 3.3% (p = 0.019, D = 0.1296; Figure 4.7 C) but not the nodal gap (p = 0.319, 
D = 0.0815, Figure 4.8 B) when compared to sham animals of the same genotype. 
Moreover, there was no significant difference in the Nav1.6 cluster length between 
the two genotypes in the sham (p = 0.340, D = 0.0829 Figure 4.7 D) or the 
hypoperfused animals (p = 0.346, D = 0.0795, Figure 4.7 E). Similarly, the nodal gap 
length was not different between wild-type and TgAPPSw,Ind either sham (p = 
0.041, D = 0.1224, Figure 4.8 C) or hypoperfused animals (p = 0.406, D = 0.0757, 
Figure 4.8 D) compared to wild-type animals. 
These findings suggest that similarly to the young animals, hypoperfusion causes a 
decrease in the size of the nodes of Ranvier in the corpus callosum of the aged 
animals. However, contrary to what is observed in the young mice, this effect was 
not exacerbated in the TgAPPSw,Ind mice. Additionally, ageing appears to increase 
susceptibility of the brain to hypoperfusion as the nodes of Ranvier in the 




Figure 4.7 Nav1.6 cluster length is decreased in hippocampus of aged animals in 
response to hypoperfusion. Nav1.6 clusters bounded by the paranodal protein Caspr 
outline the node of Ranvier [A]. There is a significant decrease in the length [B & C] 
of the Nav1.6 clusters in both WT (p < 0.01) and TgAPPSw,Ind (p < 0.025) 
hypoperfused animals. No difference (p > 0.05) was observed between genotypes in 
the sham or the hypoperfused animals [D & E]. The lengths of thirty Nav1.6 clusters 
per animal were analysed and plotted as percentage of cumulative frequency 
distribution. WT sham: n=8, WT hypoperfused: n=9, TgAPPSw,Ind sham: n=8, 
TgAPPSw,Ind hypoperfused n=8. Scale bar 2 μm.  
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Figure 4.8 Nodal gap is decreased in the hippocampus of aged WT animals in 
response to hypoperfusion. A significant decrease (p < 0.01) in nodal gap length of 
WT animals in response to hypoperfusion was observed [A]. Nodal gap length was 
not different (p > 0.05) between sham and hypoperfused TgAPPSw,Ind animals [B] 
or between WT and TgAPPSw,Ind either in the sham or the hypoperfused animals [C 
& D]. The nodal gap lengths of thirty nodes per animal was analysed and plotted as 
percentage of cumulative frequency distribution. WT sham: n=8, WT hypoperfused: 
n=9, TgAPPSw,Ind sham: n=8, TgAPPSw,Ind hypoperfused n=8.  
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4.3.3 Number of nodes unchanged with hypoperfusion in the corpus 
callosum and the hippocampus of young and aged animals  
It was next determined whether the overall number of nodes of Ranvier may be 
changed with hypoperfusion or between genotypes in young and aged animals in the 
same regions where the nodal size was measured by stereologically counting the 
number of nodes in the same confocal stacks used for nodal measurements.  
In the young animals (Figure 4.9 A and B) there was no significant effect of 
genotype (corpus callosum: p = 0.6824, F (1-29) = 0.1708; hippocampus: p = 0.5931, F 
(1-29) = 0.2916) or surgery (corpus callosum: p = 0.1875, F (1-29) = 1.822; 
hippocampus: p = 0.1551, F (1-29) = 2.124) in the number of nodes in either of the 
examined regions.  
Similarly in the aged animals (Figure 4.9 C and D), no significant effect of genotype 
(corpus callosum: p = 0.3568, F (1-29) = 0.8768; hippocampus: p = 0.4999, F (1-29) = 
0.4660) or surgery (corpus callosum: p = 0.6404, F (1-29) = 0.2229; hippocampus: p = 
0.6659, F (1-29) = 0.1900) in the number of nodes in either region was observed. 
These findings indicate that hypoperfusion does not result in a change of the number 
of nodes of Ranvier.  
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Figure 4.9 No change of the number of nodes in response to hypoperfusion either 
in young or aged animals. The number of nodes was stereologically counted in 
47x47x5 μm
3
 confocal stacks of the corpus callosum and in 47x47x10 μm
3
 confocal 
stacks of stratum lacunosum moleculare of the hippocampus. In both regions no 
significant change (p > 0.05) in the nodal number was observed in response to 
hypoperfusion in either the young [A & B] or the aged animals [C &D].Young: WT 
sham: n=9, WT hypoperfused: n=8, TgAPPSw,Ind sham: n=8, TgAPPSw,Ind 
hypoperfused n=8; Aged: WT sham: n=8, WT hypoperfused: n=9, TgAPPSw,Ind 
sham: n=8, TgAPPSw,Ind hypoperfused n=8. Graphs show mean ± SEM. 
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4.3.4 Nav1.6 cluster length to nodal gap length ratio is altered 
suggesting paranodal disruption in the corpus callosum of young and 
aged animals 
Normally there is a well-defined spatial distribution of Caspr and Nav1.6 in the 
paranodes and the nodes of Ranvier respectively. Since the length of both the Nav1.6 
cluster and nodal gap was reduced in response to hypoperfusion, it was investigated 
whether this well-defined spatial relationship was maintained or whether this was 
also disrupted which would suggest paranodal disruption was further investigated. 
Nodal gap and Nav1.6 cluster lengths were measured on identical nodes in the young 
and old animals which allowed the ratio between the Nav1.6 cluster and nodal gap 
length to be calculated. This could serve as a measure of paranodal disruption and 
expansion of the Nav1.6 channels into the paranodal domain. Lower values would be 
representative of Nav1.6 clusters restricted in the nodes of Ranvier, while higher 
values would represent Nav1.6 clusters expanding into the paranodal domain.  
In the young animals, the values for the Nav1.6 cluster to nodal gap length ratio were 
plotted as relative frequency graphs and the distribution of the ratio values was 
examined. It was shown that in response to hypoperfusion there is a significant shift 
of the ratio such that there is higher Nav1.6 clusters to nodal gap length ratio in 
hypoperfused mice as compared to sham. This indicates that that there are more 
nodes where there is greater expansion of the Nav1.6 channels into the paranodal 
domains. This observation occurs in both the wild-type (p < 0.01, D = 0.1474, Figure 
4.10 A,) and the TgAPPSw,Ind hypoperfused animals (p < 0.0001, D = 0.3181, 
Figure 4.10 B) compared to sham. There was no significant difference between the 
sham wild-types and TgAPPSw,Ind (p = 0.372, D = 0.0803, Figure 4.10 C,) mice. 
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However, it was shown that in response to hypoperfusion the shift towards higher 
Nav1.6 cluster to nodal gap length ratio was significantly greater in the 
TgAPPSw,Ind compared to the wild-type mice (p < 0.001, D = 0.1725, Figure 4.10 
D,), suggesting that the there is greater expansion of the Nav1.6 channels into the 
paranodal domains in the APPSw,Ind hypoperfused animals compared to the wild-
type hypoperfused mice.  
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Figure 4.10 Expansion of the Nav1.6 cluster into the paranodal domain in 
response to hypoperfusion exacerbated in TgAPPSw,Ind mice in the corpus 
callosum of young animals. The Nav1.6 cluster to nodal gap length ratio was used as 
a measure of paranodal disruption and expansion of the Nav1.6 cluster into the 
paranodal domain. There is a significant increase in the ratio [A-B] of both WT (p < 
0.01) and TgAPPSw,Ind (p < 0.0001) hypoperfused animals which is exacerbated in 
the hypoperfused TgAPPSw,Ind animals (p < 0.01) [D]. No difference (p > 0.05) 
was observed between genotypes in the sham animals [C]. Nav1.6 cluster and nodal 
gap length was measured on 30 identical nodes for each animal and the ratio of 
Nav1.6 cluster to nodal gap length was plotted as distribution of percentage of 
relative frequencies. WT sham: n=9, WT hypoperfused: n=8, TgAPPSw,Ind sham: 
n=8, TgAPPSw,Ind hypoperfused n=8.   
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Similarly, in the aged animals, it was shown that in response to hypoperfusion there 
is a shift in the Nav1.6 cluster to nodal gap length ratio towards higher values in both 
the wild-type (p < 0.0001, D = 0.2375, Figure 4.11 A) and TgAPPSw,Ind mice (p < 
0.01, D = 0.1509, Figure 4.11 B) compared to sham. This again suggests that Nav1.6 
channels expand into the paranodal domains with hypoperfusion in aged animals 
similarly to the young mice. However, there was no significant difference in the 
Nav1.6 cluster to nodal gap length ratio between the sham wild-type and 
TgAPPSw,Ind mice (p = 0.889, D = 0.0509, Figure 4.11 C) or between hypoperfused 
wild-type and TgAPPSw,Ind (p = 0.059, D = 0.1238, Figure 4.11 D). 
These findings suggest that although the nodes of Ranvier are shortened in response 
to hypoperfusion the well-defined spatial distribution between the nodal Nav1.6 
channels and the paranodal Caspr is disrupted. The Nav1.6 channels are expanded 
into the Caspr domain indicating a level of paranodal disruption. This is observed in 
young and aged wild-type animals and TgAPPSw,Ind animals; however, in the 
young TgAPPSw,Ind mice this phenotype is exacerbated compared to wild-type 
hypoperfused mice.   
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Figure 4.11 Expansion of the Nav1.6 channels into the paranodal domains in 
response to hypoperfusion in the corpus callosum of aged animals. Nav1.6 cluster 
to nodal gap length was calculated as a measure of paranodal disruption and 
expansion of the Nav1.6 channels into the paranodal domain There is a significant 
increase in the Nav1.6 cluster to nodal gap length ratio [A-B] in both WT (p < 
0.0001) and TgAPPSw,Ind (p < 0.01) hypoperfused animals. No difference (p > 
0.05) was observed between genotypes in either the sham animals or the 
hypoperfused [C-D]. Nav1.6 cluster and nodal gap length was measured on 30 
identical nodes for each animal and the ratio of Nav1.6 cluster to nodal gap length 
was plotted as distribution of percentage of relative frequencies. WT sham: n=8, WT 
hypoperfused: n=9, TgAPPSw,Ind sham: n=8, TgAPPSw,Ind hypoperfused n=8.  
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4.3.5 No altered distribution of juxtaparanodal Kv1.2 channels in 
response to hypoperfusion  
The previous work indicated that cerebral hypoperfusion induced paranodal 
disruption since Nav1.6 normally contained within the nodes overlapped with Caspr 
in paranodes. To further investigate paranodal disruption the distribution of the 
juxtaparanodal Kv1.2 channels was investigated by examining the percentage volume 
of Caspr immunolabeled paranodes that is occupied by Kv1.2 channels in a 
43.5x43.5x5 μm
3
 confocal stack imaged at corpus callosum of young and old, sham 
and hypoperfused, wild-type and APPSw,Ind mutant mice.  
However the data indicated that hypoperfusion does not result in expansion of Kv1.2 
channels into the paranodal area in either the young of the aged animals. In the 
young animals [Figure 4.12 A & B], there was no significant effect of genotype (p = 
0.5750, F (1-31) = 0.3211) or surgery (F (1-31) = 0.6127, p = 0.4397) in the percentage 
volume of Caspr immunolabeled paranodes occupied by Kv1.2 channels. Moreover, 
there was no interaction between age and genotype (F (1-31) = 0.4957, p = 0.4866). 
Similarly in the aged animals [Figure 4.12 C & D] there was no significant effect of 
genotype (F (1-31) = 0.0704, p = 0.7925) or surgery (F (1-31) = 0.1182, p = 0.7333) in 
the percentage volume of CASPR immunolabeled paranodes occupied by Kv1.2 
channels. Moreover, there was no interaction overall between age and genotype (F (1-
31) = 0.5037, p = 0.4832).   
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Figure 4.12 No evidence of altered Kv1.2 distribution in response to hypoperfusion 
in young or aged animals. Representative images of Caspr (green) and Kv1.2 (red) 
double immunostaining [A & C]. No change (p > 0.05) in [%] volume of Caspr 
positive domains that are colocalised with Kv1.2 was observed in either the young or 
the aged animals [B & D]. Colocalisation was analysed in a 43.5x43.5x5 μm
3
 
confocal stack from the corpus callosum. Young: WT sham: n=9, WT hypoperfused: 
n=8, TgAPPSw,Ind sham: n=9, TgAPPSw,Ind hypoperfused n=9; Aged: WT sham: 
n=9, WT hypoperfused: n=9, TgAPPSw,Ind sham: n=8, TgAPPSw,Ind hypoperfused 
n=9.Graphs show mean ± SEM. Scale bar 2μm  
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4.3.6 No evidence of gross myelin or axonal alterations in response to 
hypoperfusion in young animals  
White matter damage is closely related to both cerebral hypoperfusion and AD. In 
addition, myelin loss has been suggested to be implicated in the disruption of the 
protein architecture at the nodes of Ranvier, therefore both components of the white 
matter, the myelin and the axons were investigated in the corpus callosum of young 
animals. Gross myelin alterations induced by hypoperfusion were examined in 
corpus callosum using immunolabelling for MBP in young wild-type and 
TgAPPSw,Ind animals. The percentage area occupied by MBP was assessed (Figure 
4.13 A-D). It was shown that neither hypoperfusion (p = 0.6214, F (1-43) = 0.2476) 
nor genotype (p = 0.6601, F (1-43) = 0.1961) had a significant effect on the percentage 
area occupied by MBP (Figure 4.13 E). In addition, gross changes in axonal integrity 
in response to hypoperfusion were examined at the same area using immunolabelling 
for total neurofilament (SMI312) (Figure 4.14 A-D). There was no significant effect 
of hypoperfusion (p = 0.0587, F (1-43) = 3.758) or genotype (p = 0.3829, F (1-43) = 
0.7761) on the percentage area occupied by total-neurofilament (Figure 4.14 E). This 
finding suggests that no gross alterations in myelin or axonal integrity are induced by 




Figure 4.13 No myelin alterations in response to hypoperfusion in the corpus 
callosum of young animals. Gross myelin integrity was assessed in the corpus 
callosum using an anti-MBP antibody [A-D]. Analysis of the [%] area of MBP 
staining did not show any significant (p > 0.05) effect of hypoperfusion or genotype 
[E]. WT sham: n=10, WT hypoperfused: n=12, TgAPPSw,Ind sham: n=13, 
TgAPPSw,Ind hypoperfused n=10.Scale bar 50 μm. Graphs show mean ± SEM.  
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Figure 4.14 No axonal alterations in response to hypoperfusion in the corpus 
callosum of young animals. Axonal pathology was assessed in the corpus callosum 
using an anti-total neurofilament antibody (SMI312). Analysis of the [%] area of 
total neurofilament staining did not show in the young [A-E] or the aged [F-J] 
animals any significant effect of hypoperfusion in either genotypes (p > 0.05). WT 
sham: n=10, WT hypoperfused: n=12, TgAPPSw,Ind sham: n=13, TgAPPSw,Ind 
hypoperfused n=10. Scale bar 50 μm. Graphs show mean ± SEM.  
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4.3.7 No evidence of gross myelin or axonal alterations in response to 
hypoperfusion in aged animals  
Gross myelin and axonal alterations induced by hypoperfusion were also examined 
in corpus callosum of aged wild-type and TgAPPSw,Ind animals. The percentage 
area occupied by MBP was assessed. It was demonstrated that neither hypoperfusion 
(p = 0.4565, F (1-43) = 0.5647) nor genotype (p = 0.0831, F (1-45) = 3.148) have a 
significant effect on the percentage area occupied by MBP (Figure 4.15 E). In 
addition, gross changes in axonal integrity in response to hypoperfusion were 
examined at the same area using immunolabelling for total neurofilament (SMI312) 
(Figure 4.16 A-D). There was no significant effect of hypoperfusion (p = 0.8101, F 
(1-43) = 0.05846) or genotype (p = 0.7288, F (1-43) = 0.1218) on the percentage area 
occupied by total-neurofilament. This finding suggests that no gross alterations in 
myelin or axonal integrity are induced by hypoperfusion in the corpus callosum of 
aged wild-type and TgAPPSw,Ind animals.  
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Figure 4.15 No myelin alterations in response to hypoperfusion in the corpus 
callosum of aged animals. Gross myelin integrity was assessed in the corpus 
callosum using an anti MBP antibody [A-D]. Analysis of the [%] area of MBP 
staining did not show any significant (p > 0.05) effect of hypoperfusion or genotype 
[E]. WT sham: n=11, WT hypoperfused: n=13, TgAPPSw,Ind sham: n=11, 
TgAPPSw,Ind hypoperfused n=12. Scale bar 50 μm. Graphs show mean ± SEM.  
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Figure 4.16 No axonal alterations in response to hypoperfusion in the corpus 
callosum of aged animals. Gross axonal integrity was assessed in the corpus 
callosum using an anti-total neurofilament antibody (SMI312) [A-D]. Analysis of the 
[%] area of MBP staining did not show any significant change (p > 0.05) in response 
to hypoperfusion or genotype [E]. WT sham: n=11, WT hypoperfused: n=13, 
TgAPPSw,Ind sham: n=11, TgAPPSw,Ind hypoperfused n=12. Scale bar 50 μm. 
Graphs show mean ± SEM.  
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4.3.8 Myelin basic protein and neurofilament levels are not changed in 
response to hypoperfusion in young and aged animals 
To further confirm that there is no overall change to the protein levels of myelin and 
axonal markers in response to hypoperfusion, the levels of myelin basic protein 
(MBP), total neurofilament and heavy neurofilament (NF-H, 200 KDa) were 
examined in the tissue homogenates of young and old TgAPPSw,Ind and wild-type 
hypoperfused mice with western blotting. Western blotting for MBP showed four 
bands at 21.5, 18.5, 17 and 14 KDa All four bands were quantified. Western blotting 
for total neurofilament and NF-H showed bands at 200 KDa which were quantified.  
In the young animals (Figure 4.17 A) no significant change in the protein levels of 
MBP, total neurofilament or NF-H in response to hypoperfusion (MBP: p = 0.5223, 
F(1-48) = 0.413; total neurofilament: p = 0.7662, F(1-49) = 0.0894; NF-H: p = 0.6835, 
F(1-48) = 0.1683) or between the different genotypes (MBP: p = 0.9019, F(1-48) = 
0.0153; total neurofilament: p = 0.4084,F(1-49) = 0.0954; NF-H: p = 0.2742, F(1-48) = 
1.223) was observed (Figure 4.17 B-D).  
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Figure 4.17 No change in the protein levels of myelin basic protein, total 
neurofilament and neurofilament 200 KDa in young animals. Total levels of MBP, 
total neurofilament (SMI312) and NF200 were assessed in tissue homogenates of 
young animals using western blotting [A]. There is no significant (p > 0.05) effect of 
hypoperfusion or genotype in the levels of MBP [B], total neurofilament [C] or 
NF200 [D]. Graphs show mean ± SEM.  
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Similarly in the aged animals the levels of MBP, total neurofilament and NF-H 
(Figure 4.18 A) were not significantly different in response to hypoperfusion (MBP: 
p = 0.1609, F(1-47) = 0.2029; total neurofilament: p = 0.8354,F(1-48) = 0.0436; NF-H: 
p = 0.9256, F(1-48) = 0.0088) between the different genotypes (MBP: p = 0.2656, F(1-
47) = 0.1.269; total neurofilament: p = 0.9747; F(1-48) = 0.0010; NF-H: p = 0.7585; 
F(1-48) = 0.0955) (Figure 4.18 B-D)  
These finding combined with those described in the previous chapter suggest that 
there are no changes in either the protein levels or the pattern of staining of myelin 
basic protein and neurofilament in response to hypoperfusion.  
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Figure 4.18 No change in the protein levels of myelin basic protein, total 
neurofilament and neurofilament 200 KDa in aged animals. Total levels of MBP, 
total neurofilament (SMI312) and NF200 were assessed in tissue homogenates using 
western blotting [A]. In the aged animals there was no significant effect of 
hypoperfusion or genotype (p > 0.05) in the levels of MBP [B], total neurofilament 
[C] or NF200 [D]. Graphs show mean ± SEM.  
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4.3.9 Human Aβ42 levels change in response to hypoperfusion in young 
but not aged TgAPPSw,Ind  
Some the observed changes in response to hypoperfusion described in this chapter 
are indicated to be exacerbated in the TgAPPSw,Ind animals which may reflect 
changes in the Aβ levels. To examine this, the levels of hAβ42 were examined in 
tissue homogenates of young and aged hypoperfused TgAPPSw,Ind animals.  
Interestingly in the young animals, chronic cerebral hypoperfusion significantly 
reduced hAβ2 levels in the TgAPPSw,Ind animals (p = 0.0145, │t│= 2.665, Figure 
4.19 A) as compared to sham animals.  
In the aged animals, however, there was no significant change in the levels of hAβ2 
in response to hypoperfusion in the aged TgAPPSw,Ind mice (p = 0.570, │t│= 
0.5759, Figure 4.19 B) as compared to sham. 
These finding suggest that cerebral hypoperfusion affects the levels of Aβ42 in the 
brain of young but not aged TgAPPSw,Ind animals.  
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Figure 4.19 Human Aβ42 levels are reduced in response to hypoperfusion in 
young but not aged TgAPPSw,Ind mice. Human Aβ42 levels detected with ELISA 
are significantly reduced (p < 0.01) in young TgAPPSw,Ind animals [A]. No 
significant (p > 0.05) change is detected in the aged TgAPPSw,Ind hypoperfused 
animals [B]. Young: TgAPPSw,Ind sham: n=13, TgAPPSw,Ind hypoperfused n=10; 
Aged: TgAPPSw,Ind sham: n=11, TgAPPSw,Ind hypoperfused n=15. Graphs show 
mean ± SEM.  
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4.3.10 Levels of APP and APP processing products unchanged with 
hypoperfusion 
Amyloid precursor protein and the C-terminal products, C83 and C99, of the 
amyloidogenic and non-amyloidogenic processing of APP were quantified in brain 
tissue homogenates in order to investigate whether total APP levels of APP-
processing are altered in response to hypoperfusion. Western blotting for APP in the 
TgAPPSw,Ind mice showed a triple band around 100 KDa detecting both mouse and 
human APP, while in the wild-type animals; it showed only one band around 100 
KDa. C83 and C99 are C-terminal fragments deriving from the proteolytic 
processing of the APP through the non-amyloidogenic and the amyloidogenic 
pathway respectively. Western blotting for C-terminal fragments showed a C83 band 
at 9 KDa and C99 at 11 KDa (Figure 4.20 A and 4.21 A). 
In the young TgAPPSw,Ind animals, there is a significant increase overall in APP 
levels (p < 0.0001, F(1-49) = 228.3) compared to wild-type (Figure 4.20 B). However, 
it was shown that hypoperfusion did not have any overall effect on APP expression 
levels (p = 0.0997, F(1-49) = 2.816). Post-hoc analysis showed that both in young 
hypoperfused and sham TgAPPSw,Ind mice, APP levels are significantly higher 
compared to young hypoperfused (p < 0.001, │t│= 10.55) and sham (p < 0.001, 
│t│= 10.82) wild-types. Moreover, there is a significant overall increase in the levels 
of C83 (, p < 0.0001, F(1-48) = 48.04) and C99 (p < 0.0001, F(1-49) = 27.06) fragments 
in the TgAPPSw,Ind mice compared to wild-type (Figure 4.20 C and D). However, 
hypoperfusion did not have any overall effect on C83 (p = 0.1515, F(1-49) = 2.124) or 
C99 (p = 0.2656, F(1-49) = 1.257) expression levels. Post-hoc analysis showed that in 
young hypoperfused and in young sham TgAPPSw,Ind mice C83 and C99 levels are 
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significantly higher when compared to young hypoperfused (for C83: p < 0.001, 
│t│= 5.543; for C99: p < 0.001, │t│= 4.285) and young sham (for C83: p < 0.001, 
│t│= 4.285; for C99: p < 0.01, │t│= 3.144) wild-types respectively.   
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Figure 4.20 APP protein levels and APP processing unchanged with 
hypoperfusion in young animals. Full length APP and the C-terminal products, C83 
and C99, of the amyloidogenic and non-amyloidogenic processing of APP were 
detected with western blotting [A]. There was a significant increase (p < 0.0001) 
overall in the levels of full length APP, C83 and C99 in the TgAPPSw,Ind animals 
compared to wild-types, but no change (p < 0.05) in response to hypoperfusion in the 
levels of APP, C83 or C99 was observed. Graphs show mean ± SEM.  
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Similarly, in the aged TgAPPSw,Ind mice APP levels (Figure 4.21 B) were overall 
increased compared to wild-type animals (p < 0.0001, F(1-48) = 222.2). However, it 
was shown that hypoperfusion did not change overall APP levels (p = 0.2783, F(1-48) 
= 1.203). Post-hoc analysis for the aged animals showed that in both the 
hypoperfused and the sham TgAPPSw,Ind mice APP expression levels are 
significantly increased compared to young hypoperfused (p < 0.001, │t│= 10.64) 
and sham (p < 0.001, │t│= 10.48) wild-types. In addition, a significant increase 
overall in the levels of C83 (p < 0.0001, F(1-49) = 57.05) and C99 (p < 0.0001, F(1-49) = 
41.69) fragments compared to wild-type animals was observed (Figure 4.21 C and 
D). However, hypoperfusion did not have any overall effect on C83 (p = 0.1515, F(1-
49) = 0.3842) or C99 (p = 0.3113, F(1-49) = 1.047,) expression levels (Figure 4.2 E & 
G). Post-hoc analysis showed that in aged hypoperfused and in aged sham 
TgAPPSw,Ind mice C83 and C99 levels are significantly higher when compared to 
young hypoperfused (for C83: p < 0.001, │t│= 6.092; for C99: p < 0.001, │t│= 
4.934) and aged sham (for C83: p < 0.001, │t│= 4.707; for C99: p < 0.001, │t│= 
4.262) wild-types respectively. 
These findings suggest that hypoperfusion does not alter APP levels or APP 
processing and not surprisingly the introduction of the APP transgene in the 
TgAPPSw,Ind increases the levels of full length APP and APP processing products.   
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Figure 4.21 APP protein levels and APP processing unchanged with 
hypoperfusion in aged animals. Full length APP and the C-terminal products, C83 
and C99, of the amyloidogenic and non-amyloidogenic processing of APP were 
detected with western blotting [A]. There was a significant increase (p < 0.0001) 
overall in the levels of full length APP, C83 and C99 in the TgAPPSw,Ind animals 
compared to wild-types, but no change (p < 0.05) in response to hypoperfusion in the 
levels of APP, C83 or C99 was observed. Graphs show mean ± SEM.  
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4.3.11 Impairment of spatial working memory in response to 
hypoperfusion in young animals 
Hypoperfusion is suggested to affect spatial working memory, thus this effect may be 
exacerbated in the TgAPPSw,Ind animals. To investigate that, spatial working 
memory performance was examined in response to hypoperfusion in young wild-
type and TgAPPSw,Ind mice.  
Spatial working memory performance was assessed by measuring the number of 
revisiting errors in the 8-arm radial arm maze. Over the 16-day training period (trial 
block 1-8) the number of errors made by the animals was reduced (F (5.4, 235) = 5.569; 
p < 0.001) which indicated that the mice were able to learn the task (Figure 4.22). 
There was also a significant main effect of hypoperfusion with hypoperfused mice 
making more revisiting errors than the shams (p < 0.001, F (1, 43) = 26.172) 
demonstrating that hypoperfusion impairs working memory performance (Figure 
4.22 A and B). In addition, there was also significant interaction between the 
different genotype and surgery condition over trial blocks (p = 0.02, F (5.4, 235.9) = 
2.645) which may indicate that the effect of hypoperfusion on spatial working 
memory is different between wild-type and TgAPPSw,Ind mice.  
Moreover, memory acquisition was examined by calculating the gradient of the line 
generated between the numbers of errors in block 1 to block 8. Each group yielded 
the following acquisition slopes WT sham: -0.452 ± 0.253, WT hypoperfused: -1.5 ± 
0.424, TgAPPSw,Ind sham: -1.093 ± 0.279 and TgAPPSw,Ind hypoperfused: 0.193 
± 0.281 where greater negative values are indicative of good memory acquisition 
ability and values greater or equal to zero suggest that the animals do not improve 
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their performance over time. Analysis showed a significant interaction between 
genotype and hypoperfusion (p = 0.001, F (1, 43) = 13.216) suggesting that the deficit 
induced by hypoperfusion differently affects wild-type and APPSw,Ind mice. Indeed, 
there was a significant difference in the acquisition rate between hypoperfused wild-
type and TgAPPSw,Ind (p < 0.01, │t│= 3.610), with the TgAPPSw,Ind 
hypoperfused mice showing slower memory acquisition (Figure 4.22 D). In addition, 
no difference in the acquisition rate was observed between the two genotypes under 
sham conditions (p > 0.05, │t│= 1.462) (Figure 4.22 C). 
These finding suggest that hypoperfusion impairs spatial working memory in both 




Figure 4.22 Spatial working memory impairment induced by hypoperfusion is 
exacerbated in young TgAPPSw,Ind mice. Hypoperfused mice make significantly 
more revisiting errors than the sham mice (p<0.05) [A & B]. There is no difference 
between the genotypes under sham conditions [C] TgAPPSw,Ind hypoperfused mice 
showing significantly (p < 0.01) slower memory acquisition than the WT [D]. WT 
sham: n=12, WT hypoperfused: n=12, TgAPPSw,Ind sham: n=13, TgAPPSw,Ind 
hypoperfused n=10. Data presented in two-trial blocks. Graphs show mean ± SEM.  
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4.3.12 Impairment of spatial working memory in response to 
hypoperfusion in aged animals 
Spatial working memory was next examined in aged wild-type and TgAPPSw,Ind 
and in response to hypoperfusion. 
Over the 16-day training period (trial block 1-8) the number of errors made by the 
animals was reduced (F (5.29, 259.3) = 8.058; p < 0.001) which indicated that the mice 
were able to learn the task (Figure 4.23). There was also a significant main effect of 
hypoperfusion with hypoperfused mice making more revisiting errors than the shams 
(p < 0.001, F (1, 49) = 21.549) demonstrating that hypoperfusion impairs working 
memory performance (Figure 4.23 A and B). Moreover, memory acquisition was 
also examined. Each group yielded the following acquisition slopes: WT sham: -
0.887 ± 0.292, WT hypoperfused: -1 ± 0.25, APPSw,Ind sham: -0.195 ± 0.332 and 
TgAPPSw,Ind hypoperfused: -0.305 ± 0.274, however no difference (p > 0.05) in the 
performance of the two genotypes either under sham or hypoperfused conditions 
(Figure 4.23 C-D) was revealed. 
These findings indicate that in both aged wild-type and TgAPPSw,Ind mice 
hypoperfusion results in an impairment in spatial working memory. This impairment 
was severe, with both genotypes being poorly able to improve their performance and 
as a result it was similarly affected in both wild-type and TgAPPSw,Ind mice.  
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Figure 4.23 Spatial working memory impairment induced by hypoperfusion is 
exacerbated in aged TgAPPSw,Ind mice. Hypoperfused mice make significantly 
more revisiting errors than the sham mice (p<0.05) [A & B]. There is no difference 
between the genotypes under sham conditions [C] TgAPPSw,Ind hypoperfused mice 
made the same number of errors compared to WT [D]. WT sham: n=14, WT 
hypoperfused: n=12, TgAPPSw,Ind sham: n=11, TgAPPSw,Ind hypoperfused n=15. 
Data presented in two-trial blocks. Graphs show mean ± SEM.  
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4.3.13 Impairment of spatial working memory associated with nodal 
alterations in aged animals 
It is indicated here that hypoperfusion affects working memory in the eight-arm 
radial arm maze and causes alterations at the nodal/paranodal regions of the 
myelinated axons. These regions are important for saltatory conduction hence 
effective for neural function. Therefore it may be suggested that alterations to 
paranodal integrity are associated with spatial working memory performance  
To investigate that, in the aged animals, where spatial working memory performance 
was investigated in the same cohort, the association between the number of revisiting 
errors at trial block 8 with the average Nav1.6 cluster to nodal gap length ratio was 
determined. A significant correlation between spatial working memory impairment 
and paranodal disruption was found (Figure 4.24), indicating that the animals which 
make more errors are more likely to have higher Nav1.6 cluster to nodal gap length 
ratio (r = 0.3833, p = 0.0303), hence greater expansion of the Nav1.6 cluster into the 
paranodal domain. This data provides a link between nodal alterations and cognitive 
performance. Unfortunately, the same association was not possible in the young 
animals as different cohorts of animals were used the evaluation of working memory 
performance and nodal integrity.   
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Figure 4.24 Working memory performance correlates with Nav1.6 cluster to nodal 
gap ratio. Plotting the number of revisiting errors at trial block 8 with the average 
Nav1.6 cluster: nodal gap ratio revealed a significant correlation (p < 0.05) indicating 
a link between nodal alterations and cognitive deficits.  
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4.3.14 Summary of results 
The following table (Table 4.3) summarises the findings described in the present 
chapter 








↓ with hypoperfusion (both WT and APPSw,Ind) 
↓ in APPSw,Ind hypoperfused compared to WT hypoperfused  





↓ with hypoperfusion (both WT and APPSw,Ind) 
↓ in APPSw,Ind hypoperfused compared to WT hypoperfused 
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MBP (% area) 
Y ↓ in aged WT compared to young 
A  
Nav1.6 cluster 
to nodal gap 
length ratio 
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↑ with hypoperfusion (both WT and APPSw,Ind) 
↑ in APPSw,Ind hypoperfused compared to WT hypoperfused 













Y ↓ (in APPSw,Ind) 
A ↔ 






↑ in APPSw,Ind compare to WT 
↔ in response to hypoperfusion 
A 
↑ in APPSw,Ind compare to WT 








↑ number of revisiting errors in response to hypoperfusion 
(both WT and APPSw,Ind) 
WT hypoperfused perform better than the APPSw,Ind 
hypoperfused perform (fail to improve) 
A 
↑ number of revisiting errors in response to hypoperfusion 
(both WT and APPSw,Ind) 





Disruption of myelinated axons within the brain’s white matter in ageing and 
Alzheimer’s disease is associated with cerebral hypoperfusion (Fernando et al., 2006; 
Scheltens et al., 1995; Ruitenberg et al., 2005). This study sought to investigate the 
effects of cerebral hypoperfusion in specialized regions of myelinated axons, the 
nodes of Ranvier and the paranodes. This study demonstrated that these regions are 
vulnerable to the effects of hypoperfusion. A decrease in nodal length is observed 
and the well-defined spatial organization of Nav1.6 channels in the Caspr positive 
paranodes is disrupted in response to hypoperfusion in young and aged animals. This 
effect was shown to be exacerbated in the young TgAPPSw,Ind animals. Moreover, 
the disruption of the nodal domain was shown to occur without any gross alterations 
in myelin integrity or change in nodal density. It was also demonstrated that in 
response to hypoperfusion, spatial working memory performance is defected in 
young and aged animals whilst this deficit is exacerbated in young TgAPPSw,Ind 
animals. Interestingly, working memory performance was associated with nodal 
integrity. 
In support of this study, other work has shown that these regions within the 
myelinated axons are vulnerable to the effect of ageing. As discussed in Chapter 3, a 
decrease Nav1.6 cluster and nodal gap length was observed in the stratum lacunosum 
moleculare of the hippocampus in aged animals. Moreover, reduction in the length of 
the Nav cluster at the nodes has also been observed in the optic nerve of 2 year old 
wild-type mice (Rios et al., 2003). In contrast to the present study, previous work in 
our lab investigating the length of the Nav1.6 cluster in the same model of cerebral 
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hypoperfusion demonstrated increased nodal length after three and 30 days of 
hypoperfusion (Reimer et al., 2011). There are several explanations to account for 
these differences. Firstly, the duration of hypoperfusion is different between the two 
studies, here the alterations in nodal size were observed after 8 weeks of 
hypoperfusion. Secondly, only the distribution of Nav1.6 channels was examined by 
Reimer et al. (2011) whilst it is not known if the nodal gap also increased. Moreover, 
both studies are snapshots of the nodal integrity at specific time points which may be 
representative of a progressive pathology at the nodes induced by hypoperfusion over 
time. To further investigate that, nodal integrity could be examined at multiple time 
points after the induction of hypoperfusion which would provide information about 
the time course of nodal alterations. 
In the CNS after injury, the remyelinated axons are associated with a decrease in the 
length of internodes and a subsequent increase in nodal density (Powers et al., 2012). 
To determine whether there may be remyelination in the present study, the number of 
nodes was investigated. Hypoperfusion, however, did not appear to have an effect on 
the number of nodes in either the young or the aged animals suggesting that 
remyelination might not be responsible for the observed changes. However, in order 
to investigate myelin in further detail, ultrastructural analysis of the myelinated 
axons using electron microscopy may be helpful as new remyelinated axons appear 
to have thinner myelin sheaths (Patrikios et al., 2006; Peters and Sethares, 2003).  
Alternatively, the observed reduction in the size of the nodes could be attributed to a 
loss of Nav1.6 channels or a failure of Nav1.6 to anchor to the nodal region. In 
support of this, there is evidence that different Nav channels are down-regulated with 
ischemia or injury (Berta et al., 2008; Yao et al., 2005) whilst after stroke there is an 
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elevation of the βΙV spectrin and AnkG calpain-mediated proteolytic products 
(Schafer et al 2009). For example, Berta et al. (2008) showed in a rat model of spared 
nerve injury that the levels of Nav1.6 mRNA transcripts are reduced. Reduction in 
multiple Nav1 mRNA transcripts has also been observed in rat models of ischaemic 
brain injury (Yao et al., 2002; Yao et al., 2005). Furthermore, Schafer et al. (2009) 
showed in a mouse model of stroke an increase in AnkG and βIV spectrin proteolysis 
at the site of injury. These proteins are responsible for Nav channel anchoring to the 
nodal plasma membrane (Yang et al., 2007; Gasser et al., 2012) and their ablation 
results in abnormally formed nodes of Ranvier (Yang et al., 2004; Dzhashiashvili et 
al., 2007). Nevertheless, further investigation of the mechanisms underlying the 
observed changes would include the assessment of levels of Nav1.6 channels or 
calpain mediated proteolytic products.  
Paranodal integrity is crucial for the clustering of Nav1.6 channels at the nodes of 
Ranvier. Paranodal septate-like junctions act as a diffusion barrier by restricting the 
Nav.16 channels at the nodal region (Rios et al., 2003). Cerebral hypoperfusion was 
demonstrated here to have an effect on paranodal integrity. It was shown that the 
Nav1.6 cluster to nodal gap length ratio, used as a measure of paranodal disruption 
and expansion of the Nav1.6 channels into the paranodal domain, is increased in the 
hypoperfused animals. Paranodal disruption in response to hypoperfusion, ageing 
and disease has been previously described. For example, 30 days after the induction 
of hypoperfusion in our group using the same model provided evidence of axon-glial 
disruption resulting in an increase in the Nav1.6 cluster length. This was 
accomplished by a loss of septate-like junctions in the paranodes and a loss of the 
paranodal protein NF155 (Reimer et al., 2011). In addition, ageing affects the 
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number of septate-like junctions in aged rodents. Investigation at ultrastructural level 
showed that in 22 month old mice the number of paranodes with decreased number 
of paranodal loops contacting the axolemma, or with lost septate-like junctions was 
increased (Shepherd et al., 2012). Similarly, in aged rats loss of septate-like junctions 
(Sugiyama et al., 2002) at the paranodes was observed. In both cases, however, some 
intact paranodal junctions were preserved. In human patients of demyelinating 
diseases such as multiple sclerosis as well as in animal models there has also been 
evidence of paranodal disruption. For example, Howell et al. (2006) demonstrated 
that in brain demyelinating lesions the pattern of NF155 distribution at the paranodes 
is altered and there is an increased overlap between the paranodal NF155 and the 
juxtaparanodal Kv1.2 which is indicative of paranodal disruption. Similarly, in a rat 
model of dysmyelination, the expression profile of juxtaparanodal Kv1.2 altered, 
expanding into the paranodal region (Arroyo et al., 2002). In the present study, 
despite the observed alterations in Nav1.6 and Caspr overlay indicative of paranodal 
disruption, there was no alteration in the distribution of the juxtaparanodal Kv1.2 
channels within the Caspr positive paranodal domain in response to hypoperfusion. 
A possible explanation for this could be that although the septate-like junctions of the 
paranodes that act as diffusion barriers Nav1.6 of the nodes of Ranvier may be 
disrupted, they might not be completely ablated conserving, similarly to what is 
observed in normal ageing (Shepherd et al., 2012), their role as diffusion barriers for 
the Kv1.2 channels of the juxtaparanodes. However, the approach used here is limited 
to an evaluation of the space of Caspr positive domain that is occupied by Kv1.2 
channels and does not take how dense the Kv1.2 protein was into account. These 
findings suggest that the observed changes in response to hypoperfusion are different 
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from those in demyelinating diseases. The changes in response to cerebral 
hypoperfusion appear to affect the nodal and paranodal regions rather than the Kv1.2 
distribution. To further confirm paranodal disruption, ultrastructural investigation of 
septate-like junction integrity at the paranodes would be useful to provide further 
evidence of paranodal disruption. 
In addition, absence of demyelination and axonal damage was confirmed with the 
assessment of expression levels and pattern of cellular distribution of myelin basic 
protein and neurofilament. No axonal damage or myelin loss in response to 
hypoperfusion was found which is in accordance with previous studies in our lab 
using the same model which used immunohistochemical and neuroimaging (MRI) 
approaches for evaluating myelin and axonal integrity (Reimer et al., 2011; Holland 
et al., 2011). However, the use of MBP and neurofilament is limited to a gross 
assessment of myelin integrity as other myelin and/or axonal components may be 
altered and the use of other markers would be more likely to detect alterations if any. 
For example, other studies using the same model in our lab, have indicated that 
hypoperfusion may affect axon-glial cross-talk detected by alterations in myelin 
associated glycoprotein (MAG) immunostaining (Reimer et al., 2011; Holland et al., 
2011) and sometimes in the absence of alterations in MBP or neurofilament levels or 
staining (Reimer et al., 2011). In addition, a recent study by Funfschilling et al. 
(2012) showed that oligodendrocytes may use glycolytic metabolism as an 
alternative source for the maintenance of myelin and axonal integrity which if true 
makes the oligodendrocytes and subsequently myelin and axonal integrity more 
tolerant to the energy deprivation induced by hypoperfusion. To further investigate 
myelin integrity, the use of specific markers for myelin damage, such as an anti-
 201 
damaged MBP antibody specific for pathological epitopes of MBP (Ihara et al., 
2010) or axon-glial integrity such as MAG may be helpful. Axonal integrity may 
also be further investigated with the use of markers specific for neurofilament 
phosphorylation which may serve as a marker of axonal injury (Petzold et al., 2011; 
Singh et al., 2011).  
At the onset of this study it was hypothesised that age exacerbates the effects of 
hypoperfusion. In support of this, it was demonstrated that in the young animals only 
the corpus callosum is affected whilst in the aged animals the nodes of both the 
corpus callosum and the hippocampus are affected. Previous studies using this 
cerebral hypoperfusion model in young animals have shown that it selectively 
induces diffuse white matter pathology (Shibata et al 2004; Coltman et al 2011). One 
explanation is that CBF may be compromised in the ageing brain. The white matter 
constitutes a vascular end zone (Borch et al., 2010) rendering it more sensitive to 
blood flow fluctuations and vascular insults such as those induced by hypoperfusion. 
At the same time, there is evidence that cerebral blood flow is attenuated by normal 
ageing (Park et al., 2007) which with the additional challenge induced by the 
hypoperfusion could result in greater blood flow alterations. However, blood flow 
measurements were not assessed in the present study which would securely estimate 
the nature of flood flow attenuation in young and aged animals.  
Another goal of this study was to assess nodal and paranodal integrity in a mouse 
model (TgAPPSw,Ind) which develops increased deposition of amyloid with age and 
the alterations at nodes and paranodes may be exacerbated. In confirmation of our 
hypotheses we showed that in young TgAPPSw,Ind hypoperfused mice the length of 
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the nodes of Ranvier is significantly decreased whilst the Nav1.6 cluster to nodal gap 
ratio is significantly increased compared to the wild type hypoperfused animals. 
These results suggest that there is an exacerbation of the effects of hypoperfusion 
(i.e. paranodal disruption and shorter nodes) in the TgAPPSw,Ind animals. There is a 
limited number of studies investigating components of the nodes of Ranvier in AD. 
In another AD model (3xTg) with overt amyloid pathology Nav1.6 immunoreactivity 
was decreased in the mutant animals (Desai et al., 2009). Similarly in the J20 line of 
the TgAPPSw,Ind, which develops Aβ pathology earlier than the J9 line that was 
used in the present study, Nav1.6 protein levels are reduced (Verret et al., 2012). 
Moreover, there is some evidence that that BACE1, a proteolytic enzymatic complex 
implicated in the amyloidogenic processing of APP, regulates voltage gated sodium 
channels (Kovacs et al., 2010). Kim et al. (2007) demonstrated that increased 
BACE1 protein levels result in reduced Nav1α subunit recruitment to the cell surface 
and marked reduction in sodium current examined with electrophysiology.  
The observed exacerbation in the changes induced by hypoperfusion at the nodes in 
the TgAPPSw,Ind animals could be the result of an additional vascular insult to an 
already compromised system. In support of this are studies which show that cerebral 
vasculature and cerebral blood flow are altered in animal models that develop Aβ 
pathology when compared with wild-type mice. For example, in a mouse model 
(APP23, 10 months of age), examination of the 3D vascular architecture showed 
pronounced alterations such as vessel deformation and elimination (Beckmann et al., 
2003). Similarly, in a study investigating multiple models overexpressing mutant 
human APP at a relatively young age, it was demonstrated that vascular 
autoregulation was disrupted and associated with Αβ levels (Niwa et al., 2002a). 
 203 
Interestingly, the difference in nodal length observed between young TgAPPSw,Ind 
and wild-type mice in response to hypoperfusion was not maintained in ageing. One 
explanation could be that there is a limit by which the length can be reduced with 
hypoperfusion and with ageing this could have been reached.  
A few studies have investigated the impact of hypoperfusion in transgenic mouse 
models overexpressing human mutant APP to determine whether hypoperfusion 
increases Aβ levels and deposition. However the findings have been conflicting 
(Kitaguchi et al., 2009; Yamada et al., 2011; Lee et al., 2011; Koike et al., 2010). 
Here it was demonstrated that the levels of human Aβ42 are reduced in young 
hypoperfused TgAPPSw,Ind mice whist they are unchanged in aged animals. 
Moreover, the levels of APP and C-terminal fragments from the non- and 
amyloidogenic processing of APP remain unchanged in response to hypoperfusion. 
In contrast to the present study, Kitaguchi et al. (2009) using the same transgenic 
model  showed a significant increase in perinuclear Aβ42 immunostaining in neurons 
and an increase in the levels of fibrilar but not monomeric Αβ after one month of 
cerebral hypoperfusion. In another APP mutant model (3xTg) at a relatively young 
age, where blood flow was interrupted by occlusion of the common carotid arteries 
for 4 minutes, there was an increase in the levels of soluble and insoluble Αβ42 and 
the levels of C-terminal proteolytic products of APP without any change in APP 
levels in response to oligemia (Koike et al., 2010). Furthermore, Yamada et al. 
(2011) showed that for TgAPPSw,Ind mice (J20), after 6 months of hypoperfusion, 
soluble Aβ is increased whilst the deposition of Aβ42 is decreased in the 
hippocampus but not the cortex. In addition, in Tg2576 mice amyloid plaque 
pathology was not affected by hypoperfusion (Lee et al 2011). There are several 
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explanations to account for these differences. Firstly, the protein extraction technique 
used in the present study did not include extended centrifuging or the use of 
detergents such as formic acid. These procedures allow the separation of soluble and 
insoluble fraction and the disassociation and the insoluble Aβ aggregates. The 
method used here allowed the detection of only soluble Aβ which may be decreased 
if hypoperfusion induces insoluble Aβ deposition in the young animals. Secondly, 
there are several differences in the methods used to induce hypoperfusion and 
measure amyloid: the stage of amyloid pathology development at the onset of 
hypoperfusion together with underlying differences due to genetic strain which may 
contribute to the different outcomes of hypoperfusion on amyloid pathology in these 
studies. 
Attenuation of white matter in humans has been linked with poor working memory 
performance (Appelman et al., 2010; Kennedy and Raz, 2009). At the same time 
previous studies have shown that hypoperfusion results in poor performance in the 8-
arm radial arm maze task (Coltman et al., 2011; Shibata et al., 2004) which is a well-
established method to examine working memory in rodents (Cole and Chappell-
Stephenson, 2003; Olton and Samuelson, 1976; Hyde et al., 1998). We have 
confirmed that working memory performance assessed in the 8-arm radial arm maze 
is impaired with hypoperfusion in young wild-type mice. In addition, working 
memory impairment is exacerbated in the young TgAPPSw,Ind animals when 
compared to young wild-type mice in response to hypoperfusion. However, these 
effects were not observed in the aged animals, as both the hypoperfused wild-type 
and TgAPPSw,Ind mice were unable to perform well at the task. This suggests that 
cerebral hypoperfusion combined with the additional challenge of age, results in such 
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a deficit in working memory performance that does not decipher between the two 
genotypes. A possible explanation for these finding could lie in the anatomical basis 
of spatial working memory in rodents which is dependent on multiple brain regions 
such as the hippocampus, the parahippocampus and the prefrontal cortex (Hodges 
(Hodges, 1996; Shaw and Aggleton, 1993) and requires their effective 
communication. In the present study the nodal/paranodal changes observed in 
response to hypoperfusion were more extensive in the aged animals with both the 
corpus callosum and the hippocampus being affected whilst in the young animals 
changes were observed in only the corpus callosum. This difference between young 
and aged animals may be responsible for the observed behavioural changes. 
Changes at the nodes and paranodes may result in functional alterations that could be 
responsible for the observed spatial working memory deficit in response to 
hypoperfusion. To further investigate that working memory performance was 
associated with the nodal changes and a strong association was revealed between the 
numbers of errors in the 8-arm radial arm maze task and the Nav1.6 cluster to nodal 
ratio which is a measure of paranodal disruption. This finding suggests that 
alterations to the nodes of Ranvier and paranodes induced by hypoperfusion may 
impede action potential propagation and lead to defective communication between 
brain regions impacting cognition. In support of this, Nie et al. (2006) showed that 
decrease in nodal length and decrease in the Nav1α subunit resulted in decreased 
conduction velocity of action potentials. Additionally, it has been demonstrated that a 
working memory deficit in the T maze is linked with a reduction in action potential 
velocity (Tanaka et al., 2009). Furthermore a rat model of demyelination of the PNS 
was demonstrated to have reduced Nav channel density at the nodes, which was 
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associated with slower action potential conduction (Lonigro and Devaux, 2009). 
Similarly, in a mouse model where Caspr is ablated, which develops paranodes 
without septate-like junctions, action potential velocity is reduced (Boyle et al., 
2001). Moreover, Huff et al. (2011) showed that in spinal cord white matter, high 
frequency stimulation results in retraction of myelin from the paranodes suggesting 
that they can undergo activity-dependent alterations in the paranodes. Moreover, a 
study in an AD transgenic model, (TgAPPSw,Ind, J20 line ) that develops spatial 
learning and memory deficits in the Morris water maze and has decreased protein 
levels of Nav channels, showed that induction of the Nav1.1 expression can improve 
cognitive performance to the level of the wild-types (Verret et al 2012). Although 
there is evidence that nodal alterations are linked with altered action potential 
conduction and cognitive performance, investigation of these aspects on the same 
cohort of hypoperfused animals would provide confirmation of their association. 
This could be achieved with use of the developed system of in vivo recording in 
freely behaving animals (Lin et al., 2006; Ye et al., 2008) which would provide 
information on neural activity as the animals are performing in cognitive tasks with 
neuropathological analysis to follow. 
The question that needs to be answered, however, is how hypoperfusion drives the 
observed changes at the nodes of Ranvier and subsequently working memory in the 
wild-type animals and why these are exacerbated in the young but not the aged 
TgAPPSw,Ind mice. Firstly, there is evidence from studies in our lab that 
hypoperfusion alters the numbers of mature oligodendrocytes and the pool of 
oligodendrocyte precursor cells (McQueen et al, submitted) suggesting that the 
vascular insult affects the survival of oligodendrocytes. This is further supported by 
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studies using a rat model of chronic cerebral hypoperfusion where seven days after 
the induction of hypoperfusion the number of oligodendroglia decreased (Tomimoto 
et al., 2003). Given that nodal assembly and maintenance is under glial control 
(Mathis et al., 2001; Boiko et al., 2003) alterations in the oligodendroglial cell 
number may have an impact on nodal integrity. The oligovascular niche has been 
proposed as a model by which cross-talk occurs between the oligodendrocytes and 
the vascular elements and thus is necessary for maintaining the integrity and 
homeostasis of the white matter (Arai and Lo, 2009). From studies in our lab, the 
vasculature appears to be affected in response to hypoperfusion with the vessels 
increasing in width, suggesting vascular dysfunction (Dr G. Scullion, unpublished 
data). Furthermore, there is evidence that the oligodendrocytes are susceptible to 
oxidative stress and inflammatory signalling (Balabanov et al., 2007; Cammer and 
Zhang, 1999; Deng et al., 2004; French et al., 2009) which are suggested to be up-
regulated by hypoperfusion (Kasparova et al., 2005; Wang et al., 2010). Oxidative 
stress has been directly linked with paranodal abnormalities in the rat optic nerve 
(Szymanski et al., 2013) and mitochondrial dysfunction (Lin and Beal, 2006). 
Mitochondria are distributed along the axons and serve the metabolic demands of the 
distinct regions (Zhang et al., 2010a; Chiu, 2011) which suggests that the 
deterioration of mitochondrial metabolic capacity may affect nodal and paranodal 
integrity as they are regions with high metabolic demands. In addition, microglia 
have been demonstrated to be activated in response to hypoperfusion (Shibata et al., 
2004; Holland et al., 2011) and have been implicated in paranodal disruption in a 
mouse model of experimental autoimmune encephalomyelitis (EAE) (Howell et al., 
2010). Additionally, analysis of gene expression in response to hypoperfusion has 
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pointed out multiple altered genes implicated in inflammation, vasculature, and cell-
adhesion (Reimer et al., 2011) suggesting that there are multiple mechanisms 
involved in the mechanisms of damage driven by hypoperfusion.  
In the young TgAPPSw,Ind mice the effects of hypoperfusion are exacerbated. A 
possible explanation for this is the baseline difference between TgAPPSw,Ind and 
wild type mice in the vascular structure i.e. larger size vessels (Dr G Scullion, 
unpublished data) which may potentially result in baseline CBF differences between 
the two genotypes and subsequently to the effects of hypoperfusion. Additionally, 
there is evidence that transgenic models overexpressing hAPP are more susceptible 
to ischemic injury (Zhang et al., 1997) which is potentially mediated by increased 
microglial activation (Koistinaho et al., 2002). Moreover, as described earlier 
processes such as oxidative stress and mitochondrial dysfunction may be implicated 
in nodal and paranodal integrity and there are several studies that have demonstrated 
that these processes are upregulated both in humans and in AD models (Markesbery, 
1997; Korolainen et al., 2006; Dumont et al., 2010; Zhu et al., 2004; Aliev et al., 
2004; Aliev et al., 2003). Another potential mechanism implicated in nodal 
alterations could be the down-regulation of voltage gated sodium channels mediated 
by BACE1. BACE1 levels and activity are elevated in AD both in humans and 
animal models (Heneka et al., 2005; Corbett et al., 2013; Fukumoto et al., 2002). In 
animal models, cognitive performance and defective neuronal activity is associated 
with reduced recruitment of Nav1.1 channels at the membranes (Kim et al., 2007; 
Corbett et al., 2013). This suggests that Nav channel dysregulation may be a potential 
mechanism for neuronal network dysfunction observed in AD (Bakker et al., 2012 
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(Bakker et al., 2012; Verret et al., 2012; Sanchez et al., 2012); Sanchez et al., 2012; 
Verret et al., 2012).  
In conclusion, this study highlights the vulnerability of specific molecular domains 
(nodes and paranodes) within myelinated axons to the effects of hypoperfusion 
which may be associated with a deficit cognitive performance. In the future it would 
be interesting to investigate how the alterations at the nodes and paranodes affect 
neuronal excitability using electrophysiology and also to identify the molecular 







The studies described within the thesis indicate the vulnerability of specialised 
regions within myelinated axons to ageing, cerebral hypoperfusion and to a lesser 
extent levels of amyloid. Importantly, breakdown of the nodal/paranodal regions is 
associated with working memory impairment. These findings may have implications 
for the development of strategies aimed to ameliorate cognitive impairment observed 
in ageing and AD. 
 
5.2 Vulnerability of the AIS and nodes of Ranvier  
Studying the effects of normal ageing, cerebral hypoperfusion or increasing Aβ 
levels on brain function in humans is highly complicated as they coexist with each 
other and/or other comorbidities. Therefore, the utilization of animal models is 
helpful because it allows the investigation of these pathological processes in 
isolation, under controlled conditions and the least possible genetic variability, and 
facilitates the unraveling of mechanisms that may drive changes in brain function.  
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As discussed in chapter 3 cerebral hypoperfusion was suggested to underlie the 
changes observed in normal ageing. In the cerebral hypoperfusion model used in the 
second study, one month after induction of hypoperfusion, CBF is reduced by 10-
15% of the baseline (Shibata et al., 2004) which is comparable to the modest blood 
flow reduction observed in normal ageing where CBF is reduced by ~20% between 
the age of 20 and 60 years (Leenders et al., 1990). The effects of hypoperfusion on 
nodal integrity were examined in isolation and in relation with increased Aβ levels in 
young and aged animals. It was demonstrated that hypoperfusion induces age-related 
changes to the nodes by reducing their size and producing disruption at the 
paranodes, which was associated with the severity of the spatial working memory 
deficit. Similarly to ageing, these changes are occurring without overt myelin loss 
suggesting that they are an early event in pathology progression and possibly a 
therapeutic target. Furthermore, both the disruption at the nodes and cognitive 
decline were exacerbated in the young TgAPPSw,Ind animals. As discussed in 
chapter 4 this difference may be due to intrinsic changes in the vasculature between 
the wild-type and the TgAPPSw,Ind mice (Dr G. Scullion, unpublished data) which 
may induce a greater reduction in CBF. However, when ageing is combined with 
hypoperfusion nodal integrity in more regions is affected and the effects on nodal 
integrity and cognition are independent of the genotype. These findings indicate the 
susceptibility of the ageing brain and the necessity for early interventions against the 
effects of hypoperfusion.  
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5.3 Repairing the nodes of Ranvier 
Currently, there are not any therapeutic strategies that specifically repair the nodes of 
Ranvier. The majority of the strategies that examine nodal repair are investigated in 
the context of demyelination in diseases such as the leukodystrophies, where 
demyelination has a genetic basis, or diseases such as multiple sclerosis where 
autoimmunity is responsible (Franklin and Ffrench-Constant, 2008). In these 
diseases, damage at the oligodendrocytes is usually responsible for demyelination 
(Franklin and Ffrench-Constant, 2008). Therefore, the research on the development 
of therapeutic approaches focuses on restoring the integrity of the myelinated axons 
both structurally and functionally in a process known as remyelination (Smith et al., 
1979). The two main strategies followed are cell therapy which includes the 
transplantation of stem cells that would differentiate into myelinating 
oligodendrocytes, and promotion of myelination by the endogenous population of 
OPCs, and both have shown positive results. For example, Sasaki et al. (2006) 
showed, in demyelinating lesions of rat spinal cord, repair of the molecular 
architecture of the nodes of Ranvier in remyelinated mediated fibres after 
transplantation with olfactory ensheathing cells. Moreover, administration of the 
leukaemia inhibitory factor (LIF) results in the activation of OPCs and subsequent 
remyelination (Deverman and Patterson, 2012).  
The studies presented in this thesis do not suggest that demyelination is occurring in 
response to ageing or cerebral hypoperfusion. However, it has been proposed that a 
cross-talk between the oligodendrocytes and vascular elements is necessary for 
maintaining the integrity and homeostasis of the white matter (Arai and Lo, 2009). 
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Therefore, strategies that focus on the restoration of oligodendroglial function may 
be relevant.  
There is also evidence that the oligodendrocytes are susceptible to oxidative stress 
and inflammation (Balabanov et al., 2007; Cammer and Zhang, 1999; Deng et al., 
2004; French et al., 2009) which are suggested to be up-regulated by normal ageing, 
hypoperfusion and AD (Kasparova et al., 2005; Wang et al., 2010). Oxidative stress 
and microglial activation have been directly linked with paranodal abnormalities 
(Szymanski et al., 2013; Howell et al., 2010) which suggests that the use of 
antioxidant or anti-inflammatory agents may attenuate the damage at the nodal 
region. Indeed, administration of a known antioxidant (Vitamin E) prevents 
paranodal disruption in a rat of diabetic peripheral neuropathy (Algaidi, 2011) whilst 
administration of anti-inflammatory agents such as ibuprofen attenuates white matter 
damage after ischemia (Carty et al., 2011). Furthermore, administration of 
edaravone, which is an antioxidant that scavenges free radicals, attenuates white 
matter damage by reducing the loss of oligodendrocytes and demyelination in a rat 
model of chronic cerebral hypoperfusion (Ueno et al., 2009). In the same model, 
treatment with gypenosive, a compound with anti-inflammatory and antioxidant 
effects, is shown to decrease vacuolation and demyelination of the corpus callosum 
(Zhang et al., 2011).  
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5.4 Attenuating cerebral hypoperfusion 
Chronic cerebral hypoperfusion occurs in normal ageing (Stoquart-ElSankari et al., 
2007) and is further exacerbated in the presence of vascular risk factors (Leenders et 
al., 1990). The effect of chronic hypoperfusion is the deprivation of the brain from 
the necessary energy and metabolites for brain function (Leenders et al., 1990) 
resulting in white matter damage and changes in cognition which may further 
develop to dementia (Pantoni, 2002; Appelman et al., 2010). However, cerebral 
hypoperfusion is observed prior to the development of any clinical symptoms of 
cognitive decline (de la Torre, 2009) indicating that that there is a window for 
intervention after hypoperfusion is first observed and before cognition is impaired. 
The data presented in this thesis also highlight the importance of hypoperfusion in 
the development of white matter alteration - particularly within the excitable regions 
of the myelinated axons - and cognition, and also indicate that increasing age may 
render the brain more susceptible to its detrimental effects.  
The development of strategies to prevent, delay or attenuate hypoperfusion becomes 
necessary for prolonging cognitively healthy ageing. This may be achieved by the 
accurate diagnosis of the vascular risk factors underlying hypoperfusion and by 
applying the appropriate therapeutic strategies to ameliorate them. Jack de la Torre 
(2010) proposes a series of screens for the identification of individuals at risk. The 
primary screen includes low-cost, simple, and non-invasive procedures such as 
ultrasounds, blood tests and physical examination which will highlight any potential 
risk factor. The secondary screen includes neuroimaging, cognitive tests and 
biomarkers of cerebrospinal fluid (CSF) which would determine the white matter 
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damage and the extent of cognitive decline. Accurate detection of the risk factors 
may promote healthy ageing as a number of them are modifiable by either a change 
in lifestyle or commonly available drug treatments. For example, lifestyle changes 
could include a shift towards a healthy diet, low alcohol consumption and increased 
exercise (Pope et al., 2003), whilst diabetes mellitus, hypercholesterolemia and 
hypertension could be treated with insulin therapy, statins and angiotensin converting 
enzyme (ACE) inhibitors respectively (Rockwood et al., 1997).  
Furthermore, studies in animal models have indicated pharmacological compounds 
that attenuate hypoperfusion and its effects, such as white matter damage or 
cognitive decline. For example, Maki et al. (2011) demonstrated in a mouse model of 
chronic cerebral hypoperfusion that treatment with andromedullin attenuated the 
induced hypoperfusion, induces angiogenesis and conserved white matter integrity 
and cognition. Moreover, treatment with nimodipine, a dihydropyridine which is a 
calcium entry blocker specific for cerebral vasculature, after ischemic injury may 
ameliorate cerebral blood flow by reversing cerebral vasoconstriction (Milde et al., 
1986). However, further investigation is necessary in order to utilise these 
compounds as a therapeutic strategy for hypoperfusion.   
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5.5 Future studies 
In the future, further investigation could strengthen and expand the observations 
presented in this thesis in an effort to identify the molecular mechanism underlying 
structural alterations and also to specify the implication of Aβ in these mechanisms. 
For example, computational modeling (Baalman et al., 2013) of the observed 
alterations at the nodes of Ranvier and/or the AIS would offer some information 
about specific alterations in the size of the AIS and the nodes similar to those 
induced by ageing and hypoperfusion are affecting the firing properties of the 
neurons. In a more detailed approach, electrophysiological examination of firing 
properties of the axons at the same regions where pathological alterations at the 
nodes or the AIS are observed in animals that have developed cognitive deficit would 
provide the necessary link between pathological alterations, altered signal conduction 
and cognition. 
To further identify the nature of the alterations at the myelinated axons as well as the 
mechanisms responsible, further investigation would be necessary. Detailed 
ultrastructural analysis of myelinated axons using transmission electron microscopy 
(Shepherd et al., 2012) could provide evidence for structural alterations in the myelin 
sheath such as ballooning, decompaction and thinning, and in the paranodal junction 
(loss of septate-like junction, paranodal loops pilling or disconnection from the 
axolemma) as well as an estimation of changes in number of myelinated or 
unmyelinated axons. Other hypoperfusion studies (Coltman et al., 2011; Holland et 
al., 2011; Reimer et al., 2011) have highlighted MAG to be a sensitive marker of 
axon-glial disruption in response to hypoperfusion, therefore, examining its protein 
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levels and cellular distribution would provide additional evidence for myelin 
disruption. Additionally, down-regulation or proteolytic processing of components of 
the nodes of Ranvier of the AIS could be confirmed with western blot analysis. In 
order to gain further insight on the relevance of AD and Aβ pathology in the 
observed changes, the effect of specific Aβ species on the structure of AIS and the 
nodes of Ranvier as well as neuronal excitability could be investigated in vitro in 
combined neuronal and glial cultures. Finally, cerebral blood flow measurements in 
aged and in TgAPPSw,Ind animals would be helpful for examining whether there are 




The data presented in this thesis indicate the necessity for developing strategies to 
minimize injury at the nodes of Ranvier and drive their repair. In order to be 
successful it is necessary to ensure that the nodes are formed properly and 
maintained. Moreover, the importance of therapeutic approaches against the vascular 
insults that induce hypoperfusion and lead to white matter attenuation and cognitive 
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Appendix A1 Intensity of MBP and total neurofilament staining in the stratum 
lacunosum moleculare of the hippocampus. [A] There was a significant overall 
effect of age in intensity of MBP staining (2-way ANOVA: genotype*age; p < 0.05). 
Post-hoc testing showed that MBP intensity was significantly reduced (p < 0.05) in 
aged WT when compared to young WT mice. There was no significant difference (p 
> 0.05) in myelin density with increased amyloid in old APPSw,Ind as compared to 
young APPSw,Ind [B] Analysis of total neurofilament intensity did not show any 




Appendix A2 Amyloid deposition in the stratum lacunosum moleculare of the 
hippocampus of TgAPPSw,Ind mice. Amyloid load in the stratum lacunosum 
moleculare hippocampus was assessed using 6E10 antibody in both WT [A & B] and 
TgAPPSw,Ind animals [C & D]. Aβ load (percentage area) in the hippocampus was 
significantly increased by age (p < 0.05) and by the TgAPPSw,Ind genotype (p < 
0.05). Post-hoc analysis showed that the aged TgAPPSw,Ind have significantly 
greater Aβ load in the stratum lacunosum moleculare when compared to young 
TgAPPSw,Ind (p < 0.01) and aged WT (p < 0.001). WT young: n=13, WT old: n=12 
TgAPPSw,Ind young: n=13, TgAPPSw,Ind old: n=15**: p < 0.01, ***: p < 0.001. 
Graphs show mean ± SEM. Scale bar 300μm.   
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